	PMCID	SENTENCE_NUM	SENTENCE_START	SENTENCE_END	WORD	POS_TAG	WORD_START	WORD_END	BIO_TAG	PMC_MENTION_ID	ONTOLOGY_CONCEPT_ID	ONTOLOGY_LABEL
0	11597317	11597317_0	0	167	BRCA2	NNP	0	5	B	['PR_reasoned_2017_04_17_Instance_28219']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1	11597317	11597317_0	0	167	and	CC	6	9	O	[None]	[None]	[None]
2	11597317	11597317_0	0	167	homologous	JJ	10	20	O	[None]	[None]	[None]
3	11597317	11597317_0	0	167	recombination	NN	21	34	O	[None]	[None]	[None]
4	11597317	11597317_0	0	167	Abstract	NNP	36	44	O	[None]	[None]	[None]
5	11597317	11597317_0	0	167	Two	CD	46	49	O	[None]	[None]	[None]
6	11597317	11597317_0	0	167	recent	JJ	50	56	O	[None]	[None]	[None]
7	11597317	11597317_0	0	167	papers	NNS	57	63	O	[None]	[None]	[None]
8	11597317	11597317_0	0	167	provide	VBP	64	71	O	[None]	[None]	[None]
9	11597317	11597317_0	0	167	new	JJ	72	75	O	[None]	[None]	[None]
10	11597317	11597317_0	0	167	evidence	NN	76	84	O	[None]	[None]	[None]
11	11597317	11597317_0	0	167	relevant	NN	85	93	O	[None]	[None]	[None]
12	11597317	11597317_0	0	167	to	TO	94	96	O	[None]	[None]	[None]
13	11597317	11597317_0	0	167	the	DT	97	100	O	[None]	[None]	[None]
14	11597317	11597317_0	0	167	role	NN	101	105	O	[None]	[None]	[None]
15	11597317	11597317_0	0	167	of	IN	106	108	O	[None]	[None]	[None]
16	11597317	11597317_0	0	167	the	DT	109	112	O	[None]	[None]	[None]
17	11597317	11597317_0	0	167	breast	NN	113	119	O	[None]	[None]	[None]
18	11597317	11597317_0	0	167	cancer	NN	120	126	O	[None]	[None]	[None]
19	11597317	11597317_0	0	167	susceptibility	NN	127	141	O	[None]	[None]	[None]
20	11597317	11597317_0	0	167	gene	NN	142	146	O	[None]	[None]	[None]
21	11597317	11597317_0	0	167	BRCA2	NNP	147	152	B	['PR_reasoned_2017_04_17_Instance_30275']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
22	11597317	11597317_0	0	167	in	IN	153	155	O	[None]	[None]	[None]
23	11597317	11597317_0	0	167	DNA	NNP	156	159	O	[None]	[None]	[None]
24	11597317	11597317_0	0	167	repair	NN	160	166	O	[None]	[None]	[None]
25	11597317	11597317_0	0	167	.	.	166	167	O	[None]	[None]	[None]
26	11597317	11597317_1	168	314	Moynahan	NNP	168	176	O	[None]	[None]	[None]
27	11597317	11597317_1	168	314	et	CC	177	179	O	[None]	[None]	[None]
28	11597317	11597317_1	168	314	al	JJ	180	182	O	[None]	[None]	[None]
29	11597317	11597317_1	168	314	provide	VBP	183	190	O	[None]	[None]	[None]
30	11597317	11597317_1	168	314	genetic	JJ	191	198	O	[None]	[None]	[None]
31	11597317	11597317_1	168	314	data	NNS	199	203	O	[None]	[None]	[None]
32	11597317	11597317_1	168	314	indicating	VBG	204	214	O	[None]	[None]	[None]
33	11597317	11597317_1	168	314	a	DT	215	216	O	[None]	[None]	[None]
34	11597317	11597317_1	168	314	requirement	NN	217	228	O	[None]	[None]	[None]
35	11597317	11597317_1	168	314	for	IN	229	232	O	[None]	[None]	[None]
36	11597317	11597317_1	168	314	BRCA2	NNP	233	238	B	['PR_reasoned_2017_04_17_Instance_28241']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
37	11597317	11597317_1	168	314	in	IN	239	241	O	[None]	[None]	[None]
38	11597317	11597317_1	168	314	homology	NN	242	250	O	[None]	[None]	[None]
39	11597317	11597317_1	168	314	-	:	250	251	O	[None]	[None]	[None]
40	11597317	11597317_1	168	314	dependent	NN	251	260	O	[None]	[None]	[None]
41	11597317	11597317_1	168	314	(	(	261	262	O	[None]	[None]	[None]
42	11597317	11597317_1	168	314	recombinational	JJ	262	277	O	[None]	[None]	[None]
43	11597317	11597317_1	168	314	)	)	277	278	O	[None]	[None]	[None]
44	11597317	11597317_1	168	314	repair	NN	279	285	O	[None]	[None]	[None]
45	11597317	11597317_1	168	314	of	IN	286	288	O	[None]	[None]	[None]
46	11597317	11597317_1	168	314	DNA	NNP	289	292	O	[None]	[None]	[None]
47	11597317	11597317_1	168	314	double	JJ	293	299	O	[None]	[None]	[None]
48	11597317	11597317_1	168	314	-	:	299	300	O	[None]	[None]	[None]
49	11597317	11597317_1	168	314	strand	NN	300	306	O	[None]	[None]	[None]
50	11597317	11597317_1	168	314	breaks	NNS	307	313	O	[None]	[None]	[None]
51	11597317	11597317_1	168	314	.	.	313	314	O	[None]	[None]	[None]
52	11597317	11597317_2	315	451	The	DT	315	318	O	[None]	[None]	[None]
53	11597317	11597317_2	315	451	second	JJ	319	325	O	[None]	[None]	[None]
54	11597317	11597317_2	315	451	paper	NN	326	331	O	[None]	[None]	[None]
55	11597317	11597317_2	315	451	,	,	331	332	O	[None]	[None]	[None]
56	11597317	11597317_2	315	451	by	IN	333	335	O	[None]	[None]	[None]
57	11597317	11597317_2	315	451	Davies	NNP	336	342	O	[None]	[None]	[None]
58	11597317	11597317_2	315	451	et	FW	343	345	O	[None]	[None]	[None]
59	11597317	11597317_2	315	451	al	NN	346	348	O	[None]	[None]	[None]
60	11597317	11597317_2	315	451	,	,	348	349	O	[None]	[None]	[None]
61	11597317	11597317_2	315	451	begins	VBZ	350	356	O	[None]	[None]	[None]
62	11597317	11597317_2	315	451	to	TO	357	359	O	[None]	[None]	[None]
63	11597317	11597317_2	315	451	address	VB	360	367	O	[None]	[None]	[None]
64	11597317	11597317_2	315	451	the	DT	368	371	O	[None]	[None]	[None]
65	11597317	11597317_2	315	451	mechanism	NN	372	381	O	[None]	[None]	[None]
66	11597317	11597317_2	315	451	through	IN	382	389	O	[None]	[None]	[None]
67	11597317	11597317_2	315	451	which	WDT	390	395	O	[None]	[None]	[None]
68	11597317	11597317_2	315	451	BRCA2	NNP	396	401	B	['PR_reasoned_2017_04_17_Instance_28263']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
69	11597317	11597317_2	315	451	makes	VBZ	402	407	O	[None]	[None]	[None]
70	11597317	11597317_2	315	451	its	PRP$	408	411	O	[None]	[None]	[None]
71	11597317	11597317_2	315	451	contribution	NN	412	424	O	[None]	[None]	[None]
72	11597317	11597317_2	315	451	to	TO	425	427	O	[None]	[None]	[None]
73	11597317	11597317_2	315	451	recombinational	JJ	428	443	O	[None]	[None]	[None]
74	11597317	11597317_2	315	451	repair	NN	444	450	O	[None]	[None]	[None]
75	11597317	11597317_2	315	451	.	.	450	451	O	[None]	[None]	[None]
76	11597317	11597317_3	452	564	BRCA2	NNP	452	457	B	['PR_reasoned_2017_04_17_Instance_28285']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
77	11597317	11597317_3	452	564	appears	VBZ	458	465	O	[None]	[None]	[None]
78	11597317	11597317_3	452	564	to	TO	466	468	O	[None]	[None]	[None]
79	11597317	11597317_3	452	564	function	VB	469	477	O	[None]	[None]	[None]
80	11597317	11597317_3	452	564	in	IN	478	480	O	[None]	[None]	[None]
81	11597317	11597317_3	452	564	recombination	NN	481	494	O	[None]	[None]	[None]
82	11597317	11597317_3	452	564	via	IN	495	498	O	[None]	[None]	[None]
83	11597317	11597317_3	452	564	interactions	NNS	499	511	O	[None]	[None]	[None]
84	11597317	11597317_3	452	564	with	IN	512	516	O	[None]	[None]	[None]
85	11597317	11597317_3	452	564	the	DT	517	520	O	[None]	[None]	[None]
86	11597317	11597317_3	452	564	major	JJ	521	526	O	[None]	[None]	[None]
87	11597317	11597317_3	452	564	eukaryotic	JJ	527	537	O	[None]	[None]	[None]
88	11597317	11597317_3	452	564	recombinase	NN	538	549	O	[None]	[None]	[None]
89	11597317	11597317_3	452	564	RAD51	NNP	550	555	B	['PR_reasoned_2017_04_17_Instance_28327']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
90	11597317	11597317_3	452	564	[	NNP	556	557	O	[None]	[None]	[None]
91	11597317	11597317_3	452	564	1	CD	557	558	O	[None]	[None]	[None]
92	11597317	11597317_3	452	564	,	,	558	559	O	[None]	[None]	[None]
93	11597317	11597317_3	452	564	2	CD	559	560	O	[None]	[None]	[None]
94	11597317	11597317_3	452	564	,	,	560	561	O	[None]	[None]	[None]
95	11597317	11597317_3	452	564	3	CD	561	562	O	[None]	[None]	[None]
96	11597317	11597317_3	452	564	].	NN	562	564	O	[None]	[None]	[None]
97	11597317	11597317_4	565	764	We	PRP	565	567	O	[None]	[None]	[None]
98	11597317	11597317_4	565	764	briefly	VBP	568	575	O	[None]	[None]	[None]
99	11597317	11597317_4	565	764	review	VB	576	582	O	[None]	[None]	[None]
100	11597317	11597317_4	565	764	the	DT	583	586	O	[None]	[None]	[None]
101	11597317	11597317_4	565	764	context	NN	587	594	O	[None]	[None]	[None]
102	11597317	11597317_4	565	764	in	IN	595	597	O	[None]	[None]	[None]
103	11597317	11597317_4	565	764	which	WDT	598	603	O	[None]	[None]	[None]
104	11597317	11597317_4	565	764	the	DT	604	607	O	[None]	[None]	[None]
105	11597317	11597317_4	565	764	two	CD	608	611	O	[None]	[None]	[None]
106	11597317	11597317_4	565	764	studies	NNS	612	619	O	[None]	[None]	[None]
107	11597317	11597317_4	565	764	were	VBD	620	624	O	[None]	[None]	[None]
108	11597317	11597317_4	565	764	carried	VBN	625	632	O	[None]	[None]	[None]
109	11597317	11597317_4	565	764	out	RP	633	636	O	[None]	[None]	[None]
110	11597317	11597317_4	565	764	,	,	636	637	O	[None]	[None]	[None]
111	11597317	11597317_4	565	764	we	PRP	638	640	O	[None]	[None]	[None]
112	11597317	11597317_4	565	764	comment	VBP	641	648	O	[None]	[None]	[None]
113	11597317	11597317_4	565	764	on	IN	649	651	O	[None]	[None]	[None]
114	11597317	11597317_4	565	764	the	DT	652	655	O	[None]	[None]	[None]
115	11597317	11597317_4	565	764	results	NNS	656	663	O	[None]	[None]	[None]
116	11597317	11597317_4	565	764	presented	VBD	664	673	O	[None]	[None]	[None]
117	11597317	11597317_4	565	764	,	,	673	674	O	[None]	[None]	[None]
118	11597317	11597317_4	565	764	and	CC	675	678	O	[None]	[None]	[None]
119	11597317	11597317_4	565	764	we	PRP	679	681	O	[None]	[None]	[None]
120	11597317	11597317_4	565	764	discuss	VBP	682	689	O	[None]	[None]	[None]
121	11597317	11597317_4	565	764	models	NNS	690	696	O	[None]	[None]	[None]
122	11597317	11597317_4	565	764	designed	VBN	697	705	O	[None]	[None]	[None]
123	11597317	11597317_4	565	764	to	TO	706	708	O	[None]	[None]	[None]
124	11597317	11597317_4	565	764	account	VB	709	716	O	[None]	[None]	[None]
125	11597317	11597317_4	565	764	for	IN	717	720	O	[None]	[None]	[None]
126	11597317	11597317_4	565	764	the	DT	721	724	O	[None]	[None]	[None]
127	11597317	11597317_4	565	764	role	NN	725	729	O	[None]	[None]	[None]
128	11597317	11597317_4	565	764	of	IN	730	732	O	[None]	[None]	[None]
129	11597317	11597317_4	565	764	BRCA2	NNP	733	738	B	['PR_reasoned_2017_04_17_Instance_28307']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
130	11597317	11597317_4	565	764	in	IN	739	741	O	[None]	[None]	[None]
131	11597317	11597317_4	565	764	RAD51	NNP	742	747	B	['PR_reasoned_2017_04_17_Instance_28349']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
132	11597317	11597317_4	565	764	–	NNP	747	748	O	[None]	[None]	[None]
133	11597317	11597317_4	565	764	mediated	VBD	748	756	O	[None]	[None]	[None]
134	11597317	11597317_4	565	764	repair	NN	757	763	O	[None]	[None]	[None]
135	11597317	11597317_4	565	764	.	.	763	764	O	[None]	[None]	[None]
136	11597317	11597317_5	766	999	Keywords	NNS	766	774	O	[None]	[None]	[None]
137	11597317	11597317_5	766	999	:	:	774	775	O	[None]	[None]	[None]
138	11597317	11597317_5	766	999	breast	NN	776	782	O	[None]	[None]	[None]
139	11597317	11597317_5	766	999	cancer	NN	783	789	O	[None]	[None]	[None]
140	11597317	11597317_5	766	999	,	,	789	790	O	[None]	[None]	[None]
141	11597317	11597317_5	766	999	homologous	JJ	791	801	O	[None]	[None]	[None]
142	11597317	11597317_5	766	999	recombination	NN	802	815	O	[None]	[None]	[None]
143	11597317	11597317_5	766	999	BRCA2	NNP	817	822	B	['PR_reasoned_2017_04_17_Instance_30277']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
144	11597317	11597317_5	766	999	BRCA2	NNP	824	829	B	['PR_reasoned_2017_04_17_Instance_30279']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
145	11597317	11597317_5	766	999	was	VBD	830	833	O	[None]	[None]	[None]
146	11597317	11597317_5	766	999	the	DT	834	837	O	[None]	[None]	[None]
147	11597317	11597317_5	766	999	second	JJ	838	844	O	[None]	[None]	[None]
148	11597317	11597317_5	766	999	breast	NN	845	851	O	[None]	[None]	[None]
149	11597317	11597317_5	766	999	cancer	NN	852	858	O	[None]	[None]	[None]
150	11597317	11597317_5	766	999	susceptibility	NN	859	873	O	[None]	[None]	[None]
151	11597317	11597317_5	766	999	gene	NN	874	878	O	[None]	[None]	[None]
152	11597317	11597317_5	766	999	to	TO	879	881	O	[None]	[None]	[None]
153	11597317	11597317_5	766	999	be	VB	882	884	O	[None]	[None]	[None]
154	11597317	11597317_5	766	999	discovered	VBN	885	895	O	[None]	[None]	[None]
155	11597317	11597317_5	766	999	,	,	895	896	O	[None]	[None]	[None]
156	11597317	11597317_5	766	999	and	CC	897	900	O	[None]	[None]	[None]
157	11597317	11597317_5	766	999	was	VBD	901	904	O	[None]	[None]	[None]
158	11597317	11597317_5	766	999	isolated	VBN	905	913	O	[None]	[None]	[None]
159	11597317	11597317_5	766	999	through	IN	914	921	O	[None]	[None]	[None]
160	11597317	11597317_5	766	999	positional	JJ	922	932	O	[None]	[None]	[None]
161	11597317	11597317_5	766	999	cloning	NN	933	940	O	[None]	[None]	[None]
162	11597317	11597317_5	766	999	using	VBG	941	946	O	[None]	[None]	[None]
163	11597317	11597317_5	766	999	data	NNS	947	951	O	[None]	[None]	[None]
164	11597317	11597317_5	766	999	from	IN	952	956	O	[None]	[None]	[None]
165	11597317	11597317_5	766	999	families	NNS	957	965	O	[None]	[None]	[None]
166	11597317	11597317_5	766	999	with	IN	966	970	O	[None]	[None]	[None]
167	11597317	11597317_5	766	999	inherited	JJ	971	980	O	[None]	[None]	[None]
168	11597317	11597317_5	766	999	breast	NN	981	987	O	[None]	[None]	[None]
169	11597317	11597317_5	766	999	cancer	NN	988	994	O	[None]	[None]	[None]
170	11597317	11597317_5	766	999	[	VBZ	995	996	O	[None]	[None]	[None]
171	11597317	11597317_5	766	999	4	CD	996	997	O	[None]	[None]	[None]
172	11597317	11597317_5	766	999	].	NN	997	999	O	[None]	[None]	[None]
173	11597317	11597317_6	1000	1136	Cells	NNS	1000	1005	O	[None]	[None]	[None]
174	11597317	11597317_6	1000	1136	with	IN	1006	1010	O	[None]	[None]	[None]
175	11597317	11597317_6	1000	1136	mutant	JJ	1011	1017	O	[None]	[None]	[None]
176	11597317	11597317_6	1000	1136	BRCA2	NNP	1018	1023	B	['PR_reasoned_2017_04_17_Instance_28363']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
177	11597317	11597317_6	1000	1136	protein	NN	1024	1031	O	[None]	[None]	[None]
178	11597317	11597317_6	1000	1136	are	VBP	1032	1035	O	[None]	[None]	[None]
179	11597317	11597317_6	1000	1136	,	,	1035	1036	O	[None]	[None]	[None]
180	11597317	11597317_6	1000	1136	like	IN	1037	1041	O	[None]	[None]	[None]
181	11597317	11597317_6	1000	1136	many	JJ	1042	1046	O	[None]	[None]	[None]
182	11597317	11597317_6	1000	1136	cancer	NN	1047	1053	O	[None]	[None]	[None]
183	11597317	11597317_6	1000	1136	cells	NNS	1054	1059	O	[None]	[None]	[None]
184	11597317	11597317_6	1000	1136	,	,	1059	1060	O	[None]	[None]	[None]
185	11597317	11597317_6	1000	1136	genetically	RB	1061	1072	O	[None]	[None]	[None]
186	11597317	11597317_6	1000	1136	unstable	JJ	1073	1081	O	[None]	[None]	[None]
187	11597317	11597317_6	1000	1136	and	CC	1082	1085	O	[None]	[None]	[None]
188	11597317	11597317_6	1000	1136	accumulate	JJ	1086	1096	O	[None]	[None]	[None]
189	11597317	11597317_6	1000	1136	gross	JJ	1097	1102	O	[None]	[None]	[None]
190	11597317	11597317_6	1000	1136	chromosomal	NN	1103	1114	O	[None]	[None]	[None]
191	11597317	11597317_6	1000	1136	rearrangements	NNS	1115	1129	O	[None]	[None]	[None]
192	11597317	11597317_6	1000	1136	[	VBP	1130	1131	O	[None]	[None]	[None]
193	11597317	11597317_6	1000	1136	5	CD	1131	1132	O	[None]	[None]	[None]
194	11597317	11597317_6	1000	1136	,	,	1132	1133	O	[None]	[None]	[None]
195	11597317	11597317_6	1000	1136	6	CD	1133	1134	O	[None]	[None]	[None]
196	11597317	11597317_6	1000	1136	].	NN	1134	1136	O	[None]	[None]	[None]
197	11597317	11597317_7	1137	1383	The	DT	1137	1140	O	[None]	[None]	[None]
198	11597317	11597317_7	1137	1383	sequence	NN	1141	1149	O	[None]	[None]	[None]
199	11597317	11597317_7	1137	1383	of	IN	1150	1152	O	[None]	[None]	[None]
200	11597317	11597317_7	1137	1383	this	DT	1153	1157	O	[None]	[None]	[None]
201	11597317	11597317_7	1137	1383	large	JJ	1158	1163	O	[None]	[None]	[None]
202	11597317	11597317_7	1137	1383	protein	NN	1164	1171	O	[None]	[None]	[None]
203	11597317	11597317_7	1137	1383	(	(	1172	1173	O	[None]	[None]	[None]
204	11597317	11597317_7	1137	1383	3418	CD	1173	1177	O	[None]	[None]	[None]
205	11597317	11597317_7	1137	1383	amino	NN	1178	1183	O	[None]	[None]	[None]
206	11597317	11597317_7	1137	1383	acids	NNS	1184	1189	O	[None]	[None]	[None]
207	11597317	11597317_7	1137	1383	)	)	1189	1190	O	[None]	[None]	[None]
208	11597317	11597317_7	1137	1383	offers	VBZ	1191	1197	O	[None]	[None]	[None]
209	11597317	11597317_7	1137	1383	very	RB	1198	1202	O	[None]	[None]	[None]
210	11597317	11597317_7	1137	1383	little	JJ	1203	1209	O	[None]	[None]	[None]
211	11597317	11597317_7	1137	1383	clue	NN	1210	1214	O	[None]	[None]	[None]
212	11597317	11597317_7	1137	1383	to	TO	1215	1217	O	[None]	[None]	[None]
213	11597317	11597317_7	1137	1383	its	PRP$	1218	1221	O	[None]	[None]	[None]
214	11597317	11597317_7	1137	1383	function	NN	1222	1230	O	[None]	[None]	[None]
215	11597317	11597317_7	1137	1383	,	,	1230	1231	O	[None]	[None]	[None]
216	11597317	11597317_7	1137	1383	although	IN	1232	1240	O	[None]	[None]	[None]
217	11597317	11597317_7	1137	1383	there	EX	1241	1246	O	[None]	[None]	[None]
218	11597317	11597317_7	1137	1383	are	VBP	1247	1250	O	[None]	[None]	[None]
219	11597317	11597317_7	1137	1383	eight	CD	1251	1256	O	[None]	[None]	[None]
220	11597317	11597317_7	1137	1383	repeated	VBN	1257	1265	O	[None]	[None]	[None]
221	11597317	11597317_7	1137	1383	segments	NNS	1266	1274	O	[None]	[None]	[None]
222	11597317	11597317_7	1137	1383	(	(	1275	1276	O	[None]	[None]	[None]
223	11597317	11597317_7	1137	1383	termed	VBN	1276	1282	O	[None]	[None]	[None]
224	11597317	11597317_7	1137	1383	BRC	NNP	1283	1286	O	[None]	[None]	[None]
225	11597317	11597317_7	1137	1383	repeats	NNS	1287	1294	O	[None]	[None]	[None]
226	11597317	11597317_7	1137	1383	)	)	1294	1295	O	[None]	[None]	[None]
227	11597317	11597317_7	1137	1383	in	IN	1296	1298	O	[None]	[None]	[None]
228	11597317	11597317_7	1137	1383	the	DT	1299	1302	O	[None]	[None]	[None]
229	11597317	11597317_7	1137	1383	middle	NN	1303	1309	O	[None]	[None]	[None]
230	11597317	11597317_7	1137	1383	of	IN	1310	1312	O	[None]	[None]	[None]
231	11597317	11597317_7	1137	1383	the	DT	1313	1316	O	[None]	[None]	[None]
232	11597317	11597317_7	1137	1383	protein	NN	1317	1324	O	[None]	[None]	[None]
233	11597317	11597317_7	1137	1383	that	WDT	1325	1329	O	[None]	[None]	[None]
234	11597317	11597317_7	1137	1383	are	VBP	1330	1333	O	[None]	[None]	[None]
235	11597317	11597317_7	1137	1383	highly	RB	1334	1340	O	[None]	[None]	[None]
236	11597317	11597317_7	1137	1383	conserved	VBN	1341	1350	O	[None]	[None]	[None]
237	11597317	11597317_7	1137	1383	among	IN	1351	1356	O	[None]	[None]	[None]
238	11597317	11597317_7	1137	1383	mammalian	JJ	1357	1366	O	[None]	[None]	[None]
239	11597317	11597317_7	1137	1383	orthologs	NNS	1367	1376	O	[None]	[None]	[None]
240	11597317	11597317_7	1137	1383	[	VBP	1377	1378	O	[None]	[None]	[None]
241	11597317	11597317_7	1137	1383	7	CD	1378	1379	O	[None]	[None]	[None]
242	11597317	11597317_7	1137	1383	,	,	1379	1380	O	[None]	[None]	[None]
243	11597317	11597317_7	1137	1383	8	CD	1380	1381	O	[None]	[None]	[None]
244	11597317	11597317_7	1137	1383	].	NN	1381	1383	O	[None]	[None]	[None]
245	11597317	11597317_8	1385	1704	Breast	NNP	1385	1391	O	[None]	[None]	[None]
246	11597317	11597317_8	1385	1704	cancer	NN	1392	1398	O	[None]	[None]	[None]
247	11597317	11597317_8	1385	1704	susceptibility	NN	1399	1413	O	[None]	[None]	[None]
248	11597317	11597317_8	1385	1704	genes	NNS	1414	1419	O	[None]	[None]	[None]
249	11597317	11597317_8	1385	1704	and	CC	1420	1423	O	[None]	[None]	[None]
250	11597317	11597317_8	1385	1704	DNA	NNP	1424	1427	O	[None]	[None]	[None]
251	11597317	11597317_8	1385	1704	repair	NN	1428	1434	O	[None]	[None]	[None]
252	11597317	11597317_8	1385	1704	Following	VBG	1436	1445	O	[None]	[None]	[None]
253	11597317	11597317_8	1385	1704	the	DT	1446	1449	O	[None]	[None]	[None]
254	11597317	11597317_8	1385	1704	landmark	NN	1450	1458	O	[None]	[None]	[None]
255	11597317	11597317_8	1385	1704	discovery	NN	1459	1468	O	[None]	[None]	[None]
256	11597317	11597317_8	1385	1704	by	IN	1469	1471	O	[None]	[None]	[None]
257	11597317	11597317_8	1385	1704	Scully	NNP	1472	1478	O	[None]	[None]	[None]
258	11597317	11597317_8	1385	1704	et	CC	1479	1481	O	[None]	[None]	[None]
259	11597317	11597317_8	1385	1704	al	NN	1482	1484	O	[None]	[None]	[None]
260	11597317	11597317_8	1385	1704	that	IN	1485	1489	O	[None]	[None]	[None]
261	11597317	11597317_8	1385	1704	the	DT	1490	1493	O	[None]	[None]	[None]
262	11597317	11597317_8	1385	1704	homologous	JJ	1494	1504	O	[None]	[None]	[None]
263	11597317	11597317_8	1385	1704	recombinase	NN	1505	1516	O	[None]	[None]	[None]
264	11597317	11597317_8	1385	1704	RAD51	NNP	1517	1522	B	['PR_reasoned_2017_04_17_Instance_28383']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
265	11597317	11597317_8	1385	1704	colocalizes	VBZ	1523	1534	O	[None]	[None]	[None]
266	11597317	11597317_8	1385	1704	at	IN	1535	1537	O	[None]	[None]	[None]
267	11597317	11597317_8	1385	1704	subnuclear	JJ	1538	1548	O	[None]	[None]	[None]
268	11597317	11597317_8	1385	1704	sites	NNS	1549	1554	O	[None]	[None]	[None]
269	11597317	11597317_8	1385	1704	with	IN	1555	1559	O	[None]	[None]	[None]
270	11597317	11597317_8	1385	1704	BRCA1	NNP	1560	1565	B	['PR_reasoned_2017_04_17_Instance_28403']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
271	11597317	11597317_8	1385	1704	[	NNP	1566	1567	O	[None]	[None]	[None]
272	11597317	11597317_8	1385	1704	9	CD	1567	1568	O	[None]	[None]	[None]
273	11597317	11597317_8	1385	1704	],	VBD	1568	1570	O	[None]	[None]	[None]
274	11597317	11597317_8	1385	1704	a	DT	1571	1572	O	[None]	[None]	[None]
275	11597317	11597317_8	1385	1704	number	NN	1573	1579	O	[None]	[None]	[None]
276	11597317	11597317_8	1385	1704	of	IN	1580	1582	O	[None]	[None]	[None]
277	11597317	11597317_8	1385	1704	additional	JJ	1583	1593	O	[None]	[None]	[None]
278	11597317	11597317_8	1385	1704	results	NNS	1594	1601	O	[None]	[None]	[None]
279	11597317	11597317_8	1385	1704	have	VBP	1602	1606	O	[None]	[None]	[None]
280	11597317	11597317_8	1385	1704	provided	VBN	1607	1615	O	[None]	[None]	[None]
281	11597317	11597317_8	1385	1704	evidence	NN	1616	1624	O	[None]	[None]	[None]
282	11597317	11597317_8	1385	1704	that	IN	1625	1629	O	[None]	[None]	[None]
283	11597317	11597317_8	1385	1704	both	DT	1630	1634	O	[None]	[None]	[None]
284	11597317	11597317_8	1385	1704	BRCA1	NNP	1635	1640	B	['PR_reasoned_2017_04_17_Instance_28425']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
285	11597317	11597317_8	1385	1704	and	CC	1641	1644	O	[None]	[None]	[None]
286	11597317	11597317_8	1385	1704	BRCA2	NNP	1645	1650	B	['PR_reasoned_2017_04_17_Instance_28447']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
287	11597317	11597317_8	1385	1704	are	VBP	1651	1654	O	[None]	[None]	[None]
288	11597317	11597317_8	1385	1704	involved	VBN	1655	1663	O	[None]	[None]	[None]
289	11597317	11597317_8	1385	1704	in	IN	1664	1666	O	[None]	[None]	[None]
290	11597317	11597317_8	1385	1704	recombinational	JJ	1667	1682	O	[None]	[None]	[None]
291	11597317	11597317_8	1385	1704	repair	NN	1683	1689	O	[None]	[None]	[None]
292	11597317	11597317_8	1385	1704	of	IN	1690	1692	O	[None]	[None]	[None]
293	11597317	11597317_8	1385	1704	DNA	NNP	1693	1696	O	[None]	[None]	[None]
294	11597317	11597317_8	1385	1704	damage	NN	1697	1703	O	[None]	[None]	[None]
295	11597317	11597317_8	1385	1704	.	.	1703	1704	O	[None]	[None]	[None]
296	11597317	11597317_9	1705	1819	BRCA1	NNP	1705	1710	B	['PR_reasoned_2017_04_17_Instance_28511']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
297	11597317	11597317_9	1705	1819	and	CC	1711	1714	O	[None]	[None]	[None]
298	11597317	11597317_9	1705	1819	BRCA2	NNP	1715	1720	B	['PR_reasoned_2017_04_17_Instance_28469']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
299	11597317	11597317_9	1705	1819	form	VBP	1721	1725	O	[None]	[None]	[None]
300	11597317	11597317_9	1705	1819	discrete	JJ	1726	1734	O	[None]	[None]	[None]
301	11597317	11597317_9	1705	1819	nuclear	JJ	1735	1742	O	[None]	[None]	[None]
302	11597317	11597317_9	1705	1819	foci	NN	1743	1747	O	[None]	[None]	[None]
303	11597317	11597317_9	1705	1819	during	IN	1748	1754	O	[None]	[None]	[None]
304	11597317	11597317_9	1705	1819	the	DT	1755	1758	O	[None]	[None]	[None]
305	11597317	11597317_9	1705	1819	S	NNP	1759	1760	O	[None]	[None]	[None]
306	11597317	11597317_9	1705	1819	phase	NN	1761	1766	O	[None]	[None]	[None]
307	11597317	11597317_9	1705	1819	and	CC	1767	1770	O	[None]	[None]	[None]
308	11597317	11597317_9	1705	1819	after	IN	1771	1776	O	[None]	[None]	[None]
309	11597317	11597317_9	1705	1819	exposure	NN	1777	1785	O	[None]	[None]	[None]
310	11597317	11597317_9	1705	1819	to	TO	1786	1788	O	[None]	[None]	[None]
311	11597317	11597317_9	1705	1819	DNA	NNP	1789	1792	O	[None]	[None]	[None]
312	11597317	11597317_9	1705	1819	damaging	VBG	1793	1801	O	[None]	[None]	[None]
313	11597317	11597317_9	1705	1819	agents	NNS	1802	1808	O	[None]	[None]	[None]
314	11597317	11597317_9	1705	1819	[	JJ	1809	1810	O	[None]	[None]	[None]
315	11597317	11597317_9	1705	1819	9	CD	1810	1811	O	[None]	[None]	[None]
316	11597317	11597317_9	1705	1819	,	,	1811	1812	O	[None]	[None]	[None]
317	11597317	11597317_9	1705	1819	10	CD	1812	1814	O	[None]	[None]	[None]
318	11597317	11597317_9	1705	1819	,	,	1814	1815	O	[None]	[None]	[None]
319	11597317	11597317_9	1705	1819	11	CD	1815	1817	O	[None]	[None]	[None]
320	11597317	11597317_9	1705	1819	].	NN	1817	1819	O	[None]	[None]	[None]
321	11597317	11597317_10	1820	1909	These	DT	1820	1825	O	[None]	[None]	[None]
322	11597317	11597317_10	1820	1909	foci	NNS	1826	1830	O	[None]	[None]	[None]
323	11597317	11597317_10	1820	1909	are	VBP	1831	1834	O	[None]	[None]	[None]
324	11597317	11597317_10	1820	1909	probably	RB	1835	1843	O	[None]	[None]	[None]
325	11597317	11597317_10	1820	1909	sites	NNS	1844	1849	O	[None]	[None]	[None]
326	11597317	11597317_10	1820	1909	of	IN	1850	1852	O	[None]	[None]	[None]
327	11597317	11597317_10	1820	1909	repair	NN	1853	1859	O	[None]	[None]	[None]
328	11597317	11597317_10	1820	1909	of	IN	1860	1862	O	[None]	[None]	[None]
329	11597317	11597317_10	1820	1909	spontaneous	JJ	1863	1874	O	[None]	[None]	[None]
330	11597317	11597317_10	1820	1909	and	CC	1875	1878	O	[None]	[None]	[None]
331	11597317	11597317_10	1820	1909	induced	JJ	1879	1886	O	[None]	[None]	[None]
332	11597317	11597317_10	1820	1909	DNA	NNP	1887	1890	O	[None]	[None]	[None]
333	11597317	11597317_10	1820	1909	damage	NN	1891	1897	O	[None]	[None]	[None]
334	11597317	11597317_10	1820	1909	[	VBD	1898	1899	O	[None]	[None]	[None]
335	11597317	11597317_10	1820	1909	12	CD	1899	1901	O	[None]	[None]	[None]
336	11597317	11597317_10	1820	1909	,	,	1901	1902	O	[None]	[None]	[None]
337	11597317	11597317_10	1820	1909	13	CD	1902	1904	O	[None]	[None]	[None]
338	11597317	11597317_10	1820	1909	,	,	1904	1905	O	[None]	[None]	[None]
339	11597317	11597317_10	1820	1909	14	CD	1905	1907	O	[None]	[None]	[None]
340	11597317	11597317_10	1820	1909	].	NN	1907	1909	O	[None]	[None]	[None]
341	11597317	11597317_11	1910	2107	Cell	NNP	1910	1914	O	[None]	[None]	[None]
342	11597317	11597317_11	1910	2107	lines	NNS	1915	1920	O	[None]	[None]	[None]
343	11597317	11597317_11	1910	2107	defective	VBP	1921	1930	O	[None]	[None]	[None]
344	11597317	11597317_11	1910	2107	in	IN	1931	1933	O	[None]	[None]	[None]
345	11597317	11597317_11	1910	2107	either	CC	1934	1940	O	[None]	[None]	[None]
346	11597317	11597317_11	1910	2107	BRCA1	NNP	1941	1946	B	['PR_reasoned_2017_04_17_Instance_28533']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
347	11597317	11597317_11	1910	2107	or	CC	1947	1949	O	[None]	[None]	[None]
348	11597317	11597317_11	1910	2107	BRCA2	NNP	1950	1955	B	['PR_reasoned_2017_04_17_Instance_28555']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
349	11597317	11597317_11	1910	2107	are	VBP	1956	1959	O	[None]	[None]	[None]
350	11597317	11597317_11	1910	2107	sensitive	JJ	1960	1969	O	[None]	[None]	[None]
351	11597317	11597317_11	1910	2107	to	TO	1970	1972	O	[None]	[None]	[None]
352	11597317	11597317_11	1910	2107	damaging	VBG	1973	1981	O	[None]	[None]	[None]
353	11597317	11597317_11	1910	2107	agents	NNS	1982	1988	O	[None]	[None]	[None]
354	11597317	11597317_11	1910	2107	that	WDT	1989	1993	O	[None]	[None]	[None]
355	11597317	11597317_11	1910	2107	form	VBP	1994	1998	O	[None]	[None]	[None]
356	11597317	11597317_11	1910	2107	double	JJ	1999	2005	O	[None]	[None]	[None]
357	11597317	11597317_11	1910	2107	-	:	2005	2006	O	[None]	[None]	[None]
358	11597317	11597317_11	1910	2107	strand	NN	2006	2012	O	[None]	[None]	[None]
359	11597317	11597317_11	1910	2107	breaks	NNS	2013	2019	O	[None]	[None]	[None]
360	11597317	11597317_11	1910	2107	(	(	2020	2021	O	[None]	[None]	[None]
361	11597317	11597317_11	1910	2107	DSBs	NNP	2021	2025	O	[None]	[None]	[None]
362	11597317	11597317_11	1910	2107	),	NNP	2025	2027	O	[None]	[None]	[None]
363	11597317	11597317_11	1910	2107	as	IN	2028	2030	O	[None]	[None]	[None]
364	11597317	11597317_11	1910	2107	are	VBP	2031	2034	O	[None]	[None]	[None]
365	11597317	11597317_11	1910	2107	other	JJ	2035	2040	O	[None]	[None]	[None]
366	11597317	11597317_11	1910	2107	cell	NN	2041	2045	O	[None]	[None]	[None]
367	11597317	11597317_11	1910	2107	lines	NNS	2046	2051	O	[None]	[None]	[None]
368	11597317	11597317_11	1910	2107	defective	VBP	2052	2061	O	[None]	[None]	[None]
369	11597317	11597317_11	1910	2107	in	IN	2062	2064	O	[None]	[None]	[None]
370	11597317	11597317_11	1910	2107	recombinational	JJ	2065	2080	O	[None]	[None]	[None]
371	11597317	11597317_11	1910	2107	repair	NN	2081	2087	O	[None]	[None]	[None]
372	11597317	11597317_11	1910	2107	(	(	2088	2089	O	[None]	[None]	[None]
373	11597317	11597317_11	1910	2107	reviewed	VBN	2089	2097	O	[None]	[None]	[None]
374	11597317	11597317_11	1910	2107	in	IN	2098	2100	O	[None]	[None]	[None]
375	11597317	11597317_11	1910	2107	[	JJ	2101	2102	O	[None]	[None]	[None]
376	11597317	11597317_11	1910	2107	15	CD	2102	2104	O	[None]	[None]	[None]
377	11597317	11597317_11	1910	2107	]).	NN	2104	2107	O	[None]	[None]	[None]
378	11597317	11597317_12	2108	2201	BRCA2	NNP	2108	2113	B	['PR_reasoned_2017_04_17_Instance_28577']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
379	11597317	11597317_12	2108	2201	interacts	VBZ	2114	2123	O	[None]	[None]	[None]
380	11597317	11597317_12	2108	2201	with	IN	2124	2128	O	[None]	[None]	[None]
381	11597317	11597317_12	2108	2201	the	DT	2129	2132	O	[None]	[None]	[None]
382	11597317	11597317_12	2108	2201	RAD51	NNP	2133	2138	B	['PR_reasoned_2017_04_17_Instance_28599']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
383	11597317	11597317_12	2108	2201	recombinase	NN	2139	2150	O	[None]	[None]	[None]
384	11597317	11597317_12	2108	2201	via	IN	2151	2154	O	[None]	[None]	[None]
385	11597317	11597317_12	2108	2201	direct	JJ	2155	2161	O	[None]	[None]	[None]
386	11597317	11597317_12	2108	2201	protein	NN	2162	2169	O	[None]	[None]	[None]
387	11597317	11597317_12	2108	2201	-	:	2169	2170	O	[None]	[None]	[None]
388	11597317	11597317_12	2108	2201	protein	NN	2170	2177	O	[None]	[None]	[None]
389	11597317	11597317_12	2108	2201	contacts	NNS	2178	2186	O	[None]	[None]	[None]
390	11597317	11597317_12	2108	2201	[	VBP	2187	2188	O	[None]	[None]	[None]
391	11597317	11597317_12	2108	2201	16	CD	2188	2190	O	[None]	[None]	[None]
392	11597317	11597317_12	2108	2201	,	,	2190	2191	O	[None]	[None]	[None]
393	11597317	11597317_12	2108	2201	17	CD	2191	2193	O	[None]	[None]	[None]
394	11597317	11597317_12	2108	2201	,	,	2193	2194	O	[None]	[None]	[None]
395	11597317	11597317_12	2108	2201	18	CD	2194	2196	O	[None]	[None]	[None]
396	11597317	11597317_12	2108	2201	,	,	2196	2197	O	[None]	[None]	[None]
397	11597317	11597317_12	2108	2201	19	CD	2197	2199	O	[None]	[None]	[None]
398	11597317	11597317_12	2108	2201	].	NN	2199	2201	O	[None]	[None]	[None]
399	11597317	11597317_13	2202	2336	Biochemical	JJ	2202	2213	O	[None]	[None]	[None]
400	11597317	11597317_13	2202	2336	analysis	NN	2214	2222	O	[None]	[None]	[None]
401	11597317	11597317_13	2202	2336	also	RB	2223	2227	O	[None]	[None]	[None]
402	11597317	11597317_13	2202	2336	showed	VBD	2228	2234	O	[None]	[None]	[None]
403	11597317	11597317_13	2202	2336	interaction	NN	2235	2246	O	[None]	[None]	[None]
404	11597317	11597317_13	2202	2336	between	IN	2247	2254	O	[None]	[None]	[None]
405	11597317	11597317_13	2202	2336	BRCA1	NNP	2255	2260	B	['PR_reasoned_2017_04_17_Instance_28687']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
406	11597317	11597317_13	2202	2336	and	CC	2261	2264	O	[None]	[None]	[None]
407	11597317	11597317_13	2202	2336	RAD51	NNP	2265	2270	B	['PR_reasoned_2017_04_17_Instance_28621']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
408	11597317	11597317_13	2202	2336	,	,	2270	2271	O	[None]	[None]	[None]
409	11597317	11597317_13	2202	2336	although	IN	2272	2280	O	[None]	[None]	[None]
410	11597317	11597317_13	2202	2336	these	DT	2281	2286	O	[None]	[None]	[None]
411	11597317	11597317_13	2202	2336	detected	JJ	2287	2295	O	[None]	[None]	[None]
412	11597317	11597317_13	2202	2336	interactions	NNS	2296	2308	O	[None]	[None]	[None]
413	11597317	11597317_13	2202	2336	may	MD	2309	2312	O	[None]	[None]	[None]
414	11597317	11597317_13	2202	2336	have	VB	2313	2317	O	[None]	[None]	[None]
415	11597317	11597317_13	2202	2336	been	VBN	2318	2322	O	[None]	[None]	[None]
416	11597317	11597317_13	2202	2336	indirect	JJ	2323	2331	O	[None]	[None]	[None]
417	11597317	11597317_13	2202	2336	[	$	2332	2333	O	[None]	[None]	[None]
418	11597317	11597317_13	2202	2336	9	CD	2333	2334	O	[None]	[None]	[None]
419	11597317	11597317_13	2202	2336	].	NN	2334	2336	O	[None]	[None]	[None]
420	11597317	11597317_14	2337	2407	The	DT	2337	2340	O	[None]	[None]	[None]
421	11597317	11597317_14	2337	2407	BRC	NNP	2341	2344	O	[None]	[None]	[None]
422	11597317	11597317_14	2337	2407	repeats	NNS	2345	2352	O	[None]	[None]	[None]
423	11597317	11597317_14	2337	2407	of	IN	2353	2355	O	[None]	[None]	[None]
424	11597317	11597317_14	2337	2407	BRCA2	NNP	2356	2361	B	['PR_reasoned_2017_04_17_Instance_30183']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
425	11597317	11597317_14	2337	2407	are	VBP	2362	2365	O	[None]	[None]	[None]
426	11597317	11597317_14	2337	2407	responsible	JJ	2366	2377	O	[None]	[None]	[None]
427	11597317	11597317_14	2337	2407	for	IN	2378	2381	O	[None]	[None]	[None]
428	11597317	11597317_14	2337	2407	direct	JJ	2382	2388	O	[None]	[None]	[None]
429	11597317	11597317_14	2337	2407	RAD51	NNP	2389	2394	B	['PR_reasoned_2017_04_17_Instance_28643']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
430	11597317	11597317_14	2337	2407	interaction	NN	2395	2406	O	[None]	[None]	[None]
431	11597317	11597317_14	2337	2407	.	.	2406	2407	O	[None]	[None]	[None]
432	11597317	11597317_15	2408	2626	Cells	NNS	2408	2413	O	[None]	[None]	[None]
433	11597317	11597317_15	2408	2626	lacking	VBG	2414	2421	O	[None]	[None]	[None]
434	11597317	11597317_15	2408	2626	BRCA1	NNP	2422	2427	B	['PR_reasoned_2017_04_17_Instance_28709']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
435	11597317	11597317_15	2408	2626	/	$	2427	2428	O	[None]	[None]	[None]
436	11597317	11597317_15	2408	2626	2	CD	2428	2429	O	[None]	[None]	[None]
437	11597317	11597317_15	2408	2626	fail	NN	2430	2434	O	[None]	[None]	[None]
438	11597317	11597317_15	2408	2626	to	TO	2435	2437	O	[None]	[None]	[None]
439	11597317	11597317_15	2408	2626	form	VB	2438	2442	O	[None]	[None]	[None]
440	11597317	11597317_15	2408	2626	damage	NN	2443	2449	O	[None]	[None]	[None]
441	11597317	11597317_15	2408	2626	-	:	2449	2450	O	[None]	[None]	[None]
442	11597317	11597317_15	2408	2626	induced	JJ	2450	2457	O	[None]	[None]	[None]
443	11597317	11597317_15	2408	2626	subnuclear	JJ	2458	2468	O	[None]	[None]	[None]
444	11597317	11597317_15	2408	2626	RAD51	NNP	2469	2474	B	['PR_reasoned_2017_04_17_Instance_28665']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
445	11597317	11597317_15	2408	2626	foci	NN	2475	2479	O	[None]	[None]	[None]
446	11597317	11597317_15	2408	2626	with	IN	2480	2484	O	[None]	[None]	[None]
447	11597317	11597317_15	2408	2626	normal	JJ	2485	2491	O	[None]	[None]	[None]
448	11597317	11597317_15	2408	2626	efficiency	NN	2492	2502	O	[None]	[None]	[None]
449	11597317	11597317_15	2408	2626	,	,	2502	2503	O	[None]	[None]	[None]
450	11597317	11597317_15	2408	2626	suggesting	VBG	2504	2514	O	[None]	[None]	[None]
451	11597317	11597317_15	2408	2626	that	IN	2515	2519	O	[None]	[None]	[None]
452	11597317	11597317_15	2408	2626	these	DT	2520	2525	O	[None]	[None]	[None]
453	11597317	11597317_15	2408	2626	proteins	NNS	2526	2534	O	[None]	[None]	[None]
454	11597317	11597317_15	2408	2626	are	VBP	2535	2538	O	[None]	[None]	[None]
455	11597317	11597317_15	2408	2626	required	VBN	2539	2547	O	[None]	[None]	[None]
456	11597317	11597317_15	2408	2626	for	IN	2548	2551	O	[None]	[None]	[None]
457	11597317	11597317_15	2408	2626	the	DT	2552	2555	O	[None]	[None]	[None]
458	11597317	11597317_15	2408	2626	formation	NN	2556	2565	O	[None]	[None]	[None]
459	11597317	11597317_15	2408	2626	of	IN	2566	2568	O	[None]	[None]	[None]
460	11597317	11597317_15	2408	2626	recombinase	NN	2569	2580	O	[None]	[None]	[None]
461	11597317	11597317_15	2408	2626	complexes	NNS	2581	2590	O	[None]	[None]	[None]
462	11597317	11597317_15	2408	2626	at	IN	2591	2593	O	[None]	[None]	[None]
463	11597317	11597317_15	2408	2626	the	DT	2594	2597	O	[None]	[None]	[None]
464	11597317	11597317_15	2408	2626	sites	NNS	2598	2603	O	[None]	[None]	[None]
465	11597317	11597317_15	2408	2626	of	IN	2604	2606	O	[None]	[None]	[None]
466	11597317	11597317_15	2408	2626	DNA	NNP	2607	2610	O	[None]	[None]	[None]
467	11597317	11597317_15	2408	2626	damage	NN	2611	2617	O	[None]	[None]	[None]
468	11597317	11597317_15	2408	2626	[	VBD	2618	2619	O	[None]	[None]	[None]
469	11597317	11597317_15	2408	2626	20	CD	2619	2621	O	[None]	[None]	[None]
470	11597317	11597317_15	2408	2626	,	,	2621	2622	O	[None]	[None]	[None]
471	11597317	11597317_15	2408	2626	21	CD	2622	2624	O	[None]	[None]	[None]
472	11597317	11597317_15	2408	2626	].	NN	2624	2626	O	[None]	[None]	[None]
473	11597317	11597317_16	2627	2787	Finally	RB	2627	2634	O	[None]	[None]	[None]
474	11597317	11597317_16	2627	2787	,	,	2634	2635	O	[None]	[None]	[None]
475	11597317	11597317_16	2627	2787	genetic	JJ	2636	2643	O	[None]	[None]	[None]
476	11597317	11597317_16	2627	2787	measurements	NNS	2644	2656	O	[None]	[None]	[None]
477	11597317	11597317_16	2627	2787	of	IN	2657	2659	O	[None]	[None]	[None]
478	11597317	11597317_16	2627	2787	recombination	NN	2660	2673	O	[None]	[None]	[None]
479	11597317	11597317_16	2627	2787	frequency	NN	2674	2683	O	[None]	[None]	[None]
480	11597317	11597317_16	2627	2787	have	VBP	2684	2688	O	[None]	[None]	[None]
481	11597317	11597317_16	2627	2787	shown	VBN	2689	2694	O	[None]	[None]	[None]
482	11597317	11597317_16	2627	2787	that	IN	2695	2699	O	[None]	[None]	[None]
483	11597317	11597317_16	2627	2787	Brca1	NNP	2700	2705	B	['PR_reasoned_2017_04_17_Instance_30281']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
484	11597317	11597317_16	2627	2787	-/-	NNP	2705	2708	O	[None]	[None]	[None]
485	11597317	11597317_16	2627	2787	embryonic	JJ	2709	2718	O	[None]	[None]	[None]
486	11597317	11597317_16	2627	2787	stem	NN	2719	2723	O	[None]	[None]	[None]
487	11597317	11597317_16	2627	2787	(	(	2724	2725	O	[None]	[None]	[None]
488	11597317	11597317_16	2627	2787	ES	NNP	2725	2727	O	[None]	[None]	[None]
489	11597317	11597317_16	2627	2787	)	)	2727	2728	O	[None]	[None]	[None]
490	11597317	11597317_16	2627	2787	cells	NNS	2729	2734	O	[None]	[None]	[None]
491	11597317	11597317_16	2627	2787	are	VBP	2735	2738	O	[None]	[None]	[None]
492	11597317	11597317_16	2627	2787	deficient	JJ	2739	2748	O	[None]	[None]	[None]
493	11597317	11597317_16	2627	2787	in	IN	2749	2751	O	[None]	[None]	[None]
494	11597317	11597317_16	2627	2787	recombinational	JJ	2752	2767	O	[None]	[None]	[None]
495	11597317	11597317_16	2627	2787	DSB	NNP	2768	2771	O	[None]	[None]	[None]
496	11597317	11597317_16	2627	2787	repair	NN	2772	2778	O	[None]	[None]	[None]
497	11597317	11597317_16	2627	2787	[	VBD	2779	2780	O	[None]	[None]	[None]
498	11597317	11597317_16	2627	2787	22	CD	2780	2782	O	[None]	[None]	[None]
499	11597317	11597317_16	2627	2787	,	,	2782	2783	O	[None]	[None]	[None]
500	11597317	11597317_16	2627	2787	23	CD	2783	2785	O	[None]	[None]	[None]
501	11597317	11597317_16	2627	2787	].	NN	2785	2787	O	[None]	[None]	[None]
502	11597317	11597317_17	2788	3082	The	DT	2788	2791	O	[None]	[None]	[None]
503	11597317	11597317_17	2788	3082	similarity	NN	2792	2802	O	[None]	[None]	[None]
504	11597317	11597317_17	2788	3082	between	IN	2803	2810	O	[None]	[None]	[None]
505	11597317	11597317_17	2788	3082	phenotypes	NNS	2811	2821	O	[None]	[None]	[None]
506	11597317	11597317_17	2788	3082	associated	VBN	2822	2832	O	[None]	[None]	[None]
507	11597317	11597317_17	2788	3082	with	IN	2833	2837	O	[None]	[None]	[None]
508	11597317	11597317_17	2788	3082	BRCA1	NNP	2838	2843	B	['PR_reasoned_2017_04_17_Instance_28731']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
509	11597317	11597317_17	2788	3082	and	CC	2844	2847	O	[None]	[None]	[None]
510	11597317	11597317_17	2788	3082	BRCA2	NNP	2848	2853	B	['PR_reasoned_2017_04_17_Instance_28795']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
511	11597317	11597317_17	2788	3082	deficiency	NN	2854	2864	O	[None]	[None]	[None]
512	11597317	11597317_17	2788	3082	,	,	2864	2865	O	[None]	[None]	[None]
513	11597317	11597317_17	2788	3082	together	RB	2866	2874	O	[None]	[None]	[None]
514	11597317	11597317_17	2788	3082	with	IN	2875	2879	O	[None]	[None]	[None]
515	11597317	11597317_17	2788	3082	data	NNS	2880	2884	O	[None]	[None]	[None]
516	11597317	11597317_17	2788	3082	showing	VBG	2885	2892	O	[None]	[None]	[None]
517	11597317	11597317_17	2788	3082	a	DT	2893	2894	O	[None]	[None]	[None]
518	11597317	11597317_17	2788	3082	similar	JJ	2895	2902	O	[None]	[None]	[None]
519	11597317	11597317_17	2788	3082	effect	NN	2903	2909	O	[None]	[None]	[None]
520	11597317	11597317_17	2788	3082	of	IN	2910	2912	O	[None]	[None]	[None]
521	11597317	11597317_17	2788	3082	DNA	NNP	2913	2916	O	[None]	[None]	[None]
522	11597317	11597317_17	2788	3082	damage	NN	2917	2923	O	[None]	[None]	[None]
523	11597317	11597317_17	2788	3082	on	IN	2924	2926	O	[None]	[None]	[None]
524	11597317	11597317_17	2788	3082	distribution	NN	2927	2939	O	[None]	[None]	[None]
525	11597317	11597317_17	2788	3082	of	IN	2940	2942	O	[None]	[None]	[None]
526	11597317	11597317_17	2788	3082	BRCA1	NNP	2943	2948	B	['PR_reasoned_2017_04_17_Instance_28753']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
527	11597317	11597317_17	2788	3082	and	CC	2949	2952	O	[None]	[None]	[None]
528	11597317	11597317_17	2788	3082	BRCA2	NNP	2953	2958	B	['PR_reasoned_2017_04_17_Instance_28815']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
529	11597317	11597317_17	2788	3082	in	IN	2959	2961	O	[None]	[None]	[None]
530	11597317	11597317_17	2788	3082	repair	NN	2962	2968	O	[None]	[None]	[None]
531	11597317	11597317_17	2788	3082	-	:	2968	2969	O	[None]	[None]	[None]
532	11597317	11597317_17	2788	3082	proficient	NN	2969	2979	O	[None]	[None]	[None]
533	11597317	11597317_17	2788	3082	cells	NNS	2980	2985	O	[None]	[None]	[None]
534	11597317	11597317_17	2788	3082	,	,	2985	2986	O	[None]	[None]	[None]
535	11597317	11597317_17	2788	3082	led	VBN	2987	2990	O	[None]	[None]	[None]
536	11597317	11597317_17	2788	3082	to	TO	2991	2993	O	[None]	[None]	[None]
537	11597317	11597317_17	2788	3082	the	DT	2994	2997	O	[None]	[None]	[None]
538	11597317	11597317_17	2788	3082	hypothesis	NN	2998	3008	O	[None]	[None]	[None]
539	11597317	11597317_17	2788	3082	that	WDT	3009	3013	O	[None]	[None]	[None]
540	11597317	11597317_17	2788	3082	BRCA2	NNP	3014	3019	B	['PR_reasoned_2017_04_17_Instance_28837']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
541	11597317	11597317_17	2788	3082	,	,	3019	3020	O	[None]	[None]	[None]
542	11597317	11597317_17	2788	3082	like	IN	3021	3025	O	[None]	[None]	[None]
543	11597317	11597317_17	2788	3082	BRCA1	NNP	3026	3031	B	['PR_reasoned_2017_04_17_Instance_28773']	['PR:000004803']	['breast cancer type 1 susceptibility protein']
544	11597317	11597317_17	2788	3082	,	,	3031	3032	O	[None]	[None]	[None]
545	11597317	11597317_17	2788	3082	is	VBZ	3033	3035	O	[None]	[None]	[None]
546	11597317	11597317_17	2788	3082	required	VBN	3036	3044	O	[None]	[None]	[None]
547	11597317	11597317_17	2788	3082	for	IN	3045	3048	O	[None]	[None]	[None]
548	11597317	11597317_17	2788	3082	efficient	JJ	3049	3058	O	[None]	[None]	[None]
549	11597317	11597317_17	2788	3082	recombinational	JJ	3059	3074	O	[None]	[None]	[None]
550	11597317	11597317_17	2788	3082	repair	NN	3075	3081	O	[None]	[None]	[None]
551	11597317	11597317_17	2788	3082	.	.	3081	3082	O	[None]	[None]	[None]
552	11597317	11597317_18	3083	3163	The	DT	3083	3086	O	[None]	[None]	[None]
553	11597317	11597317_18	3083	3163	paper	NN	3087	3092	O	[None]	[None]	[None]
554	11597317	11597317_18	3083	3163	by	IN	3093	3095	O	[None]	[None]	[None]
555	11597317	11597317_18	3083	3163	Moynahan	NNP	3096	3104	O	[None]	[None]	[None]
556	11597317	11597317_18	3083	3163	et	FW	3105	3107	O	[None]	[None]	[None]
557	11597317	11597317_18	3083	3163	al	NN	3108	3110	O	[None]	[None]	[None]
558	11597317	11597317_18	3083	3163	[	$	3111	3112	O	[None]	[None]	[None]
559	11597317	11597317_18	3083	3163	24	CD	3112	3114	O	[None]	[None]	[None]
560	11597317	11597317_18	3083	3163	]	NNP	3114	3115	O	[None]	[None]	[None]
561	11597317	11597317_18	3083	3163	provides	VBZ	3116	3124	O	[None]	[None]	[None]
562	11597317	11597317_18	3083	3163	important	JJ	3125	3134	O	[None]	[None]	[None]
563	11597317	11597317_18	3083	3163	support	NN	3135	3142	O	[None]	[None]	[None]
564	11597317	11597317_18	3083	3163	for	IN	3143	3146	O	[None]	[None]	[None]
565	11597317	11597317_18	3083	3163	this	DT	3147	3151	O	[None]	[None]	[None]
566	11597317	11597317_18	3083	3163	hypothesis	NN	3152	3162	O	[None]	[None]	[None]
567	11597317	11597317_18	3083	3163	.	.	3162	3163	O	[None]	[None]	[None]
568	11597317	11597317_19	3165	3363	Measuring	VBG	3165	3174	O	[None]	[None]	[None]
569	11597317	11597317_19	3165	3363	DSB	NNP	3175	3178	O	[None]	[None]	[None]
570	11597317	11597317_19	3165	3363	-	:	3178	3179	O	[None]	[None]	[None]
571	11597317	11597317_19	3165	3363	induced	JJ	3179	3186	O	[None]	[None]	[None]
572	11597317	11597317_19	3165	3363	recombination	NN	3187	3200	O	[None]	[None]	[None]
573	11597317	11597317_19	3165	3363	frequency	NN	3201	3210	O	[None]	[None]	[None]
574	11597317	11597317_19	3165	3363	in	IN	3211	3213	O	[None]	[None]	[None]
575	11597317	11597317_19	3165	3363	BRCA2	NNP	3214	3219	B	['PR_reasoned_2017_04_17_Instance_28859']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
576	11597317	11597317_19	3165	3363	-	:	3219	3220	O	[None]	[None]	[None]
577	11597317	11597317_19	3165	3363	defective	JJ	3220	3229	O	[None]	[None]	[None]
578	11597317	11597317_19	3165	3363	cells	NNS	3230	3235	O	[None]	[None]	[None]
579	11597317	11597317_19	3165	3363	Pierce	NNP	3237	3243	O	[None]	[None]	[None]
580	11597317	11597317_19	3165	3363	et	CC	3244	3246	O	[None]	[None]	[None]
581	11597317	11597317_19	3165	3363	al	NNS	3247	3249	O	[None]	[None]	[None]
582	11597317	11597317_19	3165	3363	have	VBP	3250	3254	O	[None]	[None]	[None]
583	11597317	11597317_19	3165	3363	designed	VBN	3255	3263	O	[None]	[None]	[None]
584	11597317	11597317_19	3165	3363	a	DT	3264	3265	O	[None]	[None]	[None]
585	11597317	11597317_19	3165	3363	set	NN	3266	3269	O	[None]	[None]	[None]
586	11597317	11597317_19	3165	3363	of	IN	3270	3272	O	[None]	[None]	[None]
587	11597317	11597317_19	3165	3363	recombination	NN	3273	3286	O	[None]	[None]	[None]
588	11597317	11597317_19	3165	3363	substrates	NNS	3287	3297	O	[None]	[None]	[None]
589	11597317	11597317_19	3165	3363	for	IN	3298	3301	O	[None]	[None]	[None]
590	11597317	11597317_19	3165	3363	measuring	VBG	3302	3311	O	[None]	[None]	[None]
591	11597317	11597317_19	3165	3363	the	DT	3312	3315	O	[None]	[None]	[None]
592	11597317	11597317_19	3165	3363	level	NN	3316	3321	O	[None]	[None]	[None]
593	11597317	11597317_19	3165	3363	of	IN	3322	3324	O	[None]	[None]	[None]
594	11597317	11597317_19	3165	3363	homologous	JJ	3325	3335	O	[None]	[None]	[None]
595	11597317	11597317_19	3165	3363	recombination	NN	3336	3349	O	[None]	[None]	[None]
596	11597317	11597317_19	3165	3363	in	IN	3350	3352	O	[None]	[None]	[None]
597	11597317	11597317_19	3165	3363	vivo	NN	3353	3357	O	[None]	[None]	[None]
598	11597317	11597317_19	3165	3363	(	(	3358	3359	O	[None]	[None]	[None]
599	11597317	11597317_19	3165	3363	Fig	NNP	3359	3362	O	[None]	[None]	[None]
600	11597317	11597317_19	3165	3363	.	.	3362	3363	O	[None]	[None]	[None]
601	11597317	11597317_20	3364	3372	1	CD	3364	3365	O	[None]	[None]	[None]
602	11597317	11597317_20	3364	3372	)	)	3365	3366	O	[None]	[None]	[None]
603	11597317	11597317_20	3364	3372	[	VBD	3367	3368	O	[None]	[None]	[None]
604	11597317	11597317_20	3364	3372	25	CD	3368	3370	O	[None]	[None]	[None]
605	11597317	11597317_20	3364	3372	].	NN	3370	3372	O	[None]	[None]	[None]
606	11597317	11597317_21	3373	3616	The	DT	3373	3376	O	[None]	[None]	[None]
607	11597317	11597317_21	3373	3616	DNA	NNP	3377	3380	O	[None]	[None]	[None]
608	11597317	11597317_21	3373	3616	substrate	NN	3381	3390	O	[None]	[None]	[None]
609	11597317	11597317_21	3373	3616	contains	VBZ	3391	3399	O	[None]	[None]	[None]
610	11597317	11597317_21	3373	3616	a	DT	3400	3401	O	[None]	[None]	[None]
611	11597317	11597317_21	3373	3616	pair	NN	3402	3406	O	[None]	[None]	[None]
612	11597317	11597317_21	3373	3616	of	IN	3407	3409	O	[None]	[None]	[None]
613	11597317	11597317_21	3373	3616	mutated	JJ	3410	3417	O	[None]	[None]	[None]
614	11597317	11597317_21	3373	3616	GFP	NNP	3418	3421	O	[None]	[None]	[None]
615	11597317	11597317_21	3373	3616	genes	NNS	3422	3427	O	[None]	[None]	[None]
616	11597317	11597317_21	3373	3616	(	(	3428	3429	O	[None]	[None]	[None]
617	11597317	11597317_21	3373	3616	GFP	NNP	3429	3432	O	[None]	[None]	[None]
618	11597317	11597317_21	3373	3616	encodes	VBZ	3433	3440	O	[None]	[None]	[None]
619	11597317	11597317_21	3373	3616	the	DT	3441	3444	O	[None]	[None]	[None]
620	11597317	11597317_21	3373	3616	easily	RB	3445	3451	O	[None]	[None]	[None]
621	11597317	11597317_21	3373	3616	detected	VBN	3452	3460	O	[None]	[None]	[None]
622	11597317	11597317_21	3373	3616	green	JJ	3461	3466	O	[None]	[None]	[None]
623	11597317	11597317_21	3373	3616	fluorescent	NN	3467	3478	O	[None]	[None]	[None]
624	11597317	11597317_21	3373	3616	protein	NN	3479	3486	O	[None]	[None]	[None]
625	11597317	11597317_21	3373	3616	),	VBD	3486	3488	O	[None]	[None]	[None]
626	11597317	11597317_21	3373	3616	one	CD	3489	3492	O	[None]	[None]	[None]
627	11597317	11597317_21	3373	3616	of	IN	3493	3495	O	[None]	[None]	[None]
628	11597317	11597317_21	3373	3616	which	WDT	3496	3501	O	[None]	[None]	[None]
629	11597317	11597317_21	3373	3616	contains	VBZ	3502	3510	O	[None]	[None]	[None]
630	11597317	11597317_21	3373	3616	a	DT	3511	3512	O	[None]	[None]	[None]
631	11597317	11597317_21	3373	3616	restriction	NN	3513	3524	O	[None]	[None]	[None]
632	11597317	11597317_21	3373	3616	site	NN	3525	3529	O	[None]	[None]	[None]
633	11597317	11597317_21	3373	3616	for	IN	3530	3533	O	[None]	[None]	[None]
634	11597317	11597317_21	3373	3616	I	PRP	3534	3535	B	['PR_reasoned_2017_04_17_Instance_43']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
635	11597317	11597317_21	3373	3616	-	:	3535	3536	I	['PR_reasoned_2017_04_17_Instance_43']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
636	11597317	11597317_21	3373	3616	SceI	NN	3536	3540	I	['PR_reasoned_2017_04_17_Instance_43']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
637	11597317	11597317_21	3373	3616	,	,	3540	3541	O	[None]	[None]	[None]
638	11597317	11597317_21	3373	3616	a	DT	3542	3543	O	[None]	[None]	[None]
639	11597317	11597317_21	3373	3616	yeast	NN	3544	3549	O	[None]	[None]	[None]
640	11597317	11597317_21	3373	3616	intron	NN	3550	3556	O	[None]	[None]	[None]
641	11597317	11597317_21	3373	3616	encoded	VBD	3557	3564	O	[None]	[None]	[None]
642	11597317	11597317_21	3373	3616	endonuclease	NN	3565	3577	O	[None]	[None]	[None]
643	11597317	11597317_21	3373	3616	with	IN	3578	3582	O	[None]	[None]	[None]
644	11597317	11597317_21	3373	3616	an	DT	3583	3585	O	[None]	[None]	[None]
645	11597317	11597317_21	3373	3616	18	CD	3586	3588	O	[None]	[None]	[None]
646	11597317	11597317_21	3373	3616	base	NN	3589	3593	O	[None]	[None]	[None]
647	11597317	11597317_21	3373	3616	pair	NN	3594	3598	O	[None]	[None]	[None]
648	11597317	11597317_21	3373	3616	recognition	NN	3599	3610	O	[None]	[None]	[None]
649	11597317	11597317_21	3373	3616	site	NN	3611	3615	O	[None]	[None]	[None]
650	11597317	11597317_21	3373	3616	.	.	3615	3616	O	[None]	[None]	[None]
651	11597317	11597317_22	3617	3739	Transient	JJ	3617	3626	O	[None]	[None]	[None]
652	11597317	11597317_22	3617	3739	transfection	NN	3627	3639	O	[None]	[None]	[None]
653	11597317	11597317_22	3617	3739	of	IN	3640	3642	O	[None]	[None]	[None]
654	11597317	11597317_22	3617	3739	an	DT	3643	3645	O	[None]	[None]	[None]
655	11597317	11597317_22	3617	3739	I	PRP	3646	3647	B	['PR_reasoned_2017_04_17_Instance_45']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
656	11597317	11597317_22	3617	3739	-	:	3647	3648	I	['PR_reasoned_2017_04_17_Instance_45']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
657	11597317	11597317_22	3617	3739	SceI	NNP	3648	3652	I	['PR_reasoned_2017_04_17_Instance_45']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
658	11597317	11597317_22	3617	3739	expression	NN	3653	3663	O	[None]	[None]	[None]
659	11597317	11597317_22	3617	3739	vector	NN	3664	3670	O	[None]	[None]	[None]
660	11597317	11597317_22	3617	3739	results	NNS	3671	3678	O	[None]	[None]	[None]
661	11597317	11597317_22	3617	3739	in	IN	3679	3681	O	[None]	[None]	[None]
662	11597317	11597317_22	3617	3739	the	DT	3682	3685	O	[None]	[None]	[None]
663	11597317	11597317_22	3617	3739	production	NN	3686	3696	O	[None]	[None]	[None]
664	11597317	11597317_22	3617	3739	of	IN	3697	3699	O	[None]	[None]	[None]
665	11597317	11597317_22	3617	3739	a	DT	3700	3701	O	[None]	[None]	[None]
666	11597317	11597317_22	3617	3739	DSB	NNP	3702	3705	O	[None]	[None]	[None]
667	11597317	11597317_22	3617	3739	in	IN	3706	3708	O	[None]	[None]	[None]
668	11597317	11597317_22	3617	3739	the	DT	3709	3712	O	[None]	[None]	[None]
669	11597317	11597317_22	3617	3739	first	JJ	3713	3718	O	[None]	[None]	[None]
670	11597317	11597317_22	3617	3739	mutated	VBN	3719	3726	O	[None]	[None]	[None]
671	11597317	11597317_22	3617	3739	copy	NN	3727	3731	O	[None]	[None]	[None]
672	11597317	11597317_22	3617	3739	of	IN	3732	3734	O	[None]	[None]	[None]
673	11597317	11597317_22	3617	3739	GFP	NNP	3735	3738	O	[None]	[None]	[None]
674	11597317	11597317_22	3617	3739	.	.	3738	3739	O	[None]	[None]	[None]
675	11597317	11597317_23	3740	3923	One	CD	3740	3743	O	[None]	[None]	[None]
676	11597317	11597317_23	3740	3923	or	CC	3744	3746	O	[None]	[None]	[None]
677	11597317	11597317_23	3740	3923	both	DT	3747	3751	O	[None]	[None]	[None]
678	11597317	11597317_23	3740	3923	DNA	NNP	3752	3755	O	[None]	[None]	[None]
679	11597317	11597317_23	3740	3923	ends	NNS	3756	3760	O	[None]	[None]	[None]
680	11597317	11597317_23	3740	3923	formed	VBN	3761	3767	O	[None]	[None]	[None]
681	11597317	11597317_23	3740	3923	by	IN	3768	3770	O	[None]	[None]	[None]
682	11597317	11597317_23	3740	3923	the	DT	3771	3774	O	[None]	[None]	[None]
683	11597317	11597317_23	3740	3923	break	NN	3775	3780	O	[None]	[None]	[None]
684	11597317	11597317_23	3740	3923	invade	NN	3781	3787	O	[None]	[None]	[None]
685	11597317	11597317_23	3740	3923	(	(	3787	3788	O	[None]	[None]	[None]
686	11597317	11597317_23	3740	3923	s	NN	3788	3789	O	[None]	[None]	[None]
687	11597317	11597317_23	3740	3923	)	)	3789	3790	O	[None]	[None]	[None]
688	11597317	11597317_23	3740	3923	the	DT	3791	3794	O	[None]	[None]	[None]
689	11597317	11597317_23	3740	3923	homologous	JJ	3795	3805	O	[None]	[None]	[None]
690	11597317	11597317_23	3740	3923	sequence	NN	3806	3814	O	[None]	[None]	[None]
691	11597317	11597317_23	3740	3923	in	IN	3815	3817	O	[None]	[None]	[None]
692	11597317	11597317_23	3740	3923	the	DT	3818	3821	O	[None]	[None]	[None]
693	11597317	11597317_23	3740	3923	second	JJ	3822	3828	O	[None]	[None]	[None]
694	11597317	11597317_23	3740	3923	mutant	JJ	3829	3835	O	[None]	[None]	[None]
695	11597317	11597317_23	3740	3923	GFP	NNP	3836	3839	O	[None]	[None]	[None]
696	11597317	11597317_23	3740	3923	copy	NN	3840	3844	O	[None]	[None]	[None]
697	11597317	11597317_23	3740	3923	,	,	3844	3845	O	[None]	[None]	[None]
698	11597317	11597317_23	3740	3923	resulting	VBG	3846	3855	O	[None]	[None]	[None]
699	11597317	11597317_23	3740	3923	in	IN	3856	3858	O	[None]	[None]	[None]
700	11597317	11597317_23	3740	3923	repair	NN	3859	3865	O	[None]	[None]	[None]
701	11597317	11597317_23	3740	3923	of	IN	3866	3868	O	[None]	[None]	[None]
702	11597317	11597317_23	3740	3923	the	DT	3869	3872	O	[None]	[None]	[None]
703	11597317	11597317_23	3740	3923	DSB	NNP	3873	3876	O	[None]	[None]	[None]
704	11597317	11597317_23	3740	3923	via	IN	3877	3880	O	[None]	[None]	[None]
705	11597317	11597317_23	3740	3923	a	DT	3881	3882	O	[None]	[None]	[None]
706	11597317	11597317_23	3740	3923	homology	NN	3883	3891	O	[None]	[None]	[None]
707	11597317	11597317_23	3740	3923	-	:	3891	3892	O	[None]	[None]	[None]
708	11597317	11597317_23	3740	3923	mediated	VBN	3892	3900	O	[None]	[None]	[None]
709	11597317	11597317_23	3740	3923	gene	NN	3901	3905	O	[None]	[None]	[None]
710	11597317	11597317_23	3740	3923	conversion	NN	3906	3916	O	[None]	[None]	[None]
711	11597317	11597317_23	3740	3923	event	NN	3917	3922	O	[None]	[None]	[None]
712	11597317	11597317_23	3740	3923	.	.	3922	3923	O	[None]	[None]	[None]
713	11597317	11597317_24	3924	4060	The	DT	3924	3927	O	[None]	[None]	[None]
714	11597317	11597317_24	3924	4060	configuration	NN	3928	3941	O	[None]	[None]	[None]
715	11597317	11597317_24	3924	4060	of	IN	3942	3944	O	[None]	[None]	[None]
716	11597317	11597317_24	3924	4060	the	DT	3945	3948	O	[None]	[None]	[None]
717	11597317	11597317_24	3924	4060	GFP	NNP	3949	3952	O	[None]	[None]	[None]
718	11597317	11597317_24	3924	4060	construct	NN	3953	3962	O	[None]	[None]	[None]
719	11597317	11597317_24	3924	4060	is	VBZ	3963	3965	O	[None]	[None]	[None]
720	11597317	11597317_24	3924	4060	such	JJ	3966	3970	O	[None]	[None]	[None]
721	11597317	11597317_24	3924	4060	that	IN	3971	3975	O	[None]	[None]	[None]
722	11597317	11597317_24	3924	4060	homology	NN	3976	3984	O	[None]	[None]	[None]
723	11597317	11597317_24	3924	4060	-	:	3984	3985	O	[None]	[None]	[None]
724	11597317	11597317_24	3924	4060	mediated	VBN	3985	3993	O	[None]	[None]	[None]
725	11597317	11597317_24	3924	4060	repair	NN	3994	4000	O	[None]	[None]	[None]
726	11597317	11597317_24	3924	4060	often	RB	4001	4006	O	[None]	[None]	[None]
727	11597317	11597317_24	3924	4060	results	NNS	4007	4014	O	[None]	[None]	[None]
728	11597317	11597317_24	3924	4060	in	IN	4015	4017	O	[None]	[None]	[None]
729	11597317	11597317_24	3924	4060	the	DT	4018	4021	O	[None]	[None]	[None]
730	11597317	11597317_24	3924	4060	formation	NN	4022	4031	O	[None]	[None]	[None]
731	11597317	11597317_24	3924	4060	of	IN	4032	4034	O	[None]	[None]	[None]
732	11597317	11597317_24	3924	4060	a	DT	4035	4036	O	[None]	[None]	[None]
733	11597317	11597317_24	3924	4060	functional	JJ	4037	4047	O	[None]	[None]	[None]
734	11597317	11597317_24	3924	4060	copy	NN	4048	4052	O	[None]	[None]	[None]
735	11597317	11597317_24	3924	4060	of	IN	4053	4055	O	[None]	[None]	[None]
736	11597317	11597317_24	3924	4060	GFP	NNP	4056	4059	O	[None]	[None]	[None]
737	11597317	11597317_24	3924	4060	.	.	4059	4060	O	[None]	[None]	[None]
738	11597317	11597317_25	4061	4174	Such	JJ	4061	4065	O	[None]	[None]	[None]
739	11597317	11597317_25	4061	4174	events	NNS	4066	4072	O	[None]	[None]	[None]
740	11597317	11597317_25	4061	4174	can	MD	4073	4076	O	[None]	[None]	[None]
741	11597317	11597317_25	4061	4174	be	VB	4077	4079	O	[None]	[None]	[None]
742	11597317	11597317_25	4061	4174	detected	VBN	4080	4088	O	[None]	[None]	[None]
743	11597317	11597317_25	4061	4174	by	IN	4089	4091	O	[None]	[None]	[None]
744	11597317	11597317_25	4061	4174	fluorescence	NN	4092	4104	O	[None]	[None]	[None]
745	11597317	11597317_25	4061	4174	-	:	4104	4105	O	[None]	[None]	[None]
746	11597317	11597317_25	4061	4174	activated	VBN	4105	4114	O	[None]	[None]	[None]
747	11597317	11597317_25	4061	4174	cell	NN	4115	4119	O	[None]	[None]	[None]
748	11597317	11597317_25	4061	4174	sorting	VBG	4120	4127	O	[None]	[None]	[None]
749	11597317	11597317_25	4061	4174	analysis	NN	4128	4136	O	[None]	[None]	[None]
750	11597317	11597317_25	4061	4174	by	IN	4137	4139	O	[None]	[None]	[None]
751	11597317	11597317_25	4061	4174	virtue	NN	4140	4146	O	[None]	[None]	[None]
752	11597317	11597317_25	4061	4174	of	IN	4147	4149	O	[None]	[None]	[None]
753	11597317	11597317_25	4061	4174	their	PRP$	4150	4155	O	[None]	[None]	[None]
754	11597317	11597317_25	4061	4174	expression	NN	4156	4166	O	[None]	[None]	[None]
755	11597317	11597317_25	4061	4174	of	IN	4167	4169	O	[None]	[None]	[None]
756	11597317	11597317_25	4061	4174	GFP	NNP	4170	4173	O	[None]	[None]	[None]
757	11597317	11597317_25	4061	4174	.	.	4173	4174	O	[None]	[None]	[None]
758	11597317	11597317_26	4176	4393	Moynahan	NNP	4176	4184	O	[None]	[None]	[None]
759	11597317	11597317_26	4176	4393	et	CC	4185	4187	O	[None]	[None]	[None]
760	11597317	11597317_26	4176	4393	al	JJ	4188	4190	O	[None]	[None]	[None]
761	11597317	11597317_26	4176	4393	[	NNP	4191	4192	O	[None]	[None]	[None]
762	11597317	11597317_26	4176	4393	24	CD	4192	4194	O	[None]	[None]	[None]
763	11597317	11597317_26	4176	4393	]	NN	4194	4195	O	[None]	[None]	[None]
764	11597317	11597317_26	4176	4393	have	VBP	4196	4200	O	[None]	[None]	[None]
765	11597317	11597317_26	4176	4393	used	VBN	4201	4205	O	[None]	[None]	[None]
766	11597317	11597317_26	4176	4393	such	PDT	4206	4210	O	[None]	[None]	[None]
767	11597317	11597317_26	4176	4393	a	DT	4211	4212	O	[None]	[None]	[None]
768	11597317	11597317_26	4176	4393	GFP	NNP	4213	4216	O	[None]	[None]	[None]
769	11597317	11597317_26	4176	4393	recombination	NN	4217	4230	O	[None]	[None]	[None]
770	11597317	11597317_26	4176	4393	substrate	NN	4231	4240	O	[None]	[None]	[None]
771	11597317	11597317_26	4176	4393	to	TO	4241	4243	O	[None]	[None]	[None]
772	11597317	11597317_26	4176	4393	demonstrate	VB	4244	4255	O	[None]	[None]	[None]
773	11597317	11597317_26	4176	4393	that	DT	4256	4260	O	[None]	[None]	[None]
774	11597317	11597317_26	4176	4393	cells	NNS	4261	4266	O	[None]	[None]	[None]
775	11597317	11597317_26	4176	4393	with	IN	4267	4271	O	[None]	[None]	[None]
776	11597317	11597317_26	4176	4393	defective	JJ	4272	4281	O	[None]	[None]	[None]
777	11597317	11597317_26	4176	4393	BRCA2	NNP	4282	4287	B	['PR_reasoned_2017_04_17_Instance_28881']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
778	11597317	11597317_26	4176	4393	protein	NN	4288	4295	O	[None]	[None]	[None]
779	11597317	11597317_26	4176	4393	are	VBP	4296	4299	O	[None]	[None]	[None]
780	11597317	11597317_26	4176	4393	deficient	VBN	4300	4309	O	[None]	[None]	[None]
781	11597317	11597317_26	4176	4393	in	IN	4310	4312	O	[None]	[None]	[None]
782	11597317	11597317_26	4176	4393	their	PRP$	4313	4318	O	[None]	[None]	[None]
783	11597317	11597317_26	4176	4393	ability	NN	4319	4326	O	[None]	[None]	[None]
784	11597317	11597317_26	4176	4393	to	TO	4327	4329	O	[None]	[None]	[None]
785	11597317	11597317_26	4176	4393	repair	VB	4330	4336	O	[None]	[None]	[None]
786	11597317	11597317_26	4176	4393	the	DT	4337	4340	O	[None]	[None]	[None]
787	11597317	11597317_26	4176	4393	I	PRP	4341	4342	B	['PR_reasoned_2017_04_17_Instance_47']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
788	11597317	11597317_26	4176	4393	-	:	4342	4343	I	['PR_reasoned_2017_04_17_Instance_47']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
789	11597317	11597317_26	4176	4393	SceI	NNP	4343	4347	I	['PR_reasoned_2017_04_17_Instance_47']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
790	11597317	11597317_26	4176	4393	-	:	4347	4348	O	[None]	[None]	[None]
791	11597317	11597317_26	4176	4393	induced	VBD	4348	4355	O	[None]	[None]	[None]
792	11597317	11597317_26	4176	4393	DSB	NNP	4356	4359	O	[None]	[None]	[None]
793	11597317	11597317_26	4176	4393	through	IN	4360	4367	O	[None]	[None]	[None]
794	11597317	11597317_26	4176	4393	homologous	JJ	4368	4378	O	[None]	[None]	[None]
795	11597317	11597317_26	4176	4393	recombination	NN	4379	4392	O	[None]	[None]	[None]
796	11597317	11597317_26	4176	4393	.	.	4392	4393	O	[None]	[None]	[None]
797	11597317	11597317_27	4394	4538	Expression	NN	4394	4404	O	[None]	[None]	[None]
798	11597317	11597317_27	4394	4538	of	IN	4405	4407	O	[None]	[None]	[None]
799	11597317	11597317_27	4394	4538	I	PRP	4408	4409	B	['PR_reasoned_2017_04_17_Instance_49']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
800	11597317	11597317_27	4394	4538	-	:	4409	4410	I	['PR_reasoned_2017_04_17_Instance_49']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
801	11597317	11597317_27	4394	4538	SceI	NN	4410	4414	I	['PR_reasoned_2017_04_17_Instance_49']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
802	11597317	11597317_27	4394	4538	resulted	VBD	4415	4423	O	[None]	[None]	[None]
803	11597317	11597317_27	4394	4538	in	IN	4424	4426	O	[None]	[None]	[None]
804	11597317	11597317_27	4394	4538	1	CD	4427	4428	O	[None]	[None]	[None]
805	11597317	11597317_27	4394	4538	out	IN	4429	4432	O	[None]	[None]	[None]
806	11597317	11597317_27	4394	4538	of	IN	4433	4435	O	[None]	[None]	[None]
807	11597317	11597317_27	4394	4538	1400	CD	4436	4440	O	[None]	[None]	[None]
808	11597317	11597317_27	4394	4538	cells	NNS	4441	4446	O	[None]	[None]	[None]
809	11597317	11597317_27	4394	4538	producing	VBG	4447	4456	O	[None]	[None]	[None]
810	11597317	11597317_27	4394	4538	GFP	NNP	4457	4460	O	[None]	[None]	[None]
811	11597317	11597317_27	4394	4538	via	IN	4461	4464	O	[None]	[None]	[None]
812	11597317	11597317_27	4394	4538	homologous	JJ	4465	4475	O	[None]	[None]	[None]
813	11597317	11597317_27	4394	4538	recombination	NN	4476	4489	O	[None]	[None]	[None]
814	11597317	11597317_27	4394	4538	in	IN	4490	4492	O	[None]	[None]	[None]
815	11597317	11597317_27	4394	4538	the	DT	4493	4496	O	[None]	[None]	[None]
816	11597317	11597317_27	4394	4538	human	JJ	4497	4502	O	[None]	[None]	[None]
817	11597317	11597317_27	4394	4538	pancreatic	JJ	4503	4513	O	[None]	[None]	[None]
818	11597317	11597317_27	4394	4538	tumor	NN	4514	4519	O	[None]	[None]	[None]
819	11597317	11597317_27	4394	4538	cell	NN	4520	4524	O	[None]	[None]	[None]
820	11597317	11597317_27	4394	4538	line	NN	4525	4529	O	[None]	[None]	[None]
821	11597317	11597317_27	4394	4538	CAPAN	NNP	4530	4535	O	[None]	[None]	[None]
822	11597317	11597317_27	4394	4538	-	:	4535	4536	O	[None]	[None]	[None]
823	11597317	11597317_27	4394	4538	1	CD	4536	4537	O	[None]	[None]	[None]
824	11597317	11597317_27	4394	4538	.	.	4537	4538	O	[None]	[None]	[None]
825	11597317	11597317_28	4539	4668	CAPAN	NNP	4539	4544	O	[None]	[None]	[None]
826	11597317	11597317_28	4539	4668	-	:	4544	4545	O	[None]	[None]	[None]
827	11597317	11597317_28	4539	4668	1	CD	4545	4546	O	[None]	[None]	[None]
828	11597317	11597317_28	4539	4668	cells	NNS	4547	4552	O	[None]	[None]	[None]
829	11597317	11597317_28	4539	4668	carry	VBP	4553	4558	O	[None]	[None]	[None]
830	11597317	11597317_28	4539	4668	a	DT	4559	4560	O	[None]	[None]	[None]
831	11597317	11597317_28	4539	4668	deletion	NN	4561	4569	O	[None]	[None]	[None]
832	11597317	11597317_28	4539	4668	of	IN	4570	4572	O	[None]	[None]	[None]
833	11597317	11597317_28	4539	4668	BRCA2	NNP	4573	4578	B	['PR_reasoned_2017_04_17_Instance_30283']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
834	11597317	11597317_28	4539	4668	on	IN	4579	4581	O	[None]	[None]	[None]
835	11597317	11597317_28	4539	4668	one	CD	4582	4585	O	[None]	[None]	[None]
836	11597317	11597317_28	4539	4668	homolog	NN	4586	4593	O	[None]	[None]	[None]
837	11597317	11597317_28	4539	4668	and	CC	4594	4597	O	[None]	[None]	[None]
838	11597317	11597317_28	4539	4668	codes	NNS	4598	4603	O	[None]	[None]	[None]
839	11597317	11597317_28	4539	4668	for	IN	4604	4607	O	[None]	[None]	[None]
840	11597317	11597317_28	4539	4668	a	DT	4608	4609	O	[None]	[None]	[None]
841	11597317	11597317_28	4539	4668	protein	NN	4610	4617	O	[None]	[None]	[None]
842	11597317	11597317_28	4539	4668	truncated	VBN	4618	4627	O	[None]	[None]	[None]
843	11597317	11597317_28	4539	4668	at	IN	4628	4630	O	[None]	[None]	[None]
844	11597317	11597317_28	4539	4668	amino	NN	4631	4636	O	[None]	[None]	[None]
845	11597317	11597317_28	4539	4668	acid	NN	4637	4641	O	[None]	[None]	[None]
846	11597317	11597317_28	4539	4668	1981	CD	4642	4646	O	[None]	[None]	[None]
847	11597317	11597317_28	4539	4668	on	IN	4647	4649	O	[None]	[None]	[None]
848	11597317	11597317_28	4539	4668	the	DT	4650	4653	O	[None]	[None]	[None]
849	11597317	11597317_28	4539	4668	other	JJ	4654	4659	O	[None]	[None]	[None]
850	11597317	11597317_28	4539	4668	homolog	NN	4660	4667	O	[None]	[None]	[None]
851	11597317	11597317_28	4539	4668	.	.	4667	4668	O	[None]	[None]	[None]
852	11597317	11597317_29	4669	4829	The	DT	4669	4672	O	[None]	[None]	[None]
853	11597317	11597317_29	4669	4829	authors	NNS	4673	4680	O	[None]	[None]	[None]
854	11597317	11597317_29	4669	4829	indicate	VBP	4681	4689	O	[None]	[None]	[None]
855	11597317	11597317_29	4669	4829	that	IN	4690	4694	O	[None]	[None]	[None]
856	11597317	11597317_29	4669	4829	the	DT	4695	4698	O	[None]	[None]	[None]
857	11597317	11597317_29	4669	4829	level	NN	4699	4704	O	[None]	[None]	[None]
858	11597317	11597317_29	4669	4829	of	IN	4705	4707	O	[None]	[None]	[None]
859	11597317	11597317_29	4669	4829	I	PRP	4708	4709	B	['PR_reasoned_2017_04_17_Instance_51']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
860	11597317	11597317_29	4669	4829	-	:	4709	4710	I	['PR_reasoned_2017_04_17_Instance_51']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
861	11597317	11597317_29	4669	4829	SceI	NNP	4710	4714	I	['PR_reasoned_2017_04_17_Instance_51']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
862	11597317	11597317_29	4669	4829	-	:	4714	4715	O	[None]	[None]	[None]
863	11597317	11597317_29	4669	4829	induced	JJ	4715	4722	O	[None]	[None]	[None]
864	11597317	11597317_29	4669	4829	recombination	NN	4723	4736	O	[None]	[None]	[None]
865	11597317	11597317_29	4669	4829	in	IN	4737	4739	O	[None]	[None]	[None]
866	11597317	11597317_29	4669	4829	CAPAN	NNP	4740	4745	O	[None]	[None]	[None]
867	11597317	11597317_29	4669	4829	-	:	4745	4746	O	[None]	[None]	[None]
868	11597317	11597317_29	4669	4829	1	CD	4746	4747	O	[None]	[None]	[None]
869	11597317	11597317_29	4669	4829	is	VBZ	4748	4750	O	[None]	[None]	[None]
870	11597317	11597317_29	4669	4829	over	IN	4751	4755	O	[None]	[None]	[None]
871	11597317	11597317_29	4669	4829	100	CD	4756	4759	O	[None]	[None]	[None]
872	11597317	11597317_29	4669	4829	-	:	4759	4760	O	[None]	[None]	[None]
873	11597317	11597317_29	4669	4829	fold	NN	4760	4764	O	[None]	[None]	[None]
874	11597317	11597317_29	4669	4829	less	JJR	4765	4769	O	[None]	[None]	[None]
875	11597317	11597317_29	4669	4829	than	IN	4770	4774	O	[None]	[None]	[None]
876	11597317	11597317_29	4669	4829	that	DT	4775	4779	O	[None]	[None]	[None]
877	11597317	11597317_29	4669	4829	seen	VBN	4780	4784	O	[None]	[None]	[None]
878	11597317	11597317_29	4669	4829	using	VBG	4785	4790	O	[None]	[None]	[None]
879	11597317	11597317_29	4669	4829	other	JJ	4791	4796	O	[None]	[None]	[None]
880	11597317	11597317_29	4669	4829	(	(	4797	4798	O	[None]	[None]	[None]
881	11597317	11597317_29	4669	4829	BRCA2	NNP	4798	4803	B	['PR_reasoned_2017_04_17_Instance_30285']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
882	11597317	11597317_29	4669	4829	+)	NNP	4803	4805	O	[None]	[None]	[None]
883	11597317	11597317_29	4669	4829	human	JJ	4806	4811	O	[None]	[None]	[None]
884	11597317	11597317_29	4669	4829	tumor	NN	4812	4817	O	[None]	[None]	[None]
885	11597317	11597317_29	4669	4829	cell	NN	4818	4822	O	[None]	[None]	[None]
886	11597317	11597317_29	4669	4829	lines	NNS	4823	4828	O	[None]	[None]	[None]
887	11597317	11597317_29	4669	4829	.	.	4828	4829	O	[None]	[None]	[None]
888	11597317	11597317_30	4830	5006	The	DT	4830	4833	O	[None]	[None]	[None]
889	11597317	11597317_30	4830	5006	different	JJ	4834	4843	O	[None]	[None]	[None]
890	11597317	11597317_30	4830	5006	lines	NNS	4844	4849	O	[None]	[None]	[None]
891	11597317	11597317_30	4830	5006	examined	VBD	4850	4858	O	[None]	[None]	[None]
892	11597317	11597317_30	4830	5006	,	,	4858	4859	O	[None]	[None]	[None]
893	11597317	11597317_30	4830	5006	however	RB	4860	4867	O	[None]	[None]	[None]
894	11597317	11597317_30	4830	5006	,	,	4867	4868	O	[None]	[None]	[None]
895	11597317	11597317_30	4830	5006	are	VBP	4869	4872	O	[None]	[None]	[None]
896	11597317	11597317_30	4830	5006	very	RB	4873	4877	O	[None]	[None]	[None]
897	11597317	11597317_30	4830	5006	likely	JJ	4878	4884	O	[None]	[None]	[None]
898	11597317	11597317_30	4830	5006	to	TO	4885	4887	O	[None]	[None]	[None]
899	11597317	11597317_30	4830	5006	differ	VB	4888	4894	O	[None]	[None]	[None]
900	11597317	11597317_30	4830	5006	genetically	RB	4895	4906	O	[None]	[None]	[None]
901	11597317	11597317_30	4830	5006	from	IN	4907	4911	O	[None]	[None]	[None]
902	11597317	11597317_30	4830	5006	CAPAN	NNP	4912	4917	O	[None]	[None]	[None]
903	11597317	11597317_30	4830	5006	-	:	4917	4918	O	[None]	[None]	[None]
904	11597317	11597317_30	4830	5006	1	CD	4918	4919	O	[None]	[None]	[None]
905	11597317	11597317_30	4830	5006	cells	NNS	4920	4925	O	[None]	[None]	[None]
906	11597317	11597317_30	4830	5006	not	RB	4926	4929	O	[None]	[None]	[None]
907	11597317	11597317_30	4830	5006	only	RB	4930	4934	O	[None]	[None]	[None]
908	11597317	11597317_30	4830	5006	at	IN	4935	4937	O	[None]	[None]	[None]
909	11597317	11597317_30	4830	5006	the	DT	4938	4941	O	[None]	[None]	[None]
910	11597317	11597317_30	4830	5006	BRCA2	NNP	4942	4947	B	['PR_reasoned_2017_04_17_Instance_30287']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
911	11597317	11597317_30	4830	5006	locus	NN	4948	4953	O	[None]	[None]	[None]
912	11597317	11597317_30	4830	5006	,	,	4953	4954	O	[None]	[None]	[None]
913	11597317	11597317_30	4830	5006	but	CC	4955	4958	O	[None]	[None]	[None]
914	11597317	11597317_30	4830	5006	also	RB	4959	4963	O	[None]	[None]	[None]
915	11597317	11597317_30	4830	5006	at	IN	4964	4966	O	[None]	[None]	[None]
916	11597317	11597317_30	4830	5006	a	DT	4967	4968	O	[None]	[None]	[None]
917	11597317	11597317_30	4830	5006	very	RB	4969	4973	O	[None]	[None]	[None]
918	11597317	11597317_30	4830	5006	large	JJ	4974	4979	O	[None]	[None]	[None]
919	11597317	11597317_30	4830	5006	number	NN	4980	4986	O	[None]	[None]	[None]
920	11597317	11597317_30	4830	5006	of	IN	4987	4989	O	[None]	[None]	[None]
921	11597317	11597317_30	4830	5006	additional	JJ	4990	5000	O	[None]	[None]	[None]
922	11597317	11597317_30	4830	5006	loci	NN	5001	5005	O	[None]	[None]	[None]
923	11597317	11597317_30	4830	5006	.	.	5005	5006	O	[None]	[None]	[None]
924	11597317	11597317_31	5007	5154	This	DT	5007	5011	O	[None]	[None]	[None]
925	11597317	11597317_31	5007	5154	raises	VBZ	5012	5018	O	[None]	[None]	[None]
926	11597317	11597317_31	5007	5154	the	DT	5019	5022	O	[None]	[None]	[None]
927	11597317	11597317_31	5007	5154	possibility	NN	5023	5034	O	[None]	[None]	[None]
928	11597317	11597317_31	5007	5154	that	IN	5035	5039	O	[None]	[None]	[None]
929	11597317	11597317_31	5007	5154	some	DT	5040	5044	O	[None]	[None]	[None]
930	11597317	11597317_31	5007	5154	or	CC	5045	5047	O	[None]	[None]	[None]
931	11597317	11597317_31	5007	5154	even	RB	5048	5052	O	[None]	[None]	[None]
932	11597317	11597317_31	5007	5154	all	DT	5053	5056	O	[None]	[None]	[None]
933	11597317	11597317_31	5007	5154	of	IN	5057	5059	O	[None]	[None]	[None]
934	11597317	11597317_31	5007	5154	the	DT	5060	5063	O	[None]	[None]	[None]
935	11597317	11597317_31	5007	5154	recombinational	JJ	5064	5079	O	[None]	[None]	[None]
936	11597317	11597317_31	5007	5154	repair	NN	5080	5086	O	[None]	[None]	[None]
937	11597317	11597317_31	5007	5154	defect	NN	5087	5093	O	[None]	[None]	[None]
938	11597317	11597317_31	5007	5154	seen	VBN	5094	5098	O	[None]	[None]	[None]
939	11597317	11597317_31	5007	5154	in	IN	5099	5101	O	[None]	[None]	[None]
940	11597317	11597317_31	5007	5154	CAPAN	NNP	5102	5107	O	[None]	[None]	[None]
941	11597317	11597317_31	5007	5154	-	:	5107	5108	O	[None]	[None]	[None]
942	11597317	11597317_31	5007	5154	1	CD	5108	5109	O	[None]	[None]	[None]
943	11597317	11597317_31	5007	5154	could	MD	5110	5115	O	[None]	[None]	[None]
944	11597317	11597317_31	5007	5154	be	VB	5116	5118	O	[None]	[None]	[None]
945	11597317	11597317_31	5007	5154	due	JJ	5119	5122	O	[None]	[None]	[None]
946	11597317	11597317_31	5007	5154	to	TO	5123	5125	O	[None]	[None]	[None]
947	11597317	11597317_31	5007	5154	mutations	NNS	5126	5135	O	[None]	[None]	[None]
948	11597317	11597317_31	5007	5154	at	IN	5136	5138	O	[None]	[None]	[None]
949	11597317	11597317_31	5007	5154	non	JJ	5139	5142	O	[None]	[None]	[None]
950	11597317	11597317_31	5007	5154	-	:	5142	5143	O	[None]	[None]	[None]
951	11597317	11597317_31	5007	5154	BRCA2	NNP	5143	5148	B	['PR_reasoned_2017_04_17_Instance_30289']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
952	11597317	11597317_31	5007	5154	loci	NN	5149	5153	O	[None]	[None]	[None]
953	11597317	11597317_31	5007	5154	.	.	5153	5154	O	[None]	[None]	[None]
954	11597317	11597317_32	5156	5376	While	IN	5156	5161	O	[None]	[None]	[None]
955	11597317	11597317_32	5156	5376	Moynahan	NNP	5162	5170	O	[None]	[None]	[None]
956	11597317	11597317_32	5156	5376	et	VBP	5171	5173	O	[None]	[None]	[None]
957	11597317	11597317_32	5156	5376	al	NNS	5174	5176	O	[None]	[None]	[None]
958	11597317	11597317_32	5156	5376	were	VBD	5177	5181	O	[None]	[None]	[None]
959	11597317	11597317_32	5156	5376	careful	JJ	5182	5189	O	[None]	[None]	[None]
960	11597317	11597317_32	5156	5376	to	TO	5190	5192	O	[None]	[None]	[None]
961	11597317	11597317_32	5156	5376	point	VB	5193	5198	O	[None]	[None]	[None]
962	11597317	11597317_32	5156	5376	out	RP	5199	5202	O	[None]	[None]	[None]
963	11597317	11597317_32	5156	5376	this	DT	5203	5207	O	[None]	[None]	[None]
964	11597317	11597317_32	5156	5376	problem	NN	5208	5215	O	[None]	[None]	[None]
965	11597317	11597317_32	5156	5376	,	,	5215	5216	O	[None]	[None]	[None]
966	11597317	11597317_32	5156	5376	two	CD	5217	5220	O	[None]	[None]	[None]
967	11597317	11597317_32	5156	5376	sets	NNS	5221	5225	O	[None]	[None]	[None]
968	11597317	11597317_32	5156	5376	of	IN	5226	5228	O	[None]	[None]	[None]
969	11597317	11597317_32	5156	5376	results	NNS	5229	5236	O	[None]	[None]	[None]
970	11597317	11597317_32	5156	5376	argue	VBP	5237	5242	O	[None]	[None]	[None]
971	11597317	11597317_32	5156	5376	against	IN	5243	5250	O	[None]	[None]	[None]
972	11597317	11597317_32	5156	5376	the	DT	5251	5254	O	[None]	[None]	[None]
973	11597317	11597317_32	5156	5376	possibility	NN	5255	5266	O	[None]	[None]	[None]
974	11597317	11597317_32	5156	5376	that	IN	5267	5271	O	[None]	[None]	[None]
975	11597317	11597317_32	5156	5376	the	DT	5272	5275	O	[None]	[None]	[None]
976	11597317	11597317_32	5156	5376	recombinational	JJ	5276	5291	O	[None]	[None]	[None]
977	11597317	11597317_32	5156	5376	repair	NN	5292	5298	O	[None]	[None]	[None]
978	11597317	11597317_32	5156	5376	deficiency	NN	5299	5309	O	[None]	[None]	[None]
979	11597317	11597317_32	5156	5376	of	IN	5310	5312	O	[None]	[None]	[None]
980	11597317	11597317_32	5156	5376	CAPAN	NNP	5313	5318	O	[None]	[None]	[None]
981	11597317	11597317_32	5156	5376	-	:	5318	5319	O	[None]	[None]	[None]
982	11597317	11597317_32	5156	5376	1	CD	5319	5320	O	[None]	[None]	[None]
983	11597317	11597317_32	5156	5376	cells	NNS	5321	5326	O	[None]	[None]	[None]
984	11597317	11597317_32	5156	5376	is	VBZ	5327	5329	O	[None]	[None]	[None]
985	11597317	11597317_32	5156	5376	completely	RB	5330	5340	O	[None]	[None]	[None]
986	11597317	11597317_32	5156	5376	independent	JJ	5341	5352	O	[None]	[None]	[None]
987	11597317	11597317_32	5156	5376	of	IN	5353	5355	O	[None]	[None]	[None]
988	11597317	11597317_32	5156	5376	its	PRP$	5356	5359	O	[None]	[None]	[None]
989	11597317	11597317_32	5156	5376	defect	NN	5360	5366	O	[None]	[None]	[None]
990	11597317	11597317_32	5156	5376	in	IN	5367	5369	O	[None]	[None]	[None]
991	11597317	11597317_32	5156	5376	BRCA2	NNP	5370	5375	B	['PR_reasoned_2017_04_17_Instance_30291']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
992	11597317	11597317_32	5156	5376	.	.	5375	5376	O	[None]	[None]	[None]
993	11597317	11597317_33	5377	5503	First	RB	5377	5382	O	[None]	[None]	[None]
994	11597317	11597317_33	5377	5503	,	,	5382	5383	O	[None]	[None]	[None]
995	11597317	11597317_33	5377	5503	in	IN	5384	5386	O	[None]	[None]	[None]
996	11597317	11597317_33	5377	5503	the	DT	5387	5390	O	[None]	[None]	[None]
997	11597317	11597317_33	5377	5503	same	JJ	5391	5395	O	[None]	[None]	[None]
998	11597317	11597317_33	5377	5503	study	NN	5396	5401	O	[None]	[None]	[None]
999	11597317	11597317_33	5377	5503	[	VBD	5402	5403	O	[None]	[None]	[None]
1000	11597317	11597317_33	5377	5503	24	CD	5403	5405	O	[None]	[None]	[None]
1001	11597317	11597317_33	5377	5503	],	JJ	5405	5407	O	[None]	[None]	[None]
1002	11597317	11597317_33	5377	5503	recombination	NN	5408	5421	O	[None]	[None]	[None]
1003	11597317	11597317_33	5377	5503	in	IN	5422	5424	O	[None]	[None]	[None]
1004	11597317	11597317_33	5377	5503	a	DT	5425	5426	O	[None]	[None]	[None]
1005	11597317	11597317_33	5377	5503	mouse	NN	5427	5432	O	[None]	[None]	[None]
1006	11597317	11597317_33	5377	5503	ES	NNP	5433	5435	O	[None]	[None]	[None]
1007	11597317	11597317_33	5377	5503	cell	NN	5436	5440	O	[None]	[None]	[None]
1008	11597317	11597317_33	5377	5503	line	NN	5441	5445	O	[None]	[None]	[None]
1009	11597317	11597317_33	5377	5503	that	WDT	5446	5450	O	[None]	[None]	[None]
1010	11597317	11597317_33	5377	5503	expresses	VBZ	5451	5460	O	[None]	[None]	[None]
1011	11597317	11597317_33	5377	5503	only	RB	5461	5465	O	[None]	[None]	[None]
1012	11597317	11597317_33	5377	5503	truncated	JJ	5466	5475	O	[None]	[None]	[None]
1013	11597317	11597317_33	5377	5503	BRCA2	NNP	5476	5481	B	['PR_reasoned_2017_04_17_Instance_30293']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1014	11597317	11597317_33	5377	5503	protein	NN	5482	5489	O	[None]	[None]	[None]
1015	11597317	11597317_33	5377	5503	was	VBD	5490	5493	O	[None]	[None]	[None]
1016	11597317	11597317_33	5377	5503	measured	VBN	5494	5502	O	[None]	[None]	[None]
1017	11597317	11597317_33	5377	5503	.	.	5502	5503	O	[None]	[None]	[None]
1018	11597317	11597317_34	5504	5664	This	DT	5504	5508	O	[None]	[None]	[None]
1019	11597317	11597317_34	5504	5664	line	NN	5509	5513	O	[None]	[None]	[None]
1020	11597317	11597317_34	5504	5664	was	VBD	5514	5517	O	[None]	[None]	[None]
1021	11597317	11597317_34	5504	5664	found	VBN	5518	5523	O	[None]	[None]	[None]
1022	11597317	11597317_34	5504	5664	to	TO	5524	5526	O	[None]	[None]	[None]
1023	11597317	11597317_34	5504	5664	have	VB	5527	5531	O	[None]	[None]	[None]
1024	11597317	11597317_34	5504	5664	lower	JJR	5532	5537	O	[None]	[None]	[None]
1025	11597317	11597317_34	5504	5664	recombination	NN	5538	5551	O	[None]	[None]	[None]
1026	11597317	11597317_34	5504	5664	efficiency	NN	5552	5562	O	[None]	[None]	[None]
1027	11597317	11597317_34	5504	5664	than	IN	5563	5567	O	[None]	[None]	[None]
1028	11597317	11597317_34	5504	5664	isogenic	JJ	5568	5576	O	[None]	[None]	[None]
1029	11597317	11597317_34	5504	5664	cells	NNS	5577	5582	O	[None]	[None]	[None]
1030	11597317	11597317_34	5504	5664	expressing	VBG	5583	5593	O	[None]	[None]	[None]
1031	11597317	11597317_34	5504	5664	full	JJ	5594	5598	O	[None]	[None]	[None]
1032	11597317	11597317_34	5504	5664	-	:	5598	5599	O	[None]	[None]	[None]
1033	11597317	11597317_34	5504	5664	length	NN	5599	5605	O	[None]	[None]	[None]
1034	11597317	11597317_34	5504	5664	BRCA2	NNP	5606	5611	B	['PR_reasoned_2017_04_17_Instance_28903']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1035	11597317	11597317_34	5504	5664	(	(	5612	5613	O	[None]	[None]	[None]
1036	11597317	11597317_34	5504	5664	the	DT	5613	5616	O	[None]	[None]	[None]
1037	11597317	11597317_34	5504	5664	defect	NN	5617	5623	O	[None]	[None]	[None]
1038	11597317	11597317_34	5504	5664	observed	VBD	5624	5632	O	[None]	[None]	[None]
1039	11597317	11597317_34	5504	5664	was	VBD	5633	5636	O	[None]	[None]	[None]
1040	11597317	11597317_34	5504	5664	about	RB	5637	5642	O	[None]	[None]	[None]
1041	11597317	11597317_34	5504	5664	fivefold	JJ	5643	5651	O	[None]	[None]	[None]
1042	11597317	11597317_34	5504	5664	to	TO	5652	5654	O	[None]	[None]	[None]
1043	11597317	11597317_34	5504	5664	sixfold	VB	5655	5662	O	[None]	[None]	[None]
1044	11597317	11597317_34	5504	5664	).	NN	5662	5664	O	[None]	[None]	[None]
1045	11597317	11597317_35	5665	5863	Second	JJ	5665	5671	O	[None]	[None]	[None]
1046	11597317	11597317_35	5665	5863	,	,	5671	5672	O	[None]	[None]	[None]
1047	11597317	11597317_35	5665	5863	in	IN	5673	5675	O	[None]	[None]	[None]
1048	11597317	11597317_35	5665	5863	an	DT	5676	5678	O	[None]	[None]	[None]
1049	11597317	11597317_35	5665	5863	independent	JJ	5679	5690	O	[None]	[None]	[None]
1050	11597317	11597317_35	5665	5863	study	NN	5691	5696	O	[None]	[None]	[None]
1051	11597317	11597317_35	5665	5863	,	,	5696	5697	O	[None]	[None]	[None]
1052	11597317	11597317_35	5665	5863	Powell	NNP	5698	5704	O	[None]	[None]	[None]
1053	11597317	11597317_35	5665	5863	was	VBD	5705	5708	O	[None]	[None]	[None]
1054	11597317	11597317_35	5665	5863	able	JJ	5709	5713	O	[None]	[None]	[None]
1055	11597317	11597317_35	5665	5863	to	TO	5714	5716	O	[None]	[None]	[None]
1056	11597317	11597317_35	5665	5863	compare	VB	5717	5724	O	[None]	[None]	[None]
1057	11597317	11597317_35	5665	5863	derivatives	NNS	5725	5736	O	[None]	[None]	[None]
1058	11597317	11597317_35	5665	5863	of	IN	5737	5739	O	[None]	[None]	[None]
1059	11597317	11597317_35	5665	5863	CAPAN	NNP	5740	5745	O	[None]	[None]	[None]
1060	11597317	11597317_35	5665	5863	-	:	5745	5746	O	[None]	[None]	[None]
1061	11597317	11597317_35	5665	5863	1	CD	5746	5747	O	[None]	[None]	[None]
1062	11597317	11597317_35	5665	5863	that	WDT	5748	5752	O	[None]	[None]	[None]
1063	11597317	11597317_35	5665	5863	differed	VBD	5753	5761	O	[None]	[None]	[None]
1064	11597317	11597317_35	5665	5863	only	RB	5762	5766	O	[None]	[None]	[None]
1065	11597317	11597317_35	5665	5863	in	IN	5767	5769	O	[None]	[None]	[None]
1066	11597317	11597317_35	5665	5863	their	PRP$	5770	5775	O	[None]	[None]	[None]
1067	11597317	11597317_35	5665	5863	ability	NN	5776	5783	O	[None]	[None]	[None]
1068	11597317	11597317_35	5665	5863	to	TO	5784	5786	O	[None]	[None]	[None]
1069	11597317	11597317_35	5665	5863	express	VB	5787	5794	O	[None]	[None]	[None]
1070	11597317	11597317_35	5665	5863	full	JJ	5795	5799	O	[None]	[None]	[None]
1071	11597317	11597317_35	5665	5863	-	:	5799	5800	O	[None]	[None]	[None]
1072	11597317	11597317_35	5665	5863	length	NN	5800	5806	O	[None]	[None]	[None]
1073	11597317	11597317_35	5665	5863	BRCA2	NNP	5807	5812	B	['PR_reasoned_2017_04_17_Instance_28925']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1074	11597317	11597317_35	5665	5863	protein	NN	5813	5820	O	[None]	[None]	[None]
1075	11597317	11597317_35	5665	5863	(	(	5821	5822	O	[None]	[None]	[None]
1076	11597317	11597317_35	5665	5863	S	NNP	5822	5823	O	[None]	[None]	[None]
1077	11597317	11597317_35	5665	5863	.	.	5823	5824	O	[None]	[None]	[None]
1078	11597317	11597317_35	5665	5863	Powell	NNP	5825	5831	O	[None]	[None]	[None]
1079	11597317	11597317_35	5665	5863	,	,	5831	5832	O	[None]	[None]	[None]
1080	11597317	11597317_35	5665	5863	personal	JJ	5833	5841	O	[None]	[None]	[None]
1081	11597317	11597317_35	5665	5863	communication	NN	5842	5855	O	[None]	[None]	[None]
1082	11597317	11597317_35	5665	5863	,	,	5855	5856	O	[None]	[None]	[None]
1083	11597317	11597317_35	5665	5863	2001	CD	5857	5861	O	[None]	[None]	[None]
1084	11597317	11597317_35	5665	5863	).	NN	5861	5863	O	[None]	[None]	[None]
1085	11597317	11597317_36	5864	6052	In	IN	5864	5866	O	[None]	[None]	[None]
1086	11597317	11597317_36	5864	6052	these	DT	5867	5872	O	[None]	[None]	[None]
1087	11597317	11597317_36	5864	6052	experiments	NNS	5873	5884	O	[None]	[None]	[None]
1088	11597317	11597317_36	5864	6052	,	,	5884	5885	O	[None]	[None]	[None]
1089	11597317	11597317_36	5864	6052	the	DT	5886	5889	O	[None]	[None]	[None]
1090	11597317	11597317_36	5864	6052	derivative	JJ	5890	5900	O	[None]	[None]	[None]
1091	11597317	11597317_36	5864	6052	expressing	NN	5901	5911	O	[None]	[None]	[None]
1092	11597317	11597317_36	5864	6052	full	JJ	5912	5916	O	[None]	[None]	[None]
1093	11597317	11597317_36	5864	6052	-	:	5916	5917	O	[None]	[None]	[None]
1094	11597317	11597317_36	5864	6052	length	NN	5917	5923	O	[None]	[None]	[None]
1095	11597317	11597317_36	5864	6052	BRCA2	NNP	5924	5929	B	['PR_reasoned_2017_04_17_Instance_28947']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1096	11597317	11597317_36	5864	6052	yielded	VBD	5930	5937	O	[None]	[None]	[None]
1097	11597317	11597317_36	5864	6052	10	CD	5938	5940	O	[None]	[None]	[None]
1098	11597317	11597317_36	5864	6052	-	:	5940	5941	O	[None]	[None]	[None]
1099	11597317	11597317_36	5864	6052	fold	NN	5941	5945	O	[None]	[None]	[None]
1100	11597317	11597317_36	5864	6052	more	JJR	5946	5950	O	[None]	[None]	[None]
1101	11597317	11597317_36	5864	6052	recombinants	NNS	5951	5963	O	[None]	[None]	[None]
1102	11597317	11597317_36	5864	6052	than	IN	5964	5968	O	[None]	[None]	[None]
1103	11597317	11597317_36	5864	6052	controls	NNS	5969	5977	O	[None]	[None]	[None]
1104	11597317	11597317_36	5864	6052	expressing	VBG	5978	5988	O	[None]	[None]	[None]
1105	11597317	11597317_36	5864	6052	only	RB	5989	5993	O	[None]	[None]	[None]
1106	11597317	11597317_36	5864	6052	truncated	VBN	5994	6003	O	[None]	[None]	[None]
1107	11597317	11597317_36	5864	6052	BRCA2	NNP	6004	6009	B	['PR_reasoned_2017_04_17_Instance_28969']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1108	11597317	11597317_36	5864	6052	(	(	6010	6011	O	[None]	[None]	[None]
1109	11597317	11597317_36	5864	6052	S	NNP	6011	6012	O	[None]	[None]	[None]
1110	11597317	11597317_36	5864	6052	.	.	6012	6013	O	[None]	[None]	[None]
1111	11597317	11597317_36	5864	6052	Powell	NNP	6014	6020	O	[None]	[None]	[None]
1112	11597317	11597317_36	5864	6052	,	,	6020	6021	O	[None]	[None]	[None]
1113	11597317	11597317_36	5864	6052	personal	JJ	6022	6030	O	[None]	[None]	[None]
1114	11597317	11597317_36	5864	6052	communication	NN	6031	6044	O	[None]	[None]	[None]
1115	11597317	11597317_36	5864	6052	,	,	6044	6045	O	[None]	[None]	[None]
1116	11597317	11597317_36	5864	6052	2001	CD	6046	6050	O	[None]	[None]	[None]
1117	11597317	11597317_36	5864	6052	).	NN	6050	6052	O	[None]	[None]	[None]
1118	11597317	11597317_37	6053	6348	While	IN	6053	6058	O	[None]	[None]	[None]
1119	11597317	11597317_37	6053	6348	the	DT	6059	6062	O	[None]	[None]	[None]
1120	11597317	11597317_37	6053	6348	experimental	JJ	6063	6075	O	[None]	[None]	[None]
1121	11597317	11597317_37	6053	6348	design	NN	6076	6082	O	[None]	[None]	[None]
1122	11597317	11597317_37	6053	6348	of	IN	6083	6085	O	[None]	[None]	[None]
1123	11597317	11597317_37	6053	6348	these	DT	6086	6091	O	[None]	[None]	[None]
1124	11597317	11597317_37	6053	6348	experiments	NNS	6092	6103	O	[None]	[None]	[None]
1125	11597317	11597317_37	6053	6348	was	VBD	6104	6107	O	[None]	[None]	[None]
1126	11597317	11597317_37	6053	6348	somewhat	RB	6108	6116	O	[None]	[None]	[None]
1127	11597317	11597317_37	6053	6348	different	JJ	6117	6126	O	[None]	[None]	[None]
1128	11597317	11597317_37	6053	6348	from	IN	6127	6131	O	[None]	[None]	[None]
1129	11597317	11597317_37	6053	6348	that	DT	6132	6136	O	[None]	[None]	[None]
1130	11597317	11597317_37	6053	6348	of	IN	6137	6139	O	[None]	[None]	[None]
1131	11597317	11597317_37	6053	6348	Moyna	NNP	6140	6145	O	[None]	[None]	[None]
1132	11597317	11597317_37	6053	6348	-	:	6145	6146	O	[None]	[None]	[None]
1133	11597317	11597317_37	6053	6348	han	NN	6146	6149	O	[None]	[None]	[None]
1134	11597317	11597317_37	6053	6348	et	VBZ	6150	6152	O	[None]	[None]	[None]
1135	11597317	11597317_37	6053	6348	al	JJ	6153	6155	O	[None]	[None]	[None]
1136	11597317	11597317_37	6053	6348	[	NNP	6156	6157	O	[None]	[None]	[None]
1137	11597317	11597317_37	6053	6348	24	CD	6157	6159	O	[None]	[None]	[None]
1138	11597317	11597317_37	6053	6348	],	VBD	6159	6161	O	[None]	[None]	[None]
1139	11597317	11597317_37	6053	6348	the	DT	6162	6165	O	[None]	[None]	[None]
1140	11597317	11597317_37	6053	6348	results	NNS	6166	6173	O	[None]	[None]	[None]
1141	11597317	11597317_37	6053	6348	raise	VBP	6174	6179	O	[None]	[None]	[None]
1142	11597317	11597317_37	6053	6348	the	DT	6180	6183	O	[None]	[None]	[None]
1143	11597317	11597317_37	6053	6348	possibility	NN	6184	6195	O	[None]	[None]	[None]
1144	11597317	11597317_37	6053	6348	that	IN	6196	6200	O	[None]	[None]	[None]
1145	11597317	11597317_37	6053	6348	CAPAN	NNP	6201	6206	O	[None]	[None]	[None]
1146	11597317	11597317_37	6053	6348	-	:	6206	6207	O	[None]	[None]	[None]
1147	11597317	11597317_37	6053	6348	1	CD	6207	6208	O	[None]	[None]	[None]
1148	11597317	11597317_37	6053	6348	cells	NNS	6209	6214	O	[None]	[None]	[None]
1149	11597317	11597317_37	6053	6348	have	VBP	6215	6219	O	[None]	[None]	[None]
1150	11597317	11597317_37	6053	6348	more	JJR	6220	6224	O	[None]	[None]	[None]
1151	11597317	11597317_37	6053	6348	than	IN	6225	6229	O	[None]	[None]	[None]
1152	11597317	11597317_37	6053	6348	one	CD	6230	6233	O	[None]	[None]	[None]
1153	11597317	11597317_37	6053	6348	mutation	NN	6234	6242	O	[None]	[None]	[None]
1154	11597317	11597317_37	6053	6348	that	WDT	6243	6247	O	[None]	[None]	[None]
1155	11597317	11597317_37	6053	6348	lowers	VBZ	6248	6254	O	[None]	[None]	[None]
1156	11597317	11597317_37	6053	6348	the	DT	6255	6258	O	[None]	[None]	[None]
1157	11597317	11597317_37	6053	6348	efficiency	NN	6259	6269	O	[None]	[None]	[None]
1158	11597317	11597317_37	6053	6348	of	IN	6270	6272	O	[None]	[None]	[None]
1159	11597317	11597317_37	6053	6348	recombinational	JJ	6273	6288	O	[None]	[None]	[None]
1160	11597317	11597317_37	6053	6348	repair	NN	6289	6295	O	[None]	[None]	[None]
1161	11597317	11597317_37	6053	6348	relative	JJ	6296	6304	O	[None]	[None]	[None]
1162	11597317	11597317_37	6053	6348	to	TO	6305	6307	O	[None]	[None]	[None]
1163	11597317	11597317_37	6053	6348	that	DT	6308	6312	O	[None]	[None]	[None]
1164	11597317	11597317_37	6053	6348	observed	VBN	6313	6321	O	[None]	[None]	[None]
1165	11597317	11597317_37	6053	6348	in	IN	6322	6324	O	[None]	[None]	[None]
1166	11597317	11597317_37	6053	6348	other	JJ	6325	6330	O	[None]	[None]	[None]
1167	11597317	11597317_37	6053	6348	human	JJ	6331	6336	O	[None]	[None]	[None]
1168	11597317	11597317_37	6053	6348	cell	NN	6337	6341	O	[None]	[None]	[None]
1169	11597317	11597317_37	6053	6348	lines	NNS	6342	6347	O	[None]	[None]	[None]
1170	11597317	11597317_37	6053	6348	.	.	6347	6348	O	[None]	[None]	[None]
1171	11597317	11597317_38	6349	6529	Conversely	RB	6349	6359	O	[None]	[None]	[None]
1172	11597317	11597317_38	6349	6529	,	,	6359	6360	O	[None]	[None]	[None]
1173	11597317	11597317_38	6349	6529	the	DT	6361	6364	O	[None]	[None]	[None]
1174	11597317	11597317_38	6349	6529	BRCA2	NNP	6365	6370	B	['PR_reasoned_2017_04_17_Instance_28991']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1175	11597317	11597317_38	6349	6529	defect	NN	6371	6377	O	[None]	[None]	[None]
1176	11597317	11597317_38	6349	6529	in	IN	6378	6380	O	[None]	[None]	[None]
1177	11597317	11597317_38	6349	6529	CAPAN	NNP	6381	6386	O	[None]	[None]	[None]
1178	11597317	11597317_38	6349	6529	-	:	6386	6387	O	[None]	[None]	[None]
1179	11597317	11597317_38	6349	6529	1	CD	6387	6388	O	[None]	[None]	[None]
1180	11597317	11597317_38	6349	6529	could	MD	6389	6394	O	[None]	[None]	[None]
1181	11597317	11597317_38	6349	6529	be	VB	6395	6397	O	[None]	[None]	[None]
1182	11597317	11597317_38	6349	6529	fully	RB	6398	6403	O	[None]	[None]	[None]
1183	11597317	11597317_38	6349	6529	responsible	JJ	6404	6415	O	[None]	[None]	[None]
1184	11597317	11597317_38	6349	6529	for	IN	6416	6419	O	[None]	[None]	[None]
1185	11597317	11597317_38	6349	6529	the	DT	6420	6423	O	[None]	[None]	[None]
1186	11597317	11597317_38	6349	6529	100	CD	6424	6427	O	[None]	[None]	[None]
1187	11597317	11597317_38	6349	6529	-	:	6427	6428	O	[None]	[None]	[None]
1188	11597317	11597317_38	6349	6529	fold	NN	6428	6432	O	[None]	[None]	[None]
1189	11597317	11597317_38	6349	6529	defect	NN	6433	6439	O	[None]	[None]	[None]
1190	11597317	11597317_38	6349	6529	in	IN	6440	6442	O	[None]	[None]	[None]
1191	11597317	11597317_38	6349	6529	recombination	NN	6443	6456	O	[None]	[None]	[None]
1192	11597317	11597317_38	6349	6529	if	IN	6457	6459	O	[None]	[None]	[None]
1193	11597317	11597317_38	6349	6529	the	DT	6460	6463	O	[None]	[None]	[None]
1194	11597317	11597317_38	6349	6529	level	NN	6464	6469	O	[None]	[None]	[None]
1195	11597317	11597317_38	6349	6529	of	IN	6470	6472	O	[None]	[None]	[None]
1196	11597317	11597317_38	6349	6529	BRCA2	NNP	6473	6478	B	['PR_reasoned_2017_04_17_Instance_30295']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1197	11597317	11597317_38	6349	6529	complementation	NN	6479	6494	O	[None]	[None]	[None]
1198	11597317	11597317_38	6349	6529	observed	VBN	6495	6503	O	[None]	[None]	[None]
1199	11597317	11597317_38	6349	6529	by	IN	6504	6506	O	[None]	[None]	[None]
1200	11597317	11597317_38	6349	6529	Powell	NNP	6507	6513	O	[None]	[None]	[None]
1201	11597317	11597317_38	6349	6529	was	VBD	6514	6517	O	[None]	[None]	[None]
1202	11597317	11597317_38	6349	6529	incomplete	JJ	6518	6528	O	[None]	[None]	[None]
1203	11597317	11597317_38	6349	6529	.	.	6528	6529	O	[None]	[None]	[None]
1204	11597317	11597317_39	6530	6822	Furthermore	RB	6530	6541	O	[None]	[None]	[None]
1205	11597317	11597317_39	6530	6822	,	,	6541	6542	O	[None]	[None]	[None]
1206	11597317	11597317_39	6530	6822	the	DT	6543	6546	O	[None]	[None]	[None]
1207	11597317	11597317_39	6530	6822	discrepancy	NN	6547	6558	O	[None]	[None]	[None]
1208	11597317	11597317_39	6530	6822	between	IN	6559	6566	O	[None]	[None]	[None]
1209	11597317	11597317_39	6530	6822	the	DT	6567	6570	O	[None]	[None]	[None]
1210	11597317	11597317_39	6530	6822	100	CD	6571	6574	O	[None]	[None]	[None]
1211	11597317	11597317_39	6530	6822	-	:	6574	6575	O	[None]	[None]	[None]
1212	11597317	11597317_39	6530	6822	fold	NN	6575	6579	O	[None]	[None]	[None]
1213	11597317	11597317_39	6530	6822	difference	NN	6580	6590	O	[None]	[None]	[None]
1214	11597317	11597317_39	6530	6822	between	IN	6591	6598	O	[None]	[None]	[None]
1215	11597317	11597317_39	6530	6822	CAPAN	NNP	6599	6604	O	[None]	[None]	[None]
1216	11597317	11597317_39	6530	6822	-	:	6604	6605	O	[None]	[None]	[None]
1217	11597317	11597317_39	6530	6822	1	CD	6605	6606	O	[None]	[None]	[None]
1218	11597317	11597317_39	6530	6822	and	CC	6607	6610	O	[None]	[None]	[None]
1219	11597317	11597317_39	6530	6822	the	DT	6611	6614	O	[None]	[None]	[None]
1220	11597317	11597317_39	6530	6822	other	JJ	6615	6620	O	[None]	[None]	[None]
1221	11597317	11597317_39	6530	6822	human	JJ	6621	6626	O	[None]	[None]	[None]
1222	11597317	11597317_39	6530	6822	lines	NNS	6627	6632	O	[None]	[None]	[None]
1223	11597317	11597317_39	6530	6822	as	IN	6633	6635	O	[None]	[None]	[None]
1224	11597317	11597317_39	6530	6822	compared	VBN	6636	6644	O	[None]	[None]	[None]
1225	11597317	11597317_39	6530	6822	with	IN	6645	6649	O	[None]	[None]	[None]
1226	11597317	11597317_39	6530	6822	the	DT	6650	6653	O	[None]	[None]	[None]
1227	11597317	11597317_39	6530	6822	fivefold	NN	6654	6662	O	[None]	[None]	[None]
1228	11597317	11597317_39	6530	6822	to	TO	6663	6665	O	[None]	[None]	[None]
1229	11597317	11597317_39	6530	6822	sixfold	VB	6666	6673	O	[None]	[None]	[None]
1230	11597317	11597317_39	6530	6822	difference	NN	6674	6684	O	[None]	[None]	[None]
1231	11597317	11597317_39	6530	6822	between	IN	6685	6692	O	[None]	[None]	[None]
1232	11597317	11597317_39	6530	6822	the	DT	6693	6696	O	[None]	[None]	[None]
1233	11597317	11597317_39	6530	6822	Brca2lex1	NNP	6697	6706	B	['PR_reasoned_2017_04_17_Instance_53']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1234	11597317	11597317_39	6530	6822	/	NNP	6706	6707	O	[None]	[None]	[None]
1235	11597317	11597317_39	6530	6822	lex2cells	NNS	6707	6716	O	[None]	[None]	[None]
1236	11597317	11597317_39	6530	6822	and	CC	6717	6720	O	[None]	[None]	[None]
1237	11597317	11597317_39	6530	6822	Brca2	NNP	6721	6726	B	['PR_reasoned_2017_04_17_Instance_30297']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1238	11597317	11597317_39	6530	6822	+/+	NNP	6726	6729	O	[None]	[None]	[None]
1239	11597317	11597317_39	6530	6822	ES	NNP	6730	6732	O	[None]	[None]	[None]
1240	11597317	11597317_39	6530	6822	cells	NNS	6733	6738	O	[None]	[None]	[None]
1241	11597317	11597317_39	6530	6822	might	MD	6739	6744	O	[None]	[None]	[None]
1242	11597317	11597317_39	6530	6822	simply	RB	6745	6751	O	[None]	[None]	[None]
1243	11597317	11597317_39	6530	6822	be	VB	6752	6754	O	[None]	[None]	[None]
1244	11597317	11597317_39	6530	6822	accounted	VBN	6755	6764	O	[None]	[None]	[None]
1245	11597317	11597317_39	6530	6822	for	IN	6765	6768	O	[None]	[None]	[None]
1246	11597317	11597317_39	6530	6822	by	IN	6769	6771	O	[None]	[None]	[None]
1247	11597317	11597317_39	6530	6822	the	DT	6772	6775	O	[None]	[None]	[None]
1248	11597317	11597317_39	6530	6822	fact	NN	6776	6780	O	[None]	[None]	[None]
1249	11597317	11597317_39	6530	6822	that	IN	6781	6785	O	[None]	[None]	[None]
1250	11597317	11597317_39	6530	6822	Brca2lex1	NNP	6786	6795	B	['PR_reasoned_2017_04_17_Instance_55']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1251	11597317	11597317_39	6530	6822	/	NNP	6795	6796	O	[None]	[None]	[None]
1252	11597317	11597317_39	6530	6822	lex2	NN	6796	6800	O	[None]	[None]	[None]
1253	11597317	11597317_39	6530	6822	is	VBZ	6801	6803	O	[None]	[None]	[None]
1254	11597317	11597317_39	6530	6822	not	RB	6804	6807	O	[None]	[None]	[None]
1255	11597317	11597317_39	6530	6822	a	DT	6808	6809	O	[None]	[None]	[None]
1256	11597317	11597317_39	6530	6822	null	JJ	6810	6814	O	[None]	[None]	[None]
1257	11597317	11597317_39	6530	6822	allele	NN	6815	6821	O	[None]	[None]	[None]
1258	11597317	11597317_39	6530	6822	.	.	6821	6822	O	[None]	[None]	[None]
1259	11597317	11597317_40	6823	6929	Additional	JJ	6823	6833	O	[None]	[None]	[None]
1260	11597317	11597317_40	6823	6929	studies	NNS	6834	6841	O	[None]	[None]	[None]
1261	11597317	11597317_40	6823	6929	are	VBP	6842	6845	O	[None]	[None]	[None]
1262	11597317	11597317_40	6823	6929	likely	JJ	6846	6852	O	[None]	[None]	[None]
1263	11597317	11597317_40	6823	6929	to	TO	6853	6855	O	[None]	[None]	[None]
1264	11597317	11597317_40	6823	6929	shed	VB	6856	6860	O	[None]	[None]	[None]
1265	11597317	11597317_40	6823	6929	light	NN	6861	6866	O	[None]	[None]	[None]
1266	11597317	11597317_40	6823	6929	on	IN	6867	6869	O	[None]	[None]	[None]
1267	11597317	11597317_40	6823	6929	the	DT	6870	6873	O	[None]	[None]	[None]
1268	11597317	11597317_40	6823	6929	efficiency	NN	6874	6884	O	[None]	[None]	[None]
1269	11597317	11597317_40	6823	6929	of	IN	6885	6887	O	[None]	[None]	[None]
1270	11597317	11597317_40	6823	6929	BRCA2	NNP	6888	6893	B	['PR_reasoned_2017_04_17_Instance_29013']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1271	11597317	11597317_40	6823	6929	-	:	6893	6894	O	[None]	[None]	[None]
1272	11597317	11597317_40	6823	6929	independent	JJ	6894	6905	O	[None]	[None]	[None]
1273	11597317	11597317_40	6823	6929	recombination	NN	6906	6919	O	[None]	[None]	[None]
1274	11597317	11597317_40	6823	6929	pathways	NNS	6920	6928	O	[None]	[None]	[None]
1275	11597317	11597317_40	6823	6929	.	.	6928	6929	O	[None]	[None]	[None]
1276	11597317	11597317_41	6930	7063	Taken	VBN	6930	6935	O	[None]	[None]	[None]
1277	11597317	11597317_41	6930	7063	together	RB	6936	6944	O	[None]	[None]	[None]
1278	11597317	11597317_41	6930	7063	,	,	6944	6945	O	[None]	[None]	[None]
1279	11597317	11597317_41	6930	7063	the	DT	6946	6949	O	[None]	[None]	[None]
1280	11597317	11597317_41	6930	7063	results	NNS	6950	6957	O	[None]	[None]	[None]
1281	11597317	11597317_41	6930	7063	indicate	VBP	6958	6966	O	[None]	[None]	[None]
1282	11597317	11597317_41	6930	7063	that	IN	6967	6971	O	[None]	[None]	[None]
1283	11597317	11597317_41	6930	7063	BRCA2	NNP	6972	6977	B	['PR_reasoned_2017_04_17_Instance_29035']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1284	11597317	11597317_41	6930	7063	is	VBZ	6978	6980	O	[None]	[None]	[None]
1285	11597317	11597317_41	6930	7063	indeed	RB	6981	6987	O	[None]	[None]	[None]
1286	11597317	11597317_41	6930	7063	required	VBN	6988	6996	O	[None]	[None]	[None]
1287	11597317	11597317_41	6930	7063	for	IN	6997	7000	O	[None]	[None]	[None]
1288	11597317	11597317_41	6930	7063	high	JJ	7001	7005	O	[None]	[None]	[None]
1289	11597317	11597317_41	6930	7063	levels	NNS	7006	7012	O	[None]	[None]	[None]
1290	11597317	11597317_41	6930	7063	of	IN	7013	7015	O	[None]	[None]	[None]
1291	11597317	11597317_41	6930	7063	recombinational	JJ	7016	7031	O	[None]	[None]	[None]
1292	11597317	11597317_41	6930	7063	repair	NN	7032	7038	O	[None]	[None]	[None]
1293	11597317	11597317_41	6930	7063	in	IN	7039	7041	O	[None]	[None]	[None]
1294	11597317	11597317_41	6930	7063	both	DT	7042	7046	O	[None]	[None]	[None]
1295	11597317	11597317_41	6930	7063	human	JJ	7047	7052	O	[None]	[None]	[None]
1296	11597317	11597317_41	6930	7063	and	CC	7053	7056	O	[None]	[None]	[None]
1297	11597317	11597317_41	6930	7063	mouse	NN	7057	7062	O	[None]	[None]	[None]
1298	11597317	11597317_41	6930	7063	.	.	7062	7063	O	[None]	[None]	[None]
1299	11597317	11597317_42	7065	7322	The	DT	7065	7068	O	[None]	[None]	[None]
1300	11597317	11597317_42	7065	7322	function	NN	7069	7077	O	[None]	[None]	[None]
1301	11597317	11597317_42	7065	7322	of	IN	7078	7080	O	[None]	[None]	[None]
1302	11597317	11597317_42	7065	7322	BRCA2	NNP	7081	7086	B	['PR_reasoned_2017_04_17_Instance_29055']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1303	11597317	11597317_42	7065	7322	-	:	7086	7087	O	[None]	[None]	[None]
1304	11597317	11597317_42	7065	7322	RAD51	NNP	7087	7092	B	['PR_reasoned_2017_04_17_Instance_29077']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1305	11597317	11597317_42	7065	7322	interaction	NN	7093	7104	O	[None]	[None]	[None]
1306	11597317	11597317_42	7065	7322	The	DT	7106	7109	O	[None]	[None]	[None]
1307	11597317	11597317_42	7065	7322	second	JJ	7110	7116	O	[None]	[None]	[None]
1308	11597317	11597317_42	7065	7322	paper	NN	7117	7122	O	[None]	[None]	[None]
1309	11597317	11597317_42	7065	7322	providing	VBG	7123	7132	O	[None]	[None]	[None]
1310	11597317	11597317_42	7065	7322	evidence	NN	7133	7141	O	[None]	[None]	[None]
1311	11597317	11597317_42	7065	7322	,	,	7141	7142	O	[None]	[None]	[None]
1312	11597317	11597317_42	7065	7322	by	IN	7143	7145	O	[None]	[None]	[None]
1313	11597317	11597317_42	7065	7322	Davies	NNP	7146	7152	O	[None]	[None]	[None]
1314	11597317	11597317_42	7065	7322	et	CC	7153	7155	O	[None]	[None]	[None]
1315	11597317	11597317_42	7065	7322	al	JJ	7156	7158	O	[None]	[None]	[None]
1316	11597317	11597317_42	7065	7322	[	NNP	7159	7160	O	[None]	[None]	[None]
1317	11597317	11597317_42	7065	7322	26	CD	7160	7162	O	[None]	[None]	[None]
1318	11597317	11597317_42	7065	7322	],	NNP	7162	7164	O	[None]	[None]	[None]
1319	11597317	11597317_42	7065	7322	is	VBZ	7165	7167	O	[None]	[None]	[None]
1320	11597317	11597317_42	7065	7322	a	DT	7168	7169	O	[None]	[None]	[None]
1321	11597317	11597317_42	7065	7322	biochemical	JJ	7170	7181	O	[None]	[None]	[None]
1322	11597317	11597317_42	7065	7322	study	NN	7182	7187	O	[None]	[None]	[None]
1323	11597317	11597317_42	7065	7322	of	IN	7188	7190	O	[None]	[None]	[None]
1324	11597317	11597317_42	7065	7322	the	DT	7191	7194	O	[None]	[None]	[None]
1325	11597317	11597317_42	7065	7322	interaction	NN	7195	7206	O	[None]	[None]	[None]
1326	11597317	11597317_42	7065	7322	between	IN	7207	7214	O	[None]	[None]	[None]
1327	11597317	11597317_42	7065	7322	the	DT	7215	7218	O	[None]	[None]	[None]
1328	11597317	11597317_42	7065	7322	homologous	JJ	7219	7229	O	[None]	[None]	[None]
1329	11597317	11597317_42	7065	7322	recombinase	NN	7230	7241	O	[None]	[None]	[None]
1330	11597317	11597317_42	7065	7322	RAD51	NNP	7242	7247	B	['PR_reasoned_2017_04_17_Instance_29099']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1331	11597317	11597317_42	7065	7322	and	CC	7248	7251	O	[None]	[None]	[None]
1332	11597317	11597317_42	7065	7322	a	DT	7252	7253	O	[None]	[None]	[None]
1333	11597317	11597317_42	7065	7322	peptide	JJ	7254	7261	O	[None]	[None]	[None]
1334	11597317	11597317_42	7065	7322	consisting	NN	7262	7272	O	[None]	[None]	[None]
1335	11597317	11597317_42	7065	7322	of	IN	7273	7275	O	[None]	[None]	[None]
1336	11597317	11597317_42	7065	7322	one	CD	7276	7279	O	[None]	[None]	[None]
1337	11597317	11597317_42	7065	7322	of	IN	7280	7282	O	[None]	[None]	[None]
1338	11597317	11597317_42	7065	7322	the	DT	7283	7286	O	[None]	[None]	[None]
1339	11597317	11597317_42	7065	7322	eight	CD	7287	7292	O	[None]	[None]	[None]
1340	11597317	11597317_42	7065	7322	BRC	NNP	7293	7296	O	[None]	[None]	[None]
1341	11597317	11597317_42	7065	7322	repeats	NNS	7297	7304	O	[None]	[None]	[None]
1342	11597317	11597317_42	7065	7322	from	IN	7305	7309	O	[None]	[None]	[None]
1343	11597317	11597317_42	7065	7322	human	JJ	7310	7315	O	[None]	[None]	[None]
1344	11597317	11597317_42	7065	7322	BRCA2	NNP	7316	7321	B	['PR_reasoned_2017_04_17_Instance_29121']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1345	11597317	11597317_42	7065	7322	.	.	7321	7322	O	[None]	[None]	[None]
1346	11597317	11597317_43	7323	7449	Expression	NN	7323	7333	O	[None]	[None]	[None]
1347	11597317	11597317_43	7323	7449	of	IN	7334	7336	O	[None]	[None]	[None]
1348	11597317	11597317_43	7323	7449	a	DT	7337	7338	O	[None]	[None]	[None]
1349	11597317	11597317_43	7323	7449	single	JJ	7339	7345	O	[None]	[None]	[None]
1350	11597317	11597317_43	7323	7449	BRC	NNP	7346	7349	O	[None]	[None]	[None]
1351	11597317	11597317_43	7323	7449	repeat	NN	7350	7356	O	[None]	[None]	[None]
1352	11597317	11597317_43	7323	7449	(	(	7357	7358	O	[None]	[None]	[None]
1353	11597317	11597317_43	7323	7449	BRC4	NNP	7358	7362	O	[None]	[None]	[None]
1354	11597317	11597317_43	7323	7449	)	)	7362	7363	O	[None]	[None]	[None]
1355	11597317	11597317_43	7323	7449	had	VBD	7364	7367	O	[None]	[None]	[None]
1356	11597317	11597317_43	7323	7449	previously	RB	7368	7378	O	[None]	[None]	[None]
1357	11597317	11597317_43	7323	7449	been	VBN	7379	7383	O	[None]	[None]	[None]
1358	11597317	11597317_43	7323	7449	reported	VBN	7384	7392	O	[None]	[None]	[None]
1359	11597317	11597317_43	7323	7449	to	TO	7393	7395	O	[None]	[None]	[None]
1360	11597317	11597317_43	7323	7449	act	VB	7396	7399	O	[None]	[None]	[None]
1361	11597317	11597317_43	7323	7449	as	IN	7400	7402	O	[None]	[None]	[None]
1362	11597317	11597317_43	7323	7449	an	DT	7403	7405	O	[None]	[None]	[None]
1363	11597317	11597317_43	7323	7449	inhibitor	NN	7406	7415	O	[None]	[None]	[None]
1364	11597317	11597317_43	7323	7449	of	IN	7416	7418	O	[None]	[None]	[None]
1365	11597317	11597317_43	7323	7449	DNA	NNP	7419	7422	O	[None]	[None]	[None]
1366	11597317	11597317_43	7323	7449	repair	NN	7423	7429	O	[None]	[None]	[None]
1367	11597317	11597317_43	7323	7449	by	IN	7430	7432	O	[None]	[None]	[None]
1368	11597317	11597317_43	7323	7449	Chen	NNP	7433	7437	O	[None]	[None]	[None]
1369	11597317	11597317_43	7323	7449	et	CC	7438	7440	O	[None]	[None]	[None]
1370	11597317	11597317_43	7323	7449	al	JJ	7441	7443	O	[None]	[None]	[None]
1371	11597317	11597317_43	7323	7449	[	NNP	7444	7445	O	[None]	[None]	[None]
1372	11597317	11597317_43	7323	7449	27	CD	7445	7447	O	[None]	[None]	[None]
1373	11597317	11597317_43	7323	7449	].	NN	7447	7449	O	[None]	[None]	[None]
1374	11597317	11597317_44	7450	7717	These	DT	7450	7455	O	[None]	[None]	[None]
1375	11597317	11597317_44	7450	7717	investigators	NNS	7456	7469	O	[None]	[None]	[None]
1376	11597317	11597317_44	7450	7717	showed	VBD	7470	7476	O	[None]	[None]	[None]
1377	11597317	11597317_44	7450	7717	that	IN	7477	7481	O	[None]	[None]	[None]
1378	11597317	11597317_44	7450	7717	expression	NN	7482	7492	O	[None]	[None]	[None]
1379	11597317	11597317_44	7450	7717	of	IN	7493	7495	O	[None]	[None]	[None]
1380	11597317	11597317_44	7450	7717	constructs	NNS	7496	7506	O	[None]	[None]	[None]
1381	11597317	11597317_44	7450	7717	containing	VBG	7507	7517	O	[None]	[None]	[None]
1382	11597317	11597317_44	7450	7717	the	DT	7518	7521	O	[None]	[None]	[None]
1383	11597317	11597317_44	7450	7717	BRC4	NNP	7522	7526	O	[None]	[None]	[None]
1384	11597317	11597317_44	7450	7717	repeat	NN	7527	7533	O	[None]	[None]	[None]
1385	11597317	11597317_44	7450	7717	in	IN	7534	7536	O	[None]	[None]	[None]
1386	11597317	11597317_44	7450	7717	MCF	NNP	7537	7540	O	[None]	[None]	[None]
1387	11597317	11597317_44	7450	7717	-	:	7540	7541	O	[None]	[None]	[None]
1388	11597317	11597317_44	7450	7717	7	CD	7541	7542	O	[None]	[None]	[None]
1389	11597317	11597317_44	7450	7717	cells	NNS	7543	7548	O	[None]	[None]	[None]
1390	11597317	11597317_44	7450	7717	enhances	VBZ	7549	7557	O	[None]	[None]	[None]
1391	11597317	11597317_44	7450	7717	the	DT	7558	7561	O	[None]	[None]	[None]
1392	11597317	11597317_44	7450	7717	radiosensitivity	NN	7562	7578	O	[None]	[None]	[None]
1393	11597317	11597317_44	7450	7717	of	IN	7579	7581	O	[None]	[None]	[None]
1394	11597317	11597317_44	7450	7717	cells	NNS	7582	7587	O	[None]	[None]	[None]
1395	11597317	11597317_44	7450	7717	and	CC	7588	7591	O	[None]	[None]	[None]
1396	11597317	11597317_44	7450	7717	blocks	NNS	7592	7598	O	[None]	[None]	[None]
1397	11597317	11597317_44	7450	7717	both	CC	7599	7603	O	[None]	[None]	[None]
1398	11597317	11597317_44	7450	7717	the	DT	7604	7607	O	[None]	[None]	[None]
1399	11597317	11597317_44	7450	7717	G2	NNP	7608	7610	O	[None]	[None]	[None]
1400	11597317	11597317_44	7450	7717	/	NNP	7610	7611	O	[None]	[None]	[None]
1401	11597317	11597317_44	7450	7717	M	NNP	7611	7612	O	[None]	[None]	[None]
1402	11597317	11597317_44	7450	7717	delay	NN	7613	7618	O	[None]	[None]	[None]
1403	11597317	11597317_44	7450	7717	associated	VBN	7619	7629	O	[None]	[None]	[None]
1404	11597317	11597317_44	7450	7717	with	IN	7630	7634	O	[None]	[None]	[None]
1405	11597317	11597317_44	7450	7717	damage	NN	7635	7641	O	[None]	[None]	[None]
1406	11597317	11597317_44	7450	7717	and	CC	7642	7645	O	[None]	[None]	[None]
1407	11597317	11597317_44	7450	7717	the	DT	7646	7649	O	[None]	[None]	[None]
1408	11597317	11597317_44	7450	7717	ability	NN	7650	7657	O	[None]	[None]	[None]
1409	11597317	11597317_44	7450	7717	of	IN	7658	7660	O	[None]	[None]	[None]
1410	11597317	11597317_44	7450	7717	the	DT	7661	7664	O	[None]	[None]	[None]
1411	11597317	11597317_44	7450	7717	transfected	JJ	7665	7676	O	[None]	[None]	[None]
1412	11597317	11597317_44	7450	7717	cells	NNS	7677	7682	O	[None]	[None]	[None]
1413	11597317	11597317_44	7450	7717	to	TO	7683	7685	O	[None]	[None]	[None]
1414	11597317	11597317_44	7450	7717	assembly	RB	7686	7694	O	[None]	[None]	[None]
1415	11597317	11597317_44	7450	7717	subnuclear	VB	7695	7705	O	[None]	[None]	[None]
1416	11597317	11597317_44	7450	7717	RAD51	NNP	7706	7711	B	['PR_reasoned_2017_04_17_Instance_29143']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1417	11597317	11597317_44	7450	7717	foci	NN	7712	7716	O	[None]	[None]	[None]
1418	11597317	11597317_44	7450	7717	.	.	7716	7717	O	[None]	[None]	[None]
1419	11597317	11597317_45	7718	7878	In	IN	7718	7720	O	[None]	[None]	[None]
1420	11597317	11597317_45	7718	7878	the	DT	7721	7724	O	[None]	[None]	[None]
1421	11597317	11597317_45	7718	7878	paper	NN	7725	7730	O	[None]	[None]	[None]
1422	11597317	11597317_45	7718	7878	by	IN	7731	7733	O	[None]	[None]	[None]
1423	11597317	11597317_45	7718	7878	Davies	NNP	7734	7740	O	[None]	[None]	[None]
1424	11597317	11597317_45	7718	7878	et	FW	7741	7743	O	[None]	[None]	[None]
1425	11597317	11597317_45	7718	7878	al	NN	7744	7746	O	[None]	[None]	[None]
1426	11597317	11597317_45	7718	7878	,	,	7746	7747	O	[None]	[None]	[None]
1427	11597317	11597317_45	7718	7878	data	NNS	7748	7752	O	[None]	[None]	[None]
1428	11597317	11597317_45	7718	7878	provide	VBP	7753	7760	O	[None]	[None]	[None]
1429	11597317	11597317_45	7718	7878	evidence	NN	7761	7769	O	[None]	[None]	[None]
1430	11597317	11597317_45	7718	7878	for	IN	7770	7773	O	[None]	[None]	[None]
1431	11597317	11597317_45	7718	7878	a	DT	7774	7775	O	[None]	[None]	[None]
1432	11597317	11597317_45	7718	7878	plausible	JJ	7776	7785	O	[None]	[None]	[None]
1433	11597317	11597317_45	7718	7878	mechanism	NN	7786	7795	O	[None]	[None]	[None]
1434	11597317	11597317_45	7718	7878	of	IN	7796	7798	O	[None]	[None]	[None]
1435	11597317	11597317_45	7718	7878	the	DT	7799	7802	O	[None]	[None]	[None]
1436	11597317	11597317_45	7718	7878	dominant	JJ	7803	7811	O	[None]	[None]	[None]
1437	11597317	11597317_45	7718	7878	negative	JJ	7812	7820	O	[None]	[None]	[None]
1438	11597317	11597317_45	7718	7878	effect	NN	7821	7827	O	[None]	[None]	[None]
1439	11597317	11597317_45	7718	7878	associated	VBN	7828	7838	O	[None]	[None]	[None]
1440	11597317	11597317_45	7718	7878	with	IN	7839	7843	O	[None]	[None]	[None]
1441	11597317	11597317_45	7718	7878	expression	NN	7844	7854	O	[None]	[None]	[None]
1442	11597317	11597317_45	7718	7878	of	IN	7855	7857	O	[None]	[None]	[None]
1443	11597317	11597317_45	7718	7878	a	DT	7858	7859	O	[None]	[None]	[None]
1444	11597317	11597317_45	7718	7878	single	JJ	7860	7866	O	[None]	[None]	[None]
1445	11597317	11597317_45	7718	7878	BRC	NNP	7867	7870	O	[None]	[None]	[None]
1446	11597317	11597317_45	7718	7878	repeat	NN	7871	7877	O	[None]	[None]	[None]
1447	11597317	11597317_45	7718	7878	.	.	7877	7878	O	[None]	[None]	[None]
1448	11597317	11597317_46	7879	8050	DNA	NN	7879	7882	O	[None]	[None]	[None]
1449	11597317	11597317_46	7879	8050	binding	NN	7883	7890	O	[None]	[None]	[None]
1450	11597317	11597317_46	7879	8050	assays	NNS	7891	7897	O	[None]	[None]	[None]
1451	11597317	11597317_46	7879	8050	and	CC	7898	7901	O	[None]	[None]	[None]
1452	11597317	11597317_46	7879	8050	electron	VB	7902	7910	O	[None]	[None]	[None]
1453	11597317	11597317_46	7879	8050	microscopy	NN	7911	7921	O	[None]	[None]	[None]
1454	11597317	11597317_46	7879	8050	methods	NNS	7922	7929	O	[None]	[None]	[None]
1455	11597317	11597317_46	7879	8050	were	VBD	7930	7934	O	[None]	[None]	[None]
1456	11597317	11597317_46	7879	8050	used	VBN	7935	7939	O	[None]	[None]	[None]
1457	11597317	11597317_46	7879	8050	to	TO	7940	7942	O	[None]	[None]	[None]
1458	11597317	11597317_46	7879	8050	show	VB	7943	7947	O	[None]	[None]	[None]
1459	11597317	11597317_46	7879	8050	that	IN	7948	7952	O	[None]	[None]	[None]
1460	11597317	11597317_46	7879	8050	a	DT	7953	7954	O	[None]	[None]	[None]
1461	11597317	11597317_46	7879	8050	BRC3	NNP	7955	7959	O	[None]	[None]	[None]
1462	11597317	11597317_46	7879	8050	peptide	NN	7960	7967	O	[None]	[None]	[None]
1463	11597317	11597317_46	7879	8050	interferes	VBZ	7968	7978	O	[None]	[None]	[None]
1464	11597317	11597317_46	7879	8050	with	IN	7979	7983	O	[None]	[None]	[None]
1465	11597317	11597317_46	7879	8050	the	DT	7984	7987	O	[None]	[None]	[None]
1466	11597317	11597317_46	7879	8050	ability	NN	7988	7995	O	[None]	[None]	[None]
1467	11597317	11597317_46	7879	8050	of	IN	7996	7998	O	[None]	[None]	[None]
1468	11597317	11597317_46	7879	8050	RAD51	NNP	7999	8004	B	['PR_reasoned_2017_04_17_Instance_29165']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1469	11597317	11597317_46	7879	8050	to	TO	8005	8007	O	[None]	[None]	[None]
1470	11597317	11597317_46	7879	8050	assemble	VB	8008	8016	O	[None]	[None]	[None]
1471	11597317	11597317_46	7879	8050	into	IN	8017	8021	O	[None]	[None]	[None]
1472	11597317	11597317_46	7879	8050	oligomeric	JJ	8022	8032	O	[None]	[None]	[None]
1473	11597317	11597317_46	7879	8050	filaments	NNS	8033	8042	O	[None]	[None]	[None]
1474	11597317	11597317_46	7879	8050	on	IN	8043	8045	O	[None]	[None]	[None]
1475	11597317	11597317_46	7879	8050	DNA	NN	8046	8049	O	[None]	[None]	[None]
1476	11597317	11597317_46	7879	8050	.	.	8049	8050	O	[None]	[None]	[None]
1477	11597317	11597317_47	8051	8121	A	DT	8051	8052	O	[None]	[None]	[None]
1478	11597317	11597317_47	8051	8121	BRC4	NNP	8053	8057	O	[None]	[None]	[None]
1479	11597317	11597317_47	8051	8121	peptide	NN	8058	8065	O	[None]	[None]	[None]
1480	11597317	11597317_47	8051	8121	was	VBD	8066	8069	O	[None]	[None]	[None]
1481	11597317	11597317_47	8051	8121	also	RB	8070	8074	O	[None]	[None]	[None]
1482	11597317	11597317_47	8051	8121	reported	VBN	8075	8083	O	[None]	[None]	[None]
1483	11597317	11597317_47	8051	8121	to	TO	8084	8086	O	[None]	[None]	[None]
1484	11597317	11597317_47	8051	8121	inhibit	VB	8087	8094	O	[None]	[None]	[None]
1485	11597317	11597317_47	8051	8121	the	DT	8095	8098	O	[None]	[None]	[None]
1486	11597317	11597317_47	8051	8121	RAD51	NNP	8099	8104	B	['PR_reasoned_2017_04_17_Instance_29187']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1487	11597317	11597317_47	8051	8121	–	NNP	8104	8105	O	[None]	[None]	[None]
1488	11597317	11597317_47	8051	8121	DNA	NNP	8105	8108	O	[None]	[None]	[None]
1489	11597317	11597317_47	8051	8121	interaction	NN	8109	8120	O	[None]	[None]	[None]
1490	11597317	11597317_47	8051	8121	.	.	8120	8121	O	[None]	[None]	[None]
1491	11597317	11597317_48	8122	8270	These	DT	8122	8127	O	[None]	[None]	[None]
1492	11597317	11597317_48	8122	8270	experiments	NNS	8128	8139	O	[None]	[None]	[None]
1493	11597317	11597317_48	8122	8270	raise	VBP	8140	8145	O	[None]	[None]	[None]
1494	11597317	11597317_48	8122	8270	the	DT	8146	8149	O	[None]	[None]	[None]
1495	11597317	11597317_48	8122	8270	possibility	NN	8150	8161	O	[None]	[None]	[None]
1496	11597317	11597317_48	8122	8270	that	IN	8162	8166	O	[None]	[None]	[None]
1497	11597317	11597317_48	8122	8270	the	DT	8167	8170	O	[None]	[None]	[None]
1498	11597317	11597317_48	8122	8270	full	JJ	8171	8175	O	[None]	[None]	[None]
1499	11597317	11597317_48	8122	8270	-	:	8175	8176	O	[None]	[None]	[None]
1500	11597317	11597317_48	8122	8270	length	NN	8176	8182	O	[None]	[None]	[None]
1501	11597317	11597317_48	8122	8270	BRCA2	NNP	8183	8188	B	['PR_reasoned_2017_04_17_Instance_29231']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1502	11597317	11597317_48	8122	8270	protein	NN	8189	8196	O	[None]	[None]	[None]
1503	11597317	11597317_48	8122	8270	could	MD	8197	8202	O	[None]	[None]	[None]
1504	11597317	11597317_48	8122	8270	act	VB	8203	8206	O	[None]	[None]	[None]
1505	11597317	11597317_48	8122	8270	as	IN	8207	8209	O	[None]	[None]	[None]
1506	11597317	11597317_48	8122	8270	a	DT	8210	8211	O	[None]	[None]	[None]
1507	11597317	11597317_48	8122	8270	negative	JJ	8212	8220	O	[None]	[None]	[None]
1508	11597317	11597317_48	8122	8270	regulator	NN	8221	8230	O	[None]	[None]	[None]
1509	11597317	11597317_48	8122	8270	of	IN	8231	8233	O	[None]	[None]	[None]
1510	11597317	11597317_48	8122	8270	inappropriate	JJ	8234	8247	O	[None]	[None]	[None]
1511	11597317	11597317_48	8122	8270	RAD51	NNP	8248	8253	B	['PR_reasoned_2017_04_17_Instance_29209']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1512	11597317	11597317_48	8122	8270	–	NNP	8253	8254	O	[None]	[None]	[None]
1513	11597317	11597317_48	8122	8270	DNA	NNP	8254	8257	O	[None]	[None]	[None]
1514	11597317	11597317_48	8122	8270	interaction	NN	8258	8269	O	[None]	[None]	[None]
1515	11597317	11597317_48	8122	8270	.	.	8269	8270	O	[None]	[None]	[None]
1516	11597317	11597317_49	8272	8455	The	DT	8272	8275	O	[None]	[None]	[None]
1517	11597317	11597317_49	8272	8455	final	JJ	8276	8281	O	[None]	[None]	[None]
1518	11597317	11597317_49	8272	8455	experiment	NN	8282	8292	O	[None]	[None]	[None]
1519	11597317	11597317_49	8272	8455	reported	VBN	8293	8301	O	[None]	[None]	[None]
1520	11597317	11597317_49	8272	8455	by	IN	8302	8304	O	[None]	[None]	[None]
1521	11597317	11597317_49	8272	8455	Davies	NNP	8305	8311	O	[None]	[None]	[None]
1522	11597317	11597317_49	8272	8455	et	CC	8312	8314	O	[None]	[None]	[None]
1523	11597317	11597317_49	8272	8455	al	JJ	8315	8317	O	[None]	[None]	[None]
1524	11597317	11597317_49	8272	8455	[	NNP	8318	8319	O	[None]	[None]	[None]
1525	11597317	11597317_49	8272	8455	26	CD	8319	8321	O	[None]	[None]	[None]
1526	11597317	11597317_49	8272	8455	]	NNP	8321	8322	O	[None]	[None]	[None]
1527	11597317	11597317_49	8272	8455	is	VBZ	8323	8325	O	[None]	[None]	[None]
1528	11597317	11597317_49	8272	8455	particularly	RB	8326	8338	O	[None]	[None]	[None]
1529	11597317	11597317_49	8272	8455	important	JJ	8339	8348	O	[None]	[None]	[None]
1530	11597317	11597317_49	8272	8455	with	IN	8349	8353	O	[None]	[None]	[None]
1531	11597317	11597317_49	8272	8455	respect	NN	8354	8361	O	[None]	[None]	[None]
1532	11597317	11597317_49	8272	8455	to	TO	8362	8364	O	[None]	[None]	[None]
1533	11597317	11597317_49	8272	8455	understanding	VBG	8365	8378	O	[None]	[None]	[None]
1534	11597317	11597317_49	8272	8455	the	DT	8379	8382	O	[None]	[None]	[None]
1535	11597317	11597317_49	8272	8455	mechanism	NN	8383	8392	O	[None]	[None]	[None]
1536	11597317	11597317_49	8272	8455	(	(	8392	8393	O	[None]	[None]	[None]
1537	11597317	11597317_49	8272	8455	s	NN	8393	8394	O	[None]	[None]	[None]
1538	11597317	11597317_49	8272	8455	)	)	8394	8395	O	[None]	[None]	[None]
1539	11597317	11597317_49	8272	8455	through	IN	8396	8403	O	[None]	[None]	[None]
1540	11597317	11597317_49	8272	8455	which	WDT	8404	8409	O	[None]	[None]	[None]
1541	11597317	11597317_49	8272	8455	BRCA2	NNP	8410	8415	B	['PR_reasoned_2017_04_17_Instance_29275']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1542	11597317	11597317_49	8272	8455	promotes	VBZ	8416	8424	O	[None]	[None]	[None]
1543	11597317	11597317_49	8272	8455	RAD51	NNP	8425	8430	B	['PR_reasoned_2017_04_17_Instance_29253']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1544	11597317	11597317_49	8272	8455	-	:	8430	8431	O	[None]	[None]	[None]
1545	11597317	11597317_49	8272	8455	dependent	JJ	8431	8440	O	[None]	[None]	[None]
1546	11597317	11597317_49	8272	8455	recombination	NN	8441	8454	O	[None]	[None]	[None]
1547	11597317	11597317_49	8272	8455	.	.	8454	8455	O	[None]	[None]	[None]
1548	11597317	11597317_50	8456	8571	The	DT	8456	8459	O	[None]	[None]	[None]
1549	11597317	11597317_50	8456	8571	localization	NN	8460	8472	O	[None]	[None]	[None]
1550	11597317	11597317_50	8456	8571	of	IN	8473	8475	O	[None]	[None]	[None]
1551	11597317	11597317_50	8456	8571	RAD51	NNP	8476	8481	B	['PR_reasoned_2017_04_17_Instance_29297']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1552	11597317	11597317_50	8456	8571	was	VBD	8482	8485	O	[None]	[None]	[None]
1553	11597317	11597317_50	8456	8571	examined	VBN	8486	8494	O	[None]	[None]	[None]
1554	11597317	11597317_50	8456	8571	in	IN	8495	8497	O	[None]	[None]	[None]
1555	11597317	11597317_50	8456	8571	CAPAN	NNP	8498	8503	O	[None]	[None]	[None]
1556	11597317	11597317_50	8456	8571	-	:	8503	8504	O	[None]	[None]	[None]
1557	11597317	11597317_50	8456	8571	1	CD	8504	8505	O	[None]	[None]	[None]
1558	11597317	11597317_50	8456	8571	cells	NNS	8506	8511	O	[None]	[None]	[None]
1559	11597317	11597317_50	8456	8571	,	,	8511	8512	O	[None]	[None]	[None]
1560	11597317	11597317_50	8456	8571	the	DT	8513	8516	O	[None]	[None]	[None]
1561	11597317	11597317_50	8456	8571	same	JJ	8517	8521	O	[None]	[None]	[None]
1562	11597317	11597317_50	8456	8571	human	JJ	8522	8527	O	[None]	[None]	[None]
1563	11597317	11597317_50	8456	8571	tumor	NN	8528	8533	O	[None]	[None]	[None]
1564	11597317	11597317_50	8456	8571	line	NN	8534	8538	O	[None]	[None]	[None]
1565	11597317	11597317_50	8456	8571	examined	VBN	8539	8547	O	[None]	[None]	[None]
1566	11597317	11597317_50	8456	8571	by	IN	8548	8550	O	[None]	[None]	[None]
1567	11597317	11597317_50	8456	8571	Moynahan	NNP	8551	8559	O	[None]	[None]	[None]
1568	11597317	11597317_50	8456	8571	et	FW	8560	8562	O	[None]	[None]	[None]
1569	11597317	11597317_50	8456	8571	al	NN	8563	8565	O	[None]	[None]	[None]
1570	11597317	11597317_50	8456	8571	[	$	8566	8567	O	[None]	[None]	[None]
1571	11597317	11597317_50	8456	8571	24	CD	8567	8569	O	[None]	[None]	[None]
1572	11597317	11597317_50	8456	8571	].	NN	8569	8571	O	[None]	[None]	[None]
1573	11597317	11597317_51	8572	8806	It	PRP	8572	8574	O	[None]	[None]	[None]
1574	11597317	11597317_51	8572	8806	had	VBD	8575	8578	O	[None]	[None]	[None]
1575	11597317	11597317_51	8572	8806	been	VBN	8579	8583	O	[None]	[None]	[None]
1576	11597317	11597317_51	8572	8806	shown	VBN	8584	8589	O	[None]	[None]	[None]
1577	11597317	11597317_51	8572	8806	previously	RB	8590	8600	O	[None]	[None]	[None]
1578	11597317	11597317_51	8572	8806	that	IN	8601	8605	O	[None]	[None]	[None]
1579	11597317	11597317_51	8572	8806	the	DT	8606	8609	O	[None]	[None]	[None]
1580	11597317	11597317_51	8572	8806	small	JJ	8610	8615	O	[None]	[None]	[None]
1581	11597317	11597317_51	8572	8806	amount	NN	8616	8622	O	[None]	[None]	[None]
1582	11597317	11597317_51	8572	8806	of	IN	8623	8625	O	[None]	[None]	[None]
1583	11597317	11597317_51	8572	8806	truncated	JJ	8626	8635	O	[None]	[None]	[None]
1584	11597317	11597317_51	8572	8806	BRCA2	NNP	8636	8641	B	['PR_reasoned_2017_04_17_Instance_29319']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1585	11597317	11597317_51	8572	8806	protein	NN	8642	8649	O	[None]	[None]	[None]
1586	11597317	11597317_51	8572	8806	expressed	VBN	8650	8659	O	[None]	[None]	[None]
1587	11597317	11597317_51	8572	8806	by	IN	8660	8662	O	[None]	[None]	[None]
1588	11597317	11597317_51	8572	8806	CAPAN	NNP	8663	8668	O	[None]	[None]	[None]
1589	11597317	11597317_51	8572	8806	-	:	8668	8669	O	[None]	[None]	[None]
1590	11597317	11597317_51	8572	8806	1	CD	8669	8670	O	[None]	[None]	[None]
1591	11597317	11597317_51	8572	8806	cells	NNS	8671	8676	O	[None]	[None]	[None]
1592	11597317	11597317_51	8572	8806	was	VBD	8677	8680	O	[None]	[None]	[None]
1593	11597317	11597317_51	8572	8806	mislocalized	VBN	8681	8693	O	[None]	[None]	[None]
1594	11597317	11597317_51	8572	8806	to	TO	8694	8696	O	[None]	[None]	[None]
1595	11597317	11597317_51	8572	8806	the	DT	8697	8700	O	[None]	[None]	[None]
1596	11597317	11597317_51	8572	8806	cytoplasm	NN	8701	8710	O	[None]	[None]	[None]
1597	11597317	11597317_51	8572	8806	,	,	8710	8711	O	[None]	[None]	[None]
1598	11597317	11597317_51	8572	8806	consistent	JJ	8712	8722	O	[None]	[None]	[None]
1599	11597317	11597317_51	8572	8806	with	IN	8723	8727	O	[None]	[None]	[None]
1600	11597317	11597317_51	8572	8806	the	DT	8728	8731	O	[None]	[None]	[None]
1601	11597317	11597317_51	8572	8806	fact	NN	8732	8736	O	[None]	[None]	[None]
1602	11597317	11597317_51	8572	8806	that	IN	8737	8741	O	[None]	[None]	[None]
1603	11597317	11597317_51	8572	8806	the	DT	8742	8745	O	[None]	[None]	[None]
1604	11597317	11597317_51	8572	8806	truncation	NN	8746	8756	O	[None]	[None]	[None]
1605	11597317	11597317_51	8572	8806	protein	NN	8757	8764	O	[None]	[None]	[None]
1606	11597317	11597317_51	8572	8806	lacks	VBZ	8765	8770	O	[None]	[None]	[None]
1607	11597317	11597317_51	8572	8806	a	DT	8771	8772	O	[None]	[None]	[None]
1608	11597317	11597317_51	8572	8806	nuclear	JJ	8773	8780	O	[None]	[None]	[None]
1609	11597317	11597317_51	8572	8806	localization	NN	8781	8793	O	[None]	[None]	[None]
1610	11597317	11597317_51	8572	8806	signal	NN	8794	8800	O	[None]	[None]	[None]
1611	11597317	11597317_51	8572	8806	[	$	8801	8802	O	[None]	[None]	[None]
1612	11597317	11597317_51	8572	8806	28	CD	8802	8804	O	[None]	[None]	[None]
1613	11597317	11597317_51	8572	8806	].	NN	8804	8806	O	[None]	[None]	[None]
1614	11597317	11597317_52	8807	8978	Davies	NNS	8807	8813	O	[None]	[None]	[None]
1615	11597317	11597317_52	8807	8978	et	VBP	8814	8816	O	[None]	[None]	[None]
1616	11597317	11597317_52	8807	8978	al	NN	8817	8819	O	[None]	[None]	[None]
1617	11597317	11597317_52	8807	8978	showed	VBD	8820	8826	O	[None]	[None]	[None]
1618	11597317	11597317_52	8807	8978	CAPAN	NNP	8827	8832	O	[None]	[None]	[None]
1619	11597317	11597317_52	8807	8978	-	:	8832	8833	O	[None]	[None]	[None]
1620	11597317	11597317_52	8807	8978	1	CD	8833	8834	O	[None]	[None]	[None]
1621	11597317	11597317_52	8807	8978	cells	NNS	8835	8840	O	[None]	[None]	[None]
1622	11597317	11597317_52	8807	8978	to	TO	8841	8843	O	[None]	[None]	[None]
1623	11597317	11597317_52	8807	8978	be	VB	8844	8846	O	[None]	[None]	[None]
1624	11597317	11597317_52	8807	8978	defective	JJ	8847	8856	O	[None]	[None]	[None]
1625	11597317	11597317_52	8807	8978	in	IN	8857	8859	O	[None]	[None]	[None]
1626	11597317	11597317_52	8807	8978	nuclear	JJ	8860	8867	O	[None]	[None]	[None]
1627	11597317	11597317_52	8807	8978	localization	NN	8868	8880	O	[None]	[None]	[None]
1628	11597317	11597317_52	8807	8978	of	IN	8881	8883	O	[None]	[None]	[None]
1629	11597317	11597317_52	8807	8978	RAD51	NNP	8884	8889	B	['PR_reasoned_2017_04_17_Instance_29363']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1630	11597317	11597317_52	8807	8978	,	,	8889	8890	O	[None]	[None]	[None]
1631	11597317	11597317_52	8807	8978	raising	VBG	8891	8898	O	[None]	[None]	[None]
1632	11597317	11597317_52	8807	8978	the	DT	8899	8902	O	[None]	[None]	[None]
1633	11597317	11597317_52	8807	8978	possibility	NN	8903	8914	O	[None]	[None]	[None]
1634	11597317	11597317_52	8807	8978	that	IN	8915	8919	O	[None]	[None]	[None]
1635	11597317	11597317_52	8807	8978	RAD51	NNP	8920	8925	B	['PR_reasoned_2017_04_17_Instance_29385']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1636	11597317	11597317_52	8807	8978	is	VBZ	8926	8928	O	[None]	[None]	[None]
1637	11597317	11597317_52	8807	8978	normally	RB	8929	8937	O	[None]	[None]	[None]
1638	11597317	11597317_52	8807	8978	carried	VBN	8938	8945	O	[None]	[None]	[None]
1639	11597317	11597317_52	8807	8978	to	TO	8946	8948	O	[None]	[None]	[None]
1640	11597317	11597317_52	8807	8978	the	DT	8949	8952	O	[None]	[None]	[None]
1641	11597317	11597317_52	8807	8978	nucleus	NN	8953	8960	O	[None]	[None]	[None]
1642	11597317	11597317_52	8807	8978	by	IN	8961	8963	O	[None]	[None]	[None]
1643	11597317	11597317_52	8807	8978	binding	VBG	8964	8971	O	[None]	[None]	[None]
1644	11597317	11597317_52	8807	8978	BRCA2	NNP	8972	8977	B	['PR_reasoned_2017_04_17_Instance_29341']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1645	11597317	11597317_52	8807	8978	.	.	8977	8978	O	[None]	[None]	[None]
1646	11597317	11597317_53	8979	9171	It	PRP	8979	8981	O	[None]	[None]	[None]
1647	11597317	11597317_53	8979	9171	is	VBZ	8982	8984	O	[None]	[None]	[None]
1648	11597317	11597317_53	8979	9171	possible	JJ	8985	8993	O	[None]	[None]	[None]
1649	11597317	11597317_53	8979	9171	that	IN	8994	8998	O	[None]	[None]	[None]
1650	11597317	11597317_53	8979	9171	RAD51	NNP	8999	9004	B	['PR_reasoned_2017_04_17_Instance_29407']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1651	11597317	11597317_53	8979	9171	may	MD	9005	9008	O	[None]	[None]	[None]
1652	11597317	11597317_53	8979	9171	alternatively	RB	9009	9022	O	[None]	[None]	[None]
1653	11597317	11597317_53	8979	9171	be	VB	9023	9025	O	[None]	[None]	[None]
1654	11597317	11597317_53	8979	9171	capable	JJ	9026	9033	O	[None]	[None]	[None]
1655	11597317	11597317_53	8979	9171	of	IN	9034	9036	O	[None]	[None]	[None]
1656	11597317	11597317_53	8979	9171	BRCA2	NNP	9037	9042	B	['PR_reasoned_2017_04_17_Instance_29429']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1657	11597317	11597317_53	8979	9171	-	:	9042	9043	O	[None]	[None]	[None]
1658	11597317	11597317_53	8979	9171	independent	JJ	9043	9054	O	[None]	[None]	[None]
1659	11597317	11597317_53	8979	9171	transport	NN	9055	9064	O	[None]	[None]	[None]
1660	11597317	11597317_53	8979	9171	,	,	9064	9065	O	[None]	[None]	[None]
1661	11597317	11597317_53	8979	9171	but	CC	9066	9069	O	[None]	[None]	[None]
1662	11597317	11597317_53	8979	9171	mislocalization	NN	9070	9085	O	[None]	[None]	[None]
1663	11597317	11597317_53	8979	9171	of	IN	9086	9088	O	[None]	[None]	[None]
1664	11597317	11597317_53	8979	9171	BRCA2	NNP	9089	9094	B	['PR_reasoned_2017_04_17_Instance_29451']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1665	11597317	11597317_53	8979	9171	to	TO	9095	9097	O	[None]	[None]	[None]
1666	11597317	11597317_53	8979	9171	the	DT	9098	9101	O	[None]	[None]	[None]
1667	11597317	11597317_53	8979	9171	cytoplasm	NN	9102	9111	O	[None]	[None]	[None]
1668	11597317	11597317_53	8979	9171	may	MD	9112	9115	O	[None]	[None]	[None]
1669	11597317	11597317_53	8979	9171	sequester	VB	9116	9125	O	[None]	[None]	[None]
1670	11597317	11597317_53	8979	9171	RAD51	NNP	9126	9131	B	['PR_reasoned_2017_04_17_Instance_29473']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1671	11597317	11597317_53	8979	9171	and	CC	9132	9135	O	[None]	[None]	[None]
1672	11597317	11597317_53	8979	9171	block	VB	9136	9141	O	[None]	[None]	[None]
1673	11597317	11597317_53	8979	9171	its	PRP$	9142	9145	O	[None]	[None]	[None]
1674	11597317	11597317_53	8979	9171	normal	JJ	9146	9152	O	[None]	[None]	[None]
1675	11597317	11597317_53	8979	9171	mode	NN	9153	9157	O	[None]	[None]	[None]
1676	11597317	11597317_53	8979	9171	of	IN	9158	9160	O	[None]	[None]	[None]
1677	11597317	11597317_53	8979	9171	transport	NN	9161	9170	O	[None]	[None]	[None]
1678	11597317	11597317_53	8979	9171	.	.	9170	9171	O	[None]	[None]	[None]
1679	11597317	11597317_54	9172	9346	Support	NN	9172	9179	O	[None]	[None]	[None]
1680	11597317	11597317_54	9172	9346	for	IN	9180	9183	O	[None]	[None]	[None]
1681	11597317	11597317_54	9172	9346	the	DT	9184	9187	O	[None]	[None]	[None]
1682	11597317	11597317_54	9172	9346	hypothesis	NN	9188	9198	O	[None]	[None]	[None]
1683	11597317	11597317_54	9172	9346	that	IN	9199	9203	O	[None]	[None]	[None]
1684	11597317	11597317_54	9172	9346	the	DT	9204	9207	O	[None]	[None]	[None]
1685	11597317	11597317_54	9172	9346	observed	JJ	9208	9216	O	[None]	[None]	[None]
1686	11597317	11597317_54	9172	9346	mislocalization	NN	9217	9232	O	[None]	[None]	[None]
1687	11597317	11597317_54	9172	9346	of	IN	9233	9235	O	[None]	[None]	[None]
1688	11597317	11597317_54	9172	9346	RAD51	NNP	9236	9241	B	['PR_reasoned_2017_04_17_Instance_29495']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1689	11597317	11597317_54	9172	9346	is	VBZ	9242	9244	O	[None]	[None]	[None]
1690	11597317	11597317_54	9172	9346	an	DT	9245	9247	O	[None]	[None]	[None]
1691	11597317	11597317_54	9172	9346	indirect	JJ	9248	9256	O	[None]	[None]	[None]
1692	11597317	11597317_54	9172	9346	consequence	NN	9257	9268	O	[None]	[None]	[None]
1693	11597317	11597317_54	9172	9346	of	IN	9269	9271	O	[None]	[None]	[None]
1694	11597317	11597317_54	9172	9346	the	DT	9272	9275	O	[None]	[None]	[None]
1695	11597317	11597317_54	9172	9346	BRCA2	NNP	9276	9281	B	['PR_reasoned_2017_04_17_Instance_29517']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1696	11597317	11597317_54	9172	9346	defect	NN	9282	9288	O	[None]	[None]	[None]
1697	11597317	11597317_54	9172	9346	requires	VBZ	9289	9297	O	[None]	[None]	[None]
1698	11597317	11597317_54	9172	9346	reintroduction	NN	9298	9312	O	[None]	[None]	[None]
1699	11597317	11597317_54	9172	9346	of	IN	9313	9315	O	[None]	[None]	[None]
1700	11597317	11597317_54	9172	9346	functional	JJ	9316	9326	O	[None]	[None]	[None]
1701	11597317	11597317_54	9172	9346	BRCA2	NNP	9327	9332	B	['PR_reasoned_2017_04_17_Instance_29539']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1702	11597317	11597317_54	9172	9346	into	IN	9333	9337	O	[None]	[None]	[None]
1703	11597317	11597317_54	9172	9346	CAPAN	NNP	9338	9343	O	[None]	[None]	[None]
1704	11597317	11597317_54	9172	9346	-	:	9343	9344	O	[None]	[None]	[None]
1705	11597317	11597317_54	9172	9346	1	CD	9344	9345	O	[None]	[None]	[None]
1706	11597317	11597317_54	9172	9346	.	.	9345	9346	O	[None]	[None]	[None]
1707	11597317	11597317_55	9348	9544	Given	VBN	9348	9353	O	[None]	[None]	[None]
1708	11597317	11597317_55	9348	9544	the	DT	9354	9357	O	[None]	[None]	[None]
1709	11597317	11597317_55	9348	9544	elaborate	JJ	9358	9367	O	[None]	[None]	[None]
1710	11597317	11597317_55	9348	9544	nature	NN	9368	9374	O	[None]	[None]	[None]
1711	11597317	11597317_55	9348	9544	of	IN	9375	9377	O	[None]	[None]	[None]
1712	11597317	11597317_55	9348	9544	the	DT	9378	9381	O	[None]	[None]	[None]
1713	11597317	11597317_55	9348	9544	RAD51	NNP	9382	9387	B	['PR_reasoned_2017_04_17_Instance_29583']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1714	11597317	11597317_55	9348	9544	–	NNP	9387	9388	O	[None]	[None]	[None]
1715	11597317	11597317_55	9348	9544	BRCA2	NNP	9388	9393	B	['PR_reasoned_2017_04_17_Instance_29561']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1716	11597317	11597317_55	9348	9544	interaction	NN	9394	9405	O	[None]	[None]	[None]
1717	11597317	11597317_55	9348	9544	,	,	9405	9406	O	[None]	[None]	[None]
1718	11597317	11597317_55	9348	9544	it	PRP	9407	9409	O	[None]	[None]	[None]
1719	11597317	11597317_55	9348	9544	seems	VBZ	9410	9415	O	[None]	[None]	[None]
1720	11597317	11597317_55	9348	9544	somewhat	RB	9416	9424	O	[None]	[None]	[None]
1721	11597317	11597317_55	9348	9544	unlikely	JJ	9425	9433	O	[None]	[None]	[None]
1722	11597317	11597317_55	9348	9544	that	IN	9434	9438	O	[None]	[None]	[None]
1723	11597317	11597317_55	9348	9544	the	DT	9439	9442	O	[None]	[None]	[None]
1724	11597317	11597317_55	9348	9544	only	JJ	9443	9447	O	[None]	[None]	[None]
1725	11597317	11597317_55	9348	9544	role	NN	9448	9452	O	[None]	[None]	[None]
1726	11597317	11597317_55	9348	9544	of	IN	9453	9455	O	[None]	[None]	[None]
1727	11597317	11597317_55	9348	9544	BRCA2	NNP	9456	9461	B	['PR_reasoned_2017_04_17_Instance_29627']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1728	11597317	11597317_55	9348	9544	in	IN	9462	9464	O	[None]	[None]	[None]
1729	11597317	11597317_55	9348	9544	promoting	VBG	9465	9474	O	[None]	[None]	[None]
1730	11597317	11597317_55	9348	9544	recombination	NN	9475	9488	O	[None]	[None]	[None]
1731	11597317	11597317_55	9348	9544	is	VBZ	9489	9491	O	[None]	[None]	[None]
1732	11597317	11597317_55	9348	9544	to	TO	9492	9494	O	[None]	[None]	[None]
1733	11597317	11597317_55	9348	9544	serve	VB	9495	9500	O	[None]	[None]	[None]
1734	11597317	11597317_55	9348	9544	as	IN	9501	9503	O	[None]	[None]	[None]
1735	11597317	11597317_55	9348	9544	a	DT	9504	9505	O	[None]	[None]	[None]
1736	11597317	11597317_55	9348	9544	specific	JJ	9506	9514	O	[None]	[None]	[None]
1737	11597317	11597317_55	9348	9544	nuclear	JJ	9515	9522	O	[None]	[None]	[None]
1738	11597317	11597317_55	9348	9544	transporter	NN	9523	9534	O	[None]	[None]	[None]
1739	11597317	11597317_55	9348	9544	of	IN	9535	9537	O	[None]	[None]	[None]
1740	11597317	11597317_55	9348	9544	RAD51	NNP	9538	9543	B	['PR_reasoned_2017_04_17_Instance_29605']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1741	11597317	11597317_55	9348	9544	.	.	9543	9544	O	[None]	[None]	[None]
1742	11597317	11597317_56	9545	9720	An	DT	9545	9547	O	[None]	[None]	[None]
1743	11597317	11597317_56	9545	9720	attractive	JJ	9548	9558	O	[None]	[None]	[None]
1744	11597317	11597317_56	9545	9720	alternative	NN	9559	9570	O	[None]	[None]	[None]
1745	11597317	11597317_56	9545	9720	,	,	9570	9571	O	[None]	[None]	[None]
1746	11597317	11597317_56	9545	9720	favored	VBN	9572	9579	O	[None]	[None]	[None]
1747	11597317	11597317_56	9545	9720	by	IN	9580	9582	O	[None]	[None]	[None]
1748	11597317	11597317_56	9545	9720	Davies	NNP	9583	9589	O	[None]	[None]	[None]
1749	11597317	11597317_56	9545	9720	et	CC	9590	9592	O	[None]	[None]	[None]
1750	11597317	11597317_56	9545	9720	al	JJ	9593	9595	O	[None]	[None]	[None]
1751	11597317	11597317_56	9545	9720	[	NNP	9596	9597	O	[None]	[None]	[None]
1752	11597317	11597317_56	9545	9720	26	CD	9597	9599	O	[None]	[None]	[None]
1753	11597317	11597317_56	9545	9720	],	NN	9599	9601	O	[None]	[None]	[None]
1754	11597317	11597317_56	9545	9720	is	VBZ	9602	9604	O	[None]	[None]	[None]
1755	11597317	11597317_56	9545	9720	that	IN	9605	9609	O	[None]	[None]	[None]
1756	11597317	11597317_56	9545	9720	the	DT	9610	9613	O	[None]	[None]	[None]
1757	11597317	11597317_56	9545	9720	association	NN	9614	9625	O	[None]	[None]	[None]
1758	11597317	11597317_56	9545	9720	of	IN	9626	9628	O	[None]	[None]	[None]
1759	11597317	11597317_56	9545	9720	RAD51	NNP	9629	9634	B	['PR_reasoned_2017_04_17_Instance_29671']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1760	11597317	11597317_56	9545	9720	–	NNP	9634	9635	O	[None]	[None]	[None]
1761	11597317	11597317_56	9545	9720	BRCA2	NNP	9635	9640	B	['PR_reasoned_2017_04_17_Instance_29649']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1762	11597317	11597317_56	9545	9720	is	VBZ	9641	9643	O	[None]	[None]	[None]
1763	11597317	11597317_56	9545	9720	required	VBN	9644	9652	O	[None]	[None]	[None]
1764	11597317	11597317_56	9545	9720	to	TO	9653	9655	O	[None]	[None]	[None]
1765	11597317	11597317_56	9545	9720	maintain	VB	9656	9664	O	[None]	[None]	[None]
1766	11597317	11597317_56	9545	9720	RAD51	NNP	9665	9670	B	['PR_reasoned_2017_04_17_Instance_29693']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1767	11597317	11597317_56	9545	9720	in	IN	9671	9673	O	[None]	[None]	[None]
1768	11597317	11597317_56	9545	9720	a	DT	9674	9675	O	[None]	[None]	[None]
1769	11597317	11597317_56	9545	9720	form	NN	9676	9680	O	[None]	[None]	[None]
1770	11597317	11597317_56	9545	9720	that	WDT	9681	9685	O	[None]	[None]	[None]
1771	11597317	11597317_56	9545	9720	is	VBZ	9686	9688	O	[None]	[None]	[None]
1772	11597317	11597317_56	9545	9720	in	IN	9689	9691	O	[None]	[None]	[None]
1773	11597317	11597317_56	9545	9720	a	DT	9692	9693	O	[None]	[None]	[None]
1774	11597317	11597317_56	9545	9720	state	NN	9694	9699	O	[None]	[None]	[None]
1775	11597317	11597317_56	9545	9720	of	IN	9700	9702	O	[None]	[None]	[None]
1776	11597317	11597317_56	9545	9720	'	''	9703	9704	O	[None]	[None]	[None]
1777	11597317	11597317_56	9545	9720	readiness	NN	9704	9713	O	[None]	[None]	[None]
1778	11597317	11597317_56	9545	9720	'	''	9713	9714	O	[None]	[None]	[None]
1779	11597317	11597317_56	9545	9720	(	(	9715	9716	O	[None]	[None]	[None]
1780	11597317	11597317_56	9545	9720	Fig	NNP	9716	9719	O	[None]	[None]	[None]
1781	11597317	11597317_56	9545	9720	.	.	9719	9720	O	[None]	[None]	[None]
1782	11597317	11597317_57	9721	9725	2a	CD	9721	9723	O	[None]	[None]	[None]
1783	11597317	11597317_57	9721	9725	).	NN	9723	9725	O	[None]	[None]	[None]
1784	11597317	11597317_58	9726	9892	In	IN	9726	9728	O	[None]	[None]	[None]
1785	11597317	11597317_58	9726	9892	the	DT	9729	9732	O	[None]	[None]	[None]
1786	11597317	11597317_58	9726	9892	absence	NN	9733	9740	O	[None]	[None]	[None]
1787	11597317	11597317_58	9726	9892	of	IN	9741	9743	O	[None]	[None]	[None]
1788	11597317	11597317_58	9726	9892	this	DT	9744	9748	O	[None]	[None]	[None]
1789	11597317	11597317_58	9726	9892	interaction	NN	9749	9760	O	[None]	[None]	[None]
1790	11597317	11597317_58	9726	9892	with	IN	9761	9765	O	[None]	[None]	[None]
1791	11597317	11597317_58	9726	9892	BRCA2	NNP	9766	9771	B	['PR_reasoned_2017_04_17_Instance_29737']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1792	11597317	11597317_58	9726	9892	,	,	9771	9772	O	[None]	[None]	[None]
1793	11597317	11597317_58	9726	9892	RAD51	NNP	9773	9778	B	['PR_reasoned_2017_04_17_Instance_29715']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1794	11597317	11597317_58	9726	9892	might	MD	9779	9784	O	[None]	[None]	[None]
1795	11597317	11597317_58	9726	9892	exist	VB	9785	9790	O	[None]	[None]	[None]
1796	11597317	11597317_58	9726	9892	in	IN	9791	9793	O	[None]	[None]	[None]
1797	11597317	11597317_58	9726	9892	a	DT	9794	9795	O	[None]	[None]	[None]
1798	11597317	11597317_58	9726	9892	form	NN	9796	9800	O	[None]	[None]	[None]
1799	11597317	11597317_58	9726	9892	that	WDT	9801	9805	O	[None]	[None]	[None]
1800	11597317	11597317_58	9726	9892	is	VBZ	9806	9808	O	[None]	[None]	[None]
1801	11597317	11597317_58	9726	9892	not	RB	9809	9812	O	[None]	[None]	[None]
1802	11597317	11597317_58	9726	9892	capable	JJ	9813	9820	O	[None]	[None]	[None]
1803	11597317	11597317_58	9726	9892	of	IN	9821	9823	O	[None]	[None]	[None]
1804	11597317	11597317_58	9726	9892	being	VBG	9824	9829	O	[None]	[None]	[None]
1805	11597317	11597317_58	9726	9892	recruited	VBN	9830	9839	O	[None]	[None]	[None]
1806	11597317	11597317_58	9726	9892	into	IN	9840	9844	O	[None]	[None]	[None]
1807	11597317	11597317_58	9726	9892	a	DT	9845	9846	O	[None]	[None]	[None]
1808	11597317	11597317_58	9726	9892	functional	JJ	9847	9857	O	[None]	[None]	[None]
1809	11597317	11597317_58	9726	9892	repair	NN	9858	9864	O	[None]	[None]	[None]
1810	11597317	11597317_58	9726	9892	complex	JJ	9865	9872	O	[None]	[None]	[None]
1811	11597317	11597317_58	9726	9892	when	WRB	9873	9877	O	[None]	[None]	[None]
1812	11597317	11597317_58	9726	9892	damage	NN	9878	9884	O	[None]	[None]	[None]
1813	11597317	11597317_58	9726	9892	occurs	VBZ	9885	9891	O	[None]	[None]	[None]
1814	11597317	11597317_58	9726	9892	.	.	9891	9892	O	[None]	[None]	[None]
1815	11597317	11597317_59	9893	10044	For	IN	9893	9896	O	[None]	[None]	[None]
1816	11597317	11597317_59	9893	10044	example	NN	9897	9904	O	[None]	[None]	[None]
1817	11597317	11597317_59	9893	10044	,	,	9904	9905	O	[None]	[None]	[None]
1818	11597317	11597317_59	9893	10044	previous	JJ	9906	9914	O	[None]	[None]	[None]
1819	11597317	11597317_59	9893	10044	studies	NNS	9915	9922	O	[None]	[None]	[None]
1820	11597317	11597317_59	9893	10044	indicated	VBD	9923	9932	O	[None]	[None]	[None]
1821	11597317	11597317_59	9893	10044	that	IN	9933	9937	O	[None]	[None]	[None]
1822	11597317	11597317_59	9893	10044	RAD51	NNP	9938	9943	B	['PR_reasoned_2017_04_17_Instance_29757']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1823	11597317	11597317_59	9893	10044	shows	VBZ	9944	9949	O	[None]	[None]	[None]
1824	11597317	11597317_59	9893	10044	little	JJ	9950	9956	O	[None]	[None]	[None]
1825	11597317	11597317_59	9893	10044	binding	JJ	9957	9964	O	[None]	[None]	[None]
1826	11597317	11597317_59	9893	10044	preference	NN	9965	9975	O	[None]	[None]	[None]
1827	11597317	11597317_59	9893	10044	for	IN	9976	9979	O	[None]	[None]	[None]
1828	11597317	11597317_59	9893	10044	single	JJ	9980	9986	O	[None]	[None]	[None]
1829	11597317	11597317_59	9893	10044	-	:	9986	9987	O	[None]	[None]	[None]
1830	11597317	11597317_59	9893	10044	strand	NN	9987	9993	O	[None]	[None]	[None]
1831	11597317	11597317_59	9893	10044	DNA	NNP	9994	9997	O	[None]	[None]	[None]
1832	11597317	11597317_59	9893	10044	(	(	9998	9999	O	[None]	[None]	[None]
1833	11597317	11597317_59	9893	10044	ssDNA	NN	9999	10004	O	[None]	[None]	[None]
1834	11597317	11597317_59	9893	10044	)	)	10004	10005	O	[None]	[None]	[None]
1835	11597317	11597317_59	9893	10044	over	IN	10006	10010	O	[None]	[None]	[None]
1836	11597317	11597317_59	9893	10044	double	JJ	10011	10017	O	[None]	[None]	[None]
1837	11597317	11597317_59	9893	10044	-	:	10017	10018	O	[None]	[None]	[None]
1838	11597317	11597317_59	9893	10044	strand	NN	10018	10024	O	[None]	[None]	[None]
1839	11597317	11597317_59	9893	10044	DNA	NNP	10025	10028	O	[None]	[None]	[None]
1840	11597317	11597317_59	9893	10044	(	(	10029	10030	O	[None]	[None]	[None]
1841	11597317	11597317_59	9893	10044	dsDNA	NN	10030	10035	O	[None]	[None]	[None]
1842	11597317	11597317_59	9893	10044	)	)	10035	10036	O	[None]	[None]	[None]
1843	11597317	11597317_59	9893	10044	[	VBZ	10037	10038	O	[None]	[None]	[None]
1844	11597317	11597317_59	9893	10044	3	CD	10038	10039	O	[None]	[None]	[None]
1845	11597317	11597317_59	9893	10044	,	,	10039	10040	O	[None]	[None]	[None]
1846	11597317	11597317_59	9893	10044	29	CD	10040	10042	O	[None]	[None]	[None]
1847	11597317	11597317_59	9893	10044	].	NN	10042	10044	O	[None]	[None]	[None]
1848	11597317	11597317_60	10045	10216	This	DT	10045	10049	O	[None]	[None]	[None]
1849	11597317	11597317_60	10045	10216	result	NN	10050	10056	O	[None]	[None]	[None]
1850	11597317	11597317_60	10045	10216	could	MD	10057	10062	O	[None]	[None]	[None]
1851	11597317	11597317_60	10045	10216	mean	VB	10063	10067	O	[None]	[None]	[None]
1852	11597317	11597317_60	10045	10216	that	IN	10068	10072	O	[None]	[None]	[None]
1853	11597317	11597317_60	10045	10216	regulatory	JJ	10073	10083	O	[None]	[None]	[None]
1854	11597317	11597317_60	10045	10216	factors	NNS	10084	10091	O	[None]	[None]	[None]
1855	11597317	11597317_60	10045	10216	,	,	10091	10092	O	[None]	[None]	[None]
1856	11597317	11597317_60	10045	10216	such	JJ	10093	10097	O	[None]	[None]	[None]
1857	11597317	11597317_60	10045	10216	as	IN	10098	10100	O	[None]	[None]	[None]
1858	11597317	11597317_60	10045	10216	BRCA2	NNP	10101	10106	B	['PR_reasoned_2017_04_17_Instance_29823']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1859	11597317	11597317_60	10045	10216	,	,	10106	10107	O	[None]	[None]	[None]
1860	11597317	11597317_60	10045	10216	are	VBP	10108	10111	O	[None]	[None]	[None]
1861	11597317	11597317_60	10045	10216	required	VBN	10112	10120	O	[None]	[None]	[None]
1862	11597317	11597317_60	10045	10216	to	TO	10121	10123	O	[None]	[None]	[None]
1863	11597317	11597317_60	10045	10216	suppress	VB	10124	10132	O	[None]	[None]	[None]
1864	11597317	11597317_60	10045	10216	RAD51	NNP	10133	10138	B	['PR_reasoned_2017_04_17_Instance_29779']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1865	11597317	11597317_60	10045	10216	–	NNP	10138	10139	O	[None]	[None]	[None]
1866	11597317	11597317_60	10045	10216	dsDNA	NN	10139	10144	O	[None]	[None]	[None]
1867	11597317	11597317_60	10045	10216	interactions	NNS	10145	10157	O	[None]	[None]	[None]
1868	11597317	11597317_60	10045	10216	to	TO	10158	10160	O	[None]	[None]	[None]
1869	11597317	11597317_60	10045	10216	prevent	VB	10161	10168	O	[None]	[None]	[None]
1870	11597317	11597317_60	10045	10216	sequestration	NN	10169	10182	O	[None]	[None]	[None]
1871	11597317	11597317_60	10045	10216	of	IN	10183	10185	O	[None]	[None]	[None]
1872	11597317	11597317_60	10045	10216	RAD51	NNP	10186	10191	B	['PR_reasoned_2017_04_17_Instance_29801']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1873	11597317	11597317_60	10045	10216	in	IN	10192	10194	O	[None]	[None]	[None]
1874	11597317	11597317_60	10045	10216	a	DT	10195	10196	O	[None]	[None]	[None]
1875	11597317	11597317_60	10045	10216	nonfunctional	JJ	10197	10210	O	[None]	[None]	[None]
1876	11597317	11597317_60	10045	10216	form	NN	10211	10215	O	[None]	[None]	[None]
1877	11597317	11597317_60	10045	10216	.	.	10215	10216	O	[None]	[None]	[None]
1878	11597317	11597317_61	10217	10404	Alternatively	RB	10217	10230	O	[None]	[None]	[None]
1879	11597317	11597317_61	10217	10404	,	,	10230	10231	O	[None]	[None]	[None]
1880	11597317	11597317_61	10217	10404	or	CC	10232	10234	O	[None]	[None]	[None]
1881	11597317	11597317_61	10217	10404	in	IN	10235	10237	O	[None]	[None]	[None]
1882	11597317	11597317_61	10217	10404	addition	NN	10238	10246	O	[None]	[None]	[None]
1883	11597317	11597317_61	10217	10404	,	,	10246	10247	O	[None]	[None]	[None]
1884	11597317	11597317_61	10217	10404	suppression	NN	10248	10259	O	[None]	[None]	[None]
1885	11597317	11597317_61	10217	10404	of	IN	10260	10262	O	[None]	[None]	[None]
1886	11597317	11597317_61	10217	10404	RAD51	NNP	10263	10268	B	['PR_reasoned_2017_04_17_Instance_29845']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1887	11597317	11597317_61	10217	10404	–	NNP	10268	10269	O	[None]	[None]	[None]
1888	11597317	11597317_61	10217	10404	ssDNA	NN	10269	10274	O	[None]	[None]	[None]
1889	11597317	11597317_61	10217	10404	interaction	NN	10275	10286	O	[None]	[None]	[None]
1890	11597317	11597317_61	10217	10404	might	MD	10287	10292	O	[None]	[None]	[None]
1891	11597317	11597317_61	10217	10404	be	VB	10293	10295	O	[None]	[None]	[None]
1892	11597317	11597317_61	10217	10404	important	JJ	10296	10305	O	[None]	[None]	[None]
1893	11597317	11597317_61	10217	10404	for	IN	10306	10309	O	[None]	[None]	[None]
1894	11597317	11597317_61	10217	10404	preventing	VBG	10310	10320	O	[None]	[None]	[None]
1895	11597317	11597317_61	10217	10404	RAD51	NNP	10321	10326	B	['PR_reasoned_2017_04_17_Instance_29867']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1896	11597317	11597317_61	10217	10404	from	IN	10327	10331	O	[None]	[None]	[None]
1897	11597317	11597317_61	10217	10404	binding	VBG	10332	10339	O	[None]	[None]	[None]
1898	11597317	11597317_61	10217	10404	to	TO	10340	10342	O	[None]	[None]	[None]
1899	11597317	11597317_61	10217	10404	the	DT	10343	10346	O	[None]	[None]	[None]
1900	11597317	11597317_61	10217	10404	regions	NNS	10347	10354	O	[None]	[None]	[None]
1901	11597317	11597317_61	10217	10404	of	IN	10355	10357	O	[None]	[None]	[None]
1902	11597317	11597317_61	10217	10404	ssDNA	NN	10358	10363	O	[None]	[None]	[None]
1903	11597317	11597317_61	10217	10404	that	WDT	10364	10368	O	[None]	[None]	[None]
1904	11597317	11597317_61	10217	10404	form	NN	10369	10373	O	[None]	[None]	[None]
1905	11597317	11597317_61	10217	10404	during	IN	10374	10380	O	[None]	[None]	[None]
1906	11597317	11597317_61	10217	10404	normal	JJ	10381	10387	O	[None]	[None]	[None]
1907	11597317	11597317_61	10217	10404	DNA	NNP	10388	10391	O	[None]	[None]	[None]
1908	11597317	11597317_61	10217	10404	replication	NN	10392	10403	O	[None]	[None]	[None]
1909	11597317	11597317_61	10217	10404	.	.	10403	10404	O	[None]	[None]	[None]
1910	11597317	11597317_62	10405	10522	BRCA2	NNP	10405	10410	B	['PR_reasoned_2017_04_17_Instance_29999']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1911	11597317	11597317_62	10405	10522	may	MD	10411	10414	O	[None]	[None]	[None]
1912	11597317	11597317_62	10405	10522	thus	RB	10415	10419	O	[None]	[None]	[None]
1913	11597317	11597317_62	10405	10522	promote	VB	10420	10427	O	[None]	[None]	[None]
1914	11597317	11597317_62	10405	10522	RAD51	NNP	10428	10433	B	['PR_reasoned_2017_04_17_Instance_29889']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1915	11597317	11597317_62	10405	10522	assembly	RB	10434	10442	O	[None]	[None]	[None]
1916	11597317	11597317_62	10405	10522	into	IN	10443	10447	O	[None]	[None]	[None]
1917	11597317	11597317_62	10405	10522	recombinational	JJ	10448	10463	O	[None]	[None]	[None]
1918	11597317	11597317_62	10405	10522	repair	NN	10464	10470	O	[None]	[None]	[None]
1919	11597317	11597317_62	10405	10522	complexes	NNS	10471	10480	O	[None]	[None]	[None]
1920	11597317	11597317_62	10405	10522	via	IN	10481	10484	O	[None]	[None]	[None]
1921	11597317	11597317_62	10405	10522	a	DT	10485	10486	O	[None]	[None]	[None]
1922	11597317	11597317_62	10405	10522	negative	JJ	10487	10495	O	[None]	[None]	[None]
1923	11597317	11597317_62	10405	10522	regulatory	JJ	10496	10506	O	[None]	[None]	[None]
1924	11597317	11597317_62	10405	10522	mechanism	NN	10507	10516	O	[None]	[None]	[None]
1925	11597317	11597317_62	10405	10522	(	(	10517	10518	O	[None]	[None]	[None]
1926	11597317	11597317_62	10405	10522	i	JJ	10518	10519	O	[None]	[None]	[None]
1927	11597317	11597317_62	10405	10522	.	.	10519	10520	O	[None]	[None]	[None]
1928	11597317	11597317_62	10405	10522	e	NN	10520	10521	O	[None]	[None]	[None]
1929	11597317	11597317_62	10405	10522	.	.	10521	10522	O	[None]	[None]	[None]
1930	11597317	11597317_63	10523	10672	by	IN	10523	10525	O	[None]	[None]	[None]
1931	11597317	11597317_63	10523	10672	blocking	VBG	10526	10534	O	[None]	[None]	[None]
1932	11597317	11597317_63	10523	10672	RAD51	NNP	10535	10540	B	['PR_reasoned_2017_04_17_Instance_29911']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1933	11597317	11597317_63	10523	10672	–	NNP	10540	10541	O	[None]	[None]	[None]
1934	11597317	11597317_63	10523	10672	BRCA2	NNP	10541	10546	B	['PR_reasoned_2017_04_17_Instance_30021']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1935	11597317	11597317_63	10523	10672	interaction	NN	10547	10558	O	[None]	[None]	[None]
1936	11597317	11597317_63	10523	10672	until	IN	10559	10564	O	[None]	[None]	[None]
1937	11597317	11597317_63	10523	10672	damage	NN	10565	10571	O	[None]	[None]	[None]
1938	11597317	11597317_63	10523	10672	has	VBZ	10572	10575	O	[None]	[None]	[None]
1939	11597317	11597317_63	10523	10672	occurred	VBN	10576	10584	O	[None]	[None]	[None]
1940	11597317	11597317_63	10523	10672	and	CC	10585	10588	O	[None]	[None]	[None]
1941	11597317	11597317_63	10523	10672	factors	NNS	10589	10596	O	[None]	[None]	[None]
1942	11597317	11597317_63	10523	10672	required	VBN	10597	10605	O	[None]	[None]	[None]
1943	11597317	11597317_63	10523	10672	for	IN	10606	10609	O	[None]	[None]	[None]
1944	11597317	11597317_63	10523	10672	'	''	10610	10611	O	[None]	[None]	[None]
1945	11597317	11597317_63	10523	10672	productive	JJ	10611	10621	O	[None]	[None]	[None]
1946	11597317	11597317_63	10523	10672	'	POS	10621	10622	O	[None]	[None]	[None]
1947	11597317	11597317_63	10523	10672	assembly	NN	10623	10631	O	[None]	[None]	[None]
1948	11597317	11597317_63	10523	10672	of	IN	10632	10634	O	[None]	[None]	[None]
1949	11597317	11597317_63	10523	10672	RAD51	NNP	10635	10640	B	['PR_reasoned_2017_04_17_Instance_29933']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1950	11597317	11597317_63	10523	10672	at	IN	10641	10643	O	[None]	[None]	[None]
1951	11597317	11597317_63	10523	10672	damaged	VBN	10644	10651	O	[None]	[None]	[None]
1952	11597317	11597317_63	10523	10672	sites	NNS	10652	10657	O	[None]	[None]	[None]
1953	11597317	11597317_63	10523	10672	are	VBP	10658	10661	O	[None]	[None]	[None]
1954	11597317	11597317_63	10523	10672	in	IN	10662	10664	O	[None]	[None]	[None]
1955	11597317	11597317_63	10523	10672	place	NN	10665	10670	O	[None]	[None]	[None]
1956	11597317	11597317_63	10523	10672	).	NN	10670	10672	O	[None]	[None]	[None]
1957	11597317	11597317_64	10673	10859	As	IN	10673	10675	O	[None]	[None]	[None]
1958	11597317	11597317_64	10673	10859	mentioned	VBN	10676	10685	O	[None]	[None]	[None]
1959	11597317	11597317_64	10673	10859	previously	RB	10686	10696	O	[None]	[None]	[None]
1960	11597317	11597317_64	10673	10859	,	,	10696	10697	O	[None]	[None]	[None]
1961	11597317	11597317_64	10673	10859	the	DT	10698	10701	O	[None]	[None]	[None]
1962	11597317	11597317_64	10673	10859	ability	NN	10702	10709	O	[None]	[None]	[None]
1963	11597317	11597317_64	10673	10859	of	IN	10710	10712	O	[None]	[None]	[None]
1964	11597317	11597317_64	10673	10859	a	DT	10713	10714	O	[None]	[None]	[None]
1965	11597317	11597317_64	10673	10859	BRC	NNP	10715	10718	O	[None]	[None]	[None]
1966	11597317	11597317_64	10673	10859	peptide	NN	10719	10726	O	[None]	[None]	[None]
1967	11597317	11597317_64	10673	10859	to	TO	10727	10729	O	[None]	[None]	[None]
1968	11597317	11597317_64	10673	10859	repress	VB	10730	10737	O	[None]	[None]	[None]
1969	11597317	11597317_64	10673	10859	the	DT	10738	10741	O	[None]	[None]	[None]
1970	11597317	11597317_64	10673	10859	RAD51	NNP	10742	10747	B	['PR_reasoned_2017_04_17_Instance_29955']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1971	11597317	11597317_64	10673	10859	–	NNP	10747	10748	O	[None]	[None]	[None]
1972	11597317	11597317_64	10673	10859	BRCA2	NNP	10748	10753	B	['PR_reasoned_2017_04_17_Instance_30043']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1973	11597317	11597317_64	10673	10859	interaction	NN	10754	10765	O	[None]	[None]	[None]
1974	11597317	11597317_64	10673	10859	could	MD	10766	10771	O	[None]	[None]	[None]
1975	11597317	11597317_64	10673	10859	reflect	VB	10772	10779	O	[None]	[None]	[None]
1976	11597317	11597317_64	10673	10859	a	DT	10780	10781	O	[None]	[None]	[None]
1977	11597317	11597317_64	10673	10859	role	NN	10782	10786	O	[None]	[None]	[None]
1978	11597317	11597317_64	10673	10859	of	IN	10787	10789	O	[None]	[None]	[None]
1979	11597317	11597317_64	10673	10859	full	JJ	10790	10794	O	[None]	[None]	[None]
1980	11597317	11597317_64	10673	10859	-	:	10794	10795	O	[None]	[None]	[None]
1981	11597317	11597317_64	10673	10859	length	NN	10795	10801	O	[None]	[None]	[None]
1982	11597317	11597317_64	10673	10859	protein	NN	10802	10809	O	[None]	[None]	[None]
1983	11597317	11597317_64	10673	10859	in	IN	10810	10812	O	[None]	[None]	[None]
1984	11597317	11597317_64	10673	10859	suppressing	VBG	10813	10824	O	[None]	[None]	[None]
1985	11597317	11597317_64	10673	10859	unwanted	JJ	10825	10833	O	[None]	[None]	[None]
1986	11597317	11597317_64	10673	10859	RAD51	NNP	10834	10839	B	['PR_reasoned_2017_04_17_Instance_29977']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
1987	11597317	11597317_64	10673	10859	–	NNP	10839	10840	O	[None]	[None]	[None]
1988	11597317	11597317_64	10673	10859	BRCA2	NNP	10840	10845	B	['PR_reasoned_2017_04_17_Instance_30059']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1989	11597317	11597317_64	10673	10859	interactions	NNS	10846	10858	O	[None]	[None]	[None]
1990	11597317	11597317_64	10673	10859	.	.	10858	10859	O	[None]	[None]	[None]
1991	11597317	11597317_65	10861	11012	Yet	RB	10861	10864	O	[None]	[None]	[None]
1992	11597317	11597317_65	10861	11012	another	DT	10865	10872	O	[None]	[None]	[None]
1993	11597317	11597317_65	10861	11012	potential	JJ	10873	10882	O	[None]	[None]	[None]
1994	11597317	11597317_65	10861	11012	role	NN	10883	10887	O	[None]	[None]	[None]
1995	11597317	11597317_65	10861	11012	for	IN	10888	10891	O	[None]	[None]	[None]
1996	11597317	11597317_65	10861	11012	BRCA2	NNP	10892	10897	B	['PR_reasoned_2017_04_17_Instance_30079']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
1997	11597317	11597317_65	10861	11012	in	IN	10898	10900	O	[None]	[None]	[None]
1998	11597317	11597317_65	10861	11012	promoting	VBG	10901	10910	O	[None]	[None]	[None]
1999	11597317	11597317_65	10861	11012	RAD51	NNP	10911	10916	B	['PR_reasoned_2017_04_17_Instance_30087']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2000	11597317	11597317_65	10861	11012	-	:	10916	10917	O	[None]	[None]	[None]
2001	11597317	11597317_65	10861	11012	dependent	JJ	10917	10926	O	[None]	[None]	[None]
2002	11597317	11597317_65	10861	11012	recombinational	JJ	10927	10942	O	[None]	[None]	[None]
2003	11597317	11597317_65	10861	11012	repair	NN	10943	10949	O	[None]	[None]	[None]
2004	11597317	11597317_65	10861	11012	is	VBZ	10950	10952	O	[None]	[None]	[None]
2005	11597317	11597317_65	10861	11012	a	DT	10953	10954	O	[None]	[None]	[None]
2006	11597317	11597317_65	10861	11012	positive	JJ	10955	10963	O	[None]	[None]	[None]
2007	11597317	11597317_65	10861	11012	role	NN	10964	10968	O	[None]	[None]	[None]
2008	11597317	11597317_65	10861	11012	in	IN	10969	10971	O	[None]	[None]	[None]
2009	11597317	11597317_65	10861	11012	assembly	NN	10972	10980	O	[None]	[None]	[None]
2010	11597317	11597317_65	10861	11012	of	IN	10981	10983	O	[None]	[None]	[None]
2011	11597317	11597317_65	10861	11012	RAD51	NNP	10984	10989	B	['PR_reasoned_2017_04_17_Instance_30089']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2012	11597317	11597317_65	10861	11012	at	IN	10990	10992	O	[None]	[None]	[None]
2013	11597317	11597317_65	10861	11012	damaged	VBN	10993	11000	O	[None]	[None]	[None]
2014	11597317	11597317_65	10861	11012	sites	NNS	11001	11006	O	[None]	[None]	[None]
2015	11597317	11597317_65	10861	11012	(	(	11007	11008	O	[None]	[None]	[None]
2016	11597317	11597317_65	10861	11012	Fig	NNP	11008	11011	O	[None]	[None]	[None]
2017	11597317	11597317_65	10861	11012	.	.	11011	11012	O	[None]	[None]	[None]
2018	11597317	11597317_66	11013	11017	2b	CD	11013	11015	O	[None]	[None]	[None]
2019	11597317	11597317_66	11013	11017	).	NN	11015	11017	O	[None]	[None]	[None]
2020	11597317	11597317_67	11018	11145	Several	JJ	11018	11025	O	[None]	[None]	[None]
2021	11597317	11597317_67	11018	11145	proteins	NNS	11026	11034	O	[None]	[None]	[None]
2022	11597317	11597317_67	11018	11145	that	WDT	11035	11039	O	[None]	[None]	[None]
2023	11597317	11597317_67	11018	11145	interact	VBP	11040	11048	O	[None]	[None]	[None]
2024	11597317	11597317_67	11018	11145	with	IN	11049	11053	O	[None]	[None]	[None]
2025	11597317	11597317_67	11018	11145	RAD51	NNP	11054	11059	B	['PR_reasoned_2017_04_17_Instance_30091']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2026	11597317	11597317_67	11018	11145	are	VBP	11060	11063	O	[None]	[None]	[None]
2027	11597317	11597317_67	11018	11145	thought	VBN	11064	11071	O	[None]	[None]	[None]
2028	11597317	11597317_67	11018	11145	to	TO	11072	11074	O	[None]	[None]	[None]
2029	11597317	11597317_67	11018	11145	'	''	11075	11076	O	[None]	[None]	[None]
2030	11597317	11597317_67	11018	11145	mediate	NN	11076	11083	O	[None]	[None]	[None]
2031	11597317	11597317_67	11018	11145	'	''	11083	11084	O	[None]	[None]	[None]
2032	11597317	11597317_67	11018	11145	assembly	NN	11085	11093	O	[None]	[None]	[None]
2033	11597317	11597317_67	11018	11145	of	IN	11094	11096	O	[None]	[None]	[None]
2034	11597317	11597317_67	11018	11145	RAD51	NNP	11097	11102	B	['PR_reasoned_2017_04_17_Instance_30093']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2035	11597317	11597317_67	11018	11145	at	IN	11103	11105	O	[None]	[None]	[None]
2036	11597317	11597317_67	11018	11145	sites	NNS	11106	11111	O	[None]	[None]	[None]
2037	11597317	11597317_67	11018	11145	of	IN	11112	11114	O	[None]	[None]	[None]
2038	11597317	11597317_67	11018	11145	DNA	NNP	11115	11118	O	[None]	[None]	[None]
2039	11597317	11597317_67	11018	11145	damage	NN	11119	11125	O	[None]	[None]	[None]
2040	11597317	11597317_67	11018	11145	(	(	11126	11127	O	[None]	[None]	[None]
2041	11597317	11597317_67	11018	11145	reviewed	VBN	11127	11135	O	[None]	[None]	[None]
2042	11597317	11597317_67	11018	11145	in	IN	11136	11138	O	[None]	[None]	[None]
2043	11597317	11597317_67	11018	11145	[	JJ	11139	11140	O	[None]	[None]	[None]
2044	11597317	11597317_67	11018	11145	30	CD	11140	11142	O	[None]	[None]	[None]
2045	11597317	11597317_67	11018	11145	]).	NN	11142	11145	O	[None]	[None]	[None]
2046	11597317	11597317_68	11146	11296	RAD51	NNP	11146	11151	B	['PR_reasoned_2017_04_17_Instance_30095']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2047	11597317	11597317_68	11146	11296	paralogs	NNS	11152	11160	O	[None]	[None]	[None]
2048	11597317	11597317_68	11146	11296	in	IN	11161	11163	O	[None]	[None]	[None]
2049	11597317	11597317_68	11146	11296	particular	JJ	11164	11174	O	[None]	[None]	[None]
2050	11597317	11597317_68	11146	11296	,	,	11174	11175	O	[None]	[None]	[None]
2051	11597317	11597317_68	11146	11296	including	VBG	11176	11185	O	[None]	[None]	[None]
2052	11597317	11597317_68	11146	11296	XRCC2	NN	11186	11191	B	['PR_reasoned_2017_04_17_Instance_30105']	['PR:000017505']	['DNA repair protein XRCC2']
2053	11597317	11597317_68	11146	11296	,	,	11191	11192	O	[None]	[None]	[None]
2054	11597317	11597317_68	11146	11296	XRCC3	NNP	11193	11198	B	['PR_reasoned_2017_04_17_Instance_30107']	['PR:000017506']	['DNA repair protein XRCC3']
2055	11597317	11597317_68	11146	11296	,	,	11198	11199	O	[None]	[None]	[None]
2056	11597317	11597317_68	11146	11296	RAD51B	NNP	11200	11206	B	['PR_reasoned_2017_04_17_Instance_30109']	['PR:000013676']	['DNA repair protein RAD51 homolog 2']
2057	11597317	11597317_68	11146	11296	,	,	11206	11207	O	[None]	[None]	[None]
2058	11597317	11597317_68	11146	11296	RAD51C	NNP	11208	11214	B	['PR_reasoned_2017_04_17_Instance_30111']	['PR:000013675']	['DNA repair protein RAD51 homolog 3']
2059	11597317	11597317_68	11146	11296	and	CC	11215	11218	O	[None]	[None]	[None]
2060	11597317	11597317_68	11146	11296	RAD51D	NNP	11219	11225	B	['PR_reasoned_2017_04_17_Instance_30113']	['PR:000013677']	['DNA repair protein RAD51 homolog 4']
2061	11597317	11597317_68	11146	11296	,	,	11225	11226	O	[None]	[None]	[None]
2062	11597317	11597317_68	11146	11296	may	MD	11227	11230	O	[None]	[None]	[None]
2063	11597317	11597317_68	11146	11296	function	VB	11231	11239	O	[None]	[None]	[None]
2064	11597317	11597317_68	11146	11296	as	IN	11240	11242	O	[None]	[None]	[None]
2065	11597317	11597317_68	11146	11296	a	DT	11243	11244	O	[None]	[None]	[None]
2066	11597317	11597317_68	11146	11296	complex	NN	11245	11252	O	[None]	[None]	[None]
2067	11597317	11597317_68	11146	11296	that	WDT	11253	11257	O	[None]	[None]	[None]
2068	11597317	11597317_68	11146	11296	actively	RB	11258	11266	O	[None]	[None]	[None]
2069	11597317	11597317_68	11146	11296	promotes	VBZ	11267	11275	O	[None]	[None]	[None]
2070	11597317	11597317_68	11146	11296	RAD51	NNP	11276	11281	B	['PR_reasoned_2017_04_17_Instance_30097']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2071	11597317	11597317_68	11146	11296	assembly	RB	11282	11290	O	[None]	[None]	[None]
2072	11597317	11597317_68	11146	11296	[	VBD	11291	11292	O	[None]	[None]	[None]
2073	11597317	11597317_68	11146	11296	31	CD	11292	11294	O	[None]	[None]	[None]
2074	11597317	11597317_68	11146	11296	].	NN	11294	11296	O	[None]	[None]	[None]
2075	11597317	11597317_69	11297	11416	BRCA2	NNP	11297	11302	B	['PR_reasoned_2017_04_17_Instance_30081']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2076	11597317	11597317_69	11297	11416	could	MD	11303	11308	O	[None]	[None]	[None]
2077	11597317	11597317_69	11297	11416	cooperate	VB	11309	11318	O	[None]	[None]	[None]
2078	11597317	11597317_69	11297	11416	with	IN	11319	11323	O	[None]	[None]	[None]
2079	11597317	11597317_69	11297	11416	RAD51	NNP	11324	11329	B	['PR_reasoned_2017_04_17_Instance_30099']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2080	11597317	11597317_69	11297	11416	paralogs	NNS	11330	11338	O	[None]	[None]	[None]
2081	11597317	11597317_69	11297	11416	in	IN	11339	11341	O	[None]	[None]	[None]
2082	11597317	11597317_69	11297	11416	promoting	VBG	11342	11351	O	[None]	[None]	[None]
2083	11597317	11597317_69	11297	11416	RAD51	NNP	11352	11357	B	['PR_reasoned_2017_04_17_Instance_30101']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2084	11597317	11597317_69	11297	11416	assembly	RB	11358	11366	O	[None]	[None]	[None]
2085	11597317	11597317_69	11297	11416	,	,	11366	11367	O	[None]	[None]	[None]
2086	11597317	11597317_69	11297	11416	or	CC	11368	11370	O	[None]	[None]	[None]
2087	11597317	11597317_69	11297	11416	even	RB	11371	11375	O	[None]	[None]	[None]
2088	11597317	11597317_69	11297	11416	provide	VB	11376	11383	O	[None]	[None]	[None]
2089	11597317	11597317_69	11297	11416	an	DT	11384	11386	O	[None]	[None]	[None]
2090	11597317	11597317_69	11297	11416	alternative	JJ	11387	11398	O	[None]	[None]	[None]
2091	11597317	11597317_69	11297	11416	assembly	NN	11399	11407	O	[None]	[None]	[None]
2092	11597317	11597317_69	11297	11416	pathway	NN	11408	11415	O	[None]	[None]	[None]
2093	11597317	11597317_69	11297	11416	.	.	11415	11416	O	[None]	[None]	[None]
2094	11597317	11597317_70	11417	11616	The	DT	11417	11420	O	[None]	[None]	[None]
2095	11597317	11597317_70	11417	11616	observation	NN	11421	11432	O	[None]	[None]	[None]
2096	11597317	11597317_70	11417	11616	that	IN	11433	11437	O	[None]	[None]	[None]
2097	11597317	11597317_70	11417	11616	BRCA2	NNP	11438	11443	B	['PR_reasoned_2017_04_17_Instance_30083']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2098	11597317	11597317_70	11417	11616	localizes	VBZ	11444	11453	O	[None]	[None]	[None]
2099	11597317	11597317_70	11417	11616	to	TO	11454	11456	O	[None]	[None]	[None]
2100	11597317	11597317_70	11417	11616	damage	VB	11457	11463	O	[None]	[None]	[None]
2101	11597317	11597317_70	11417	11616	-	:	11463	11464	O	[None]	[None]	[None]
2102	11597317	11597317_70	11417	11616	induced	JJ	11464	11471	O	[None]	[None]	[None]
2103	11597317	11597317_70	11417	11616	subnuclear	JJ	11472	11482	O	[None]	[None]	[None]
2104	11597317	11597317_70	11417	11616	foci	NN	11483	11487	O	[None]	[None]	[None]
2105	11597317	11597317_70	11417	11616	with	IN	11488	11492	O	[None]	[None]	[None]
2106	11597317	11597317_70	11417	11616	RAD51	NNP	11493	11498	B	['PR_reasoned_2017_04_17_Instance_30103']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2107	11597317	11597317_70	11417	11616	seems	VBZ	11499	11504	O	[None]	[None]	[None]
2108	11597317	11597317_70	11417	11616	consistent	JJ	11505	11515	O	[None]	[None]	[None]
2109	11597317	11597317_70	11417	11616	with	IN	11516	11520	O	[None]	[None]	[None]
2110	11597317	11597317_70	11417	11616	the	DT	11521	11524	O	[None]	[None]	[None]
2111	11597317	11597317_70	11417	11616	possibility	NN	11525	11536	O	[None]	[None]	[None]
2112	11597317	11597317_70	11417	11616	that	IN	11537	11541	O	[None]	[None]	[None]
2113	11597317	11597317_70	11417	11616	BRCA2	NNP	11542	11547	B	['PR_reasoned_2017_04_17_Instance_30085']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2114	11597317	11597317_70	11417	11616	plays	VBZ	11548	11553	O	[None]	[None]	[None]
2115	11597317	11597317_70	11417	11616	a	DT	11554	11555	O	[None]	[None]	[None]
2116	11597317	11597317_70	11417	11616	positive	JJ	11556	11564	O	[None]	[None]	[None]
2117	11597317	11597317_70	11417	11616	role	NN	11565	11569	O	[None]	[None]	[None]
2118	11597317	11597317_70	11417	11616	in	IN	11570	11572	O	[None]	[None]	[None]
2119	11597317	11597317_70	11417	11616	assembly	NN	11573	11581	O	[None]	[None]	[None]
2120	11597317	11597317_70	11417	11616	of	IN	11582	11584	O	[None]	[None]	[None]
2121	11597317	11597317_70	11417	11616	the	DT	11585	11588	O	[None]	[None]	[None]
2122	11597317	11597317_70	11417	11616	recombination	NN	11589	11602	O	[None]	[None]	[None]
2123	11597317	11597317_70	11417	11616	complex	JJ	11603	11610	O	[None]	[None]	[None]
2124	11597317	11597317_70	11417	11616	[	NN	11611	11612	O	[None]	[None]	[None]
2125	11597317	11597317_70	11417	11616	11	CD	11612	11614	O	[None]	[None]	[None]
2126	11597317	11597317_70	11417	11616	].	NN	11614	11616	O	[None]	[None]	[None]
2127	11597317	11597317_71	11618	11764	Finally	RB	11618	11625	O	[None]	[None]	[None]
2128	11597317	11597317_71	11618	11764	,	,	11625	11626	O	[None]	[None]	[None]
2129	11597317	11597317_71	11618	11764	it	PRP	11627	11629	O	[None]	[None]	[None]
2130	11597317	11597317_71	11618	11764	is	VBZ	11630	11632	O	[None]	[None]	[None]
2131	11597317	11597317_71	11618	11764	important	JJ	11633	11642	O	[None]	[None]	[None]
2132	11597317	11597317_71	11618	11764	to	TO	11643	11645	O	[None]	[None]	[None]
2133	11597317	11597317_71	11618	11764	note	VB	11646	11650	O	[None]	[None]	[None]
2134	11597317	11597317_71	11618	11764	that	IN	11651	11655	O	[None]	[None]	[None]
2135	11597317	11597317_71	11618	11764	the	DT	11656	11659	O	[None]	[None]	[None]
2136	11597317	11597317_71	11618	11764	two	CD	11660	11663	O	[None]	[None]	[None]
2137	11597317	11597317_71	11618	11764	models	NNS	11664	11670	O	[None]	[None]	[None]
2138	11597317	11597317_71	11618	11764	for	IN	11671	11674	O	[None]	[None]	[None]
2139	11597317	11597317_71	11618	11764	the	DT	11675	11678	O	[None]	[None]	[None]
2140	11597317	11597317_71	11618	11764	function	NN	11679	11687	O	[None]	[None]	[None]
2141	11597317	11597317_71	11618	11764	of	IN	11688	11690	O	[None]	[None]	[None]
2142	11597317	11597317_71	11618	11764	the	DT	11691	11694	O	[None]	[None]	[None]
2143	11597317	11597317_71	11618	11764	BRCA2	NNP	11695	11700	B	['PR_reasoned_2017_04_17_Instance_30131']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2144	11597317	11597317_71	11618	11764	–	NNP	11700	11701	O	[None]	[None]	[None]
2145	11597317	11597317_71	11618	11764	RAD51	NNP	11701	11706	B	['PR_reasoned_2017_04_17_Instance_30115']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2146	11597317	11597317_71	11618	11764	interaction	NN	11707	11718	O	[None]	[None]	[None]
2147	11597317	11597317_71	11618	11764	shown	VBN	11719	11724	O	[None]	[None]	[None]
2148	11597317	11597317_71	11618	11764	in	IN	11725	11727	O	[None]	[None]	[None]
2149	11597317	11597317_71	11618	11764	Figure	NN	11728	11734	O	[None]	[None]	[None]
2150	11597317	11597317_71	11618	11764	2	CD	11735	11736	O	[None]	[None]	[None]
2151	11597317	11597317_71	11618	11764	are	VBP	11737	11740	O	[None]	[None]	[None]
2152	11597317	11597317_71	11618	11764	not	RB	11741	11744	O	[None]	[None]	[None]
2153	11597317	11597317_71	11618	11764	mutually	RB	11745	11753	O	[None]	[None]	[None]
2154	11597317	11597317_71	11618	11764	exclusive	JJ	11754	11763	O	[None]	[None]	[None]
2155	11597317	11597317_71	11618	11764	.	.	11763	11764	O	[None]	[None]	[None]
2156	11597317	11597317_72	11765	11919	BRCA2	NNP	11765	11770	B	['PR_reasoned_2017_04_17_Instance_30133']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2157	11597317	11597317_72	11765	11919	could	MD	11771	11776	O	[None]	[None]	[None]
2158	11597317	11597317_72	11765	11919	prevent	VB	11777	11784	O	[None]	[None]	[None]
2159	11597317	11597317_72	11765	11919	inappropriate	JJ	11785	11798	O	[None]	[None]	[None]
2160	11597317	11597317_72	11765	11919	RAD51	NNP	11799	11804	B	['PR_reasoned_2017_04_17_Instance_30117']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2161	11597317	11597317_72	11765	11919	assembly	NN	11805	11813	O	[None]	[None]	[None]
2162	11597317	11597317_72	11765	11919	in	IN	11814	11816	O	[None]	[None]	[None]
2163	11597317	11597317_72	11765	11919	the	DT	11817	11820	O	[None]	[None]	[None]
2164	11597317	11597317_72	11765	11919	absence	NN	11821	11828	O	[None]	[None]	[None]
2165	11597317	11597317_72	11765	11919	of	IN	11829	11831	O	[None]	[None]	[None]
2166	11597317	11597317_72	11765	11919	damage	NN	11832	11838	O	[None]	[None]	[None]
2167	11597317	11597317_72	11765	11919	and	CC	11839	11842	O	[None]	[None]	[None]
2168	11597317	11597317_72	11765	11919	promote	JJ	11843	11850	O	[None]	[None]	[None]
2169	11597317	11597317_72	11765	11919	functional	JJ	11851	11861	O	[None]	[None]	[None]
2170	11597317	11597317_72	11765	11919	RAD51	NNP	11862	11867	B	['PR_reasoned_2017_04_17_Instance_30119']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2171	11597317	11597317_72	11765	11919	assembly	NN	11868	11876	O	[None]	[None]	[None]
2172	11597317	11597317_72	11765	11919	at	IN	11877	11879	O	[None]	[None]	[None]
2173	11597317	11597317_72	11765	11919	DNA	NNP	11880	11883	O	[None]	[None]	[None]
2174	11597317	11597317_72	11765	11919	lesions	NNS	11884	11891	O	[None]	[None]	[None]
2175	11597317	11597317_72	11765	11919	during	IN	11892	11898	O	[None]	[None]	[None]
2176	11597317	11597317_72	11765	11919	the	DT	11899	11902	O	[None]	[None]	[None]
2177	11597317	11597317_72	11765	11919	damage	NN	11903	11909	O	[None]	[None]	[None]
2178	11597317	11597317_72	11765	11919	response	NN	11910	11918	O	[None]	[None]	[None]
2179	11597317	11597317_72	11765	11919	.	.	11918	11919	O	[None]	[None]	[None]
2180	11597317	11597317_73	11920	12054	Further	JJ	11920	11927	O	[None]	[None]	[None]
2181	11597317	11597317_73	11920	12054	experiments	NNS	11928	11939	O	[None]	[None]	[None]
2182	11597317	11597317_73	11920	12054	are	VBP	11940	11943	O	[None]	[None]	[None]
2183	11597317	11597317_73	11920	12054	clearly	RB	11944	11951	O	[None]	[None]	[None]
2184	11597317	11597317_73	11920	12054	required	VBN	11952	11960	O	[None]	[None]	[None]
2185	11597317	11597317_73	11920	12054	to	TO	11961	11963	O	[None]	[None]	[None]
2186	11597317	11597317_73	11920	12054	clarify	VB	11964	11971	O	[None]	[None]	[None]
2187	11597317	11597317_73	11920	12054	the	DT	11972	11975	O	[None]	[None]	[None]
2188	11597317	11597317_73	11920	12054	functional	JJ	11976	11986	O	[None]	[None]	[None]
2189	11597317	11597317_73	11920	12054	interactions	NNS	11987	11999	O	[None]	[None]	[None]
2190	11597317	11597317_73	11920	12054	between	IN	12000	12007	O	[None]	[None]	[None]
2191	11597317	11597317_73	11920	12054	BRCA2	NNP	12008	12013	B	['PR_reasoned_2017_04_17_Instance_30135']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2192	11597317	11597317_73	11920	12054	and	CC	12014	12017	O	[None]	[None]	[None]
2193	11597317	11597317_73	11920	12054	RAD51	NNP	12018	12023	B	['PR_reasoned_2017_04_17_Instance_30121']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2194	11597317	11597317_73	11920	12054	during	IN	12024	12030	O	[None]	[None]	[None]
2195	11597317	11597317_73	11920	12054	recombinational	JJ	12031	12046	O	[None]	[None]	[None]
2196	11597317	11597317_73	11920	12054	repair	NN	12047	12053	O	[None]	[None]	[None]
2197	11597317	11597317_73	11920	12054	.	.	12053	12054	O	[None]	[None]	[None]
2198	11597317	11597317_74	12055	12182	It	PRP	12055	12057	O	[None]	[None]	[None]
2199	11597317	11597317_74	12055	12182	should	MD	12058	12064	O	[None]	[None]	[None]
2200	11597317	11597317_74	12055	12182	be	VB	12065	12067	O	[None]	[None]	[None]
2201	11597317	11597317_74	12055	12182	relatively	RB	12068	12078	O	[None]	[None]	[None]
2202	11597317	11597317_74	12055	12182	straightforward	JJ	12079	12094	O	[None]	[None]	[None]
2203	11597317	11597317_74	12055	12182	to	TO	12095	12097	O	[None]	[None]	[None]
2204	11597317	11597317_74	12055	12182	determine	VB	12098	12107	O	[None]	[None]	[None]
2205	11597317	11597317_74	12055	12182	whether	IN	12108	12115	O	[None]	[None]	[None]
2206	11597317	11597317_74	12055	12182	the	DT	12116	12119	O	[None]	[None]	[None]
2207	11597317	11597317_74	12055	12182	role	NN	12120	12124	O	[None]	[None]	[None]
2208	11597317	11597317_74	12055	12182	of	IN	12125	12127	O	[None]	[None]	[None]
2209	11597317	11597317_74	12055	12182	BRCA2	NNP	12128	12133	B	['PR_reasoned_2017_04_17_Instance_30137']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2210	11597317	11597317_74	12055	12182	is	VBZ	12134	12136	O	[None]	[None]	[None]
2211	11597317	11597317_74	12055	12182	limited	VBN	12137	12144	O	[None]	[None]	[None]
2212	11597317	11597317_74	12055	12182	to	TO	12145	12147	O	[None]	[None]	[None]
2213	11597317	11597317_74	12055	12182	transporting	VBG	12148	12160	O	[None]	[None]	[None]
2214	11597317	11597317_74	12055	12182	RAD51	NNP	12161	12166	B	['PR_reasoned_2017_04_17_Instance_30123']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2215	11597317	11597317_74	12055	12182	to	TO	12167	12169	O	[None]	[None]	[None]
2216	11597317	11597317_74	12055	12182	the	DT	12170	12173	O	[None]	[None]	[None]
2217	11597317	11597317_74	12055	12182	nucleus	NN	12174	12181	O	[None]	[None]	[None]
2218	11597317	11597317_74	12055	12182	.	.	12181	12182	O	[None]	[None]	[None]
2219	11597317	11597317_75	12183	12336	If	IN	12183	12185	O	[None]	[None]	[None]
2220	11597317	11597317_75	12183	12336	this	DT	12186	12190	O	[None]	[None]	[None]
2221	11597317	11597317_75	12183	12336	were	VBD	12191	12195	O	[None]	[None]	[None]
2222	11597317	11597317_75	12183	12336	the	DT	12196	12199	O	[None]	[None]	[None]
2223	11597317	11597317_75	12183	12336	case	NN	12200	12204	O	[None]	[None]	[None]
2224	11597317	11597317_75	12183	12336	,	,	12204	12205	O	[None]	[None]	[None]
2225	11597317	11597317_75	12183	12336	addition	NN	12206	12214	O	[None]	[None]	[None]
2226	11597317	11597317_75	12183	12336	of	IN	12215	12217	O	[None]	[None]	[None]
2227	11597317	11597317_75	12183	12336	a	DT	12218	12219	O	[None]	[None]	[None]
2228	11597317	11597317_75	12183	12336	nuclear	JJ	12220	12227	O	[None]	[None]	[None]
2229	11597317	11597317_75	12183	12336	localization	NN	12228	12240	O	[None]	[None]	[None]
2230	11597317	11597317_75	12183	12336	signal	NN	12241	12247	O	[None]	[None]	[None]
2231	11597317	11597317_75	12183	12336	to	TO	12248	12250	O	[None]	[None]	[None]
2232	11597317	11597317_75	12183	12336	RAD51	NNP	12251	12256	B	['PR_reasoned_2017_04_17_Instance_30125']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2233	11597317	11597317_75	12183	12336	should	MD	12257	12263	O	[None]	[None]	[None]
2234	11597317	11597317_75	12183	12336	suppress	VB	12264	12272	O	[None]	[None]	[None]
2235	11597317	11597317_75	12183	12336	the	DT	12273	12276	O	[None]	[None]	[None]
2236	11597317	11597317_75	12183	12336	RAD51	NNP	12277	12282	B	['PR_reasoned_2017_04_17_Instance_30127']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2237	11597317	11597317_75	12183	12336	-	:	12282	12283	O	[None]	[None]	[None]
2238	11597317	11597317_75	12183	12336	mediated	VBD	12283	12291	O	[None]	[None]	[None]
2239	11597317	11597317_75	12183	12336	phenotypes	NNS	12292	12302	O	[None]	[None]	[None]
2240	11597317	11597317_75	12183	12336	associated	VBN	12303	12313	O	[None]	[None]	[None]
2241	11597317	11597317_75	12183	12336	with	IN	12314	12318	O	[None]	[None]	[None]
2242	11597317	11597317_75	12183	12336	a	DT	12319	12320	O	[None]	[None]	[None]
2243	11597317	11597317_75	12183	12336	BRCA2	NNP	12321	12326	B	['PR_reasoned_2017_04_17_Instance_30299']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2244	11597317	11597317_75	12183	12336	mutation	NN	12327	12335	O	[None]	[None]	[None]
2245	11597317	11597317_75	12183	12336	.	.	12335	12336	O	[None]	[None]	[None]
2246	11597317	11597317_76	12337	12463	However	RB	12337	12344	O	[None]	[None]	[None]
2247	11597317	11597317_76	12337	12463	,	,	12344	12345	O	[None]	[None]	[None]
2248	11597317	11597317_76	12337	12463	biochemical	JJ	12346	12357	O	[None]	[None]	[None]
2249	11597317	11597317_76	12337	12463	experiments	NNS	12358	12369	O	[None]	[None]	[None]
2250	11597317	11597317_76	12337	12463	are	VBP	12370	12373	O	[None]	[None]	[None]
2251	11597317	11597317_76	12337	12463	needed	VBN	12374	12380	O	[None]	[None]	[None]
2252	11597317	11597317_76	12337	12463	to	TO	12381	12383	O	[None]	[None]	[None]
2253	11597317	11597317_76	12337	12463	determine	VB	12384	12393	O	[None]	[None]	[None]
2254	11597317	11597317_76	12337	12463	whether	IN	12394	12401	O	[None]	[None]	[None]
2255	11597317	11597317_76	12337	12463	full	JJ	12402	12406	O	[None]	[None]	[None]
2256	11597317	11597317_76	12337	12463	-	:	12406	12407	O	[None]	[None]	[None]
2257	11597317	11597317_76	12337	12463	length	NN	12407	12413	O	[None]	[None]	[None]
2258	11597317	11597317_76	12337	12463	BRCA2	NNP	12414	12419	B	['PR_reasoned_2017_04_17_Instance_30139']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2259	11597317	11597317_76	12337	12463	blocks	NNS	12420	12426	O	[None]	[None]	[None]
2260	11597317	11597317_76	12337	12463	or	CC	12427	12429	O	[None]	[None]	[None]
2261	11597317	11597317_76	12337	12463	promotes	NNS	12430	12438	O	[None]	[None]	[None]
2262	11597317	11597317_76	12337	12463	RAD51	NNP	12439	12444	B	['PR_reasoned_2017_04_17_Instance_30129']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2263	11597317	11597317_76	12337	12463	–	NNP	12444	12445	O	[None]	[None]	[None]
2264	11597317	11597317_76	12337	12463	BRCA2	NNP	12445	12450	B	['PR_reasoned_2017_04_17_Instance_30141']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2265	11597317	11597317_76	12337	12463	interaction	NN	12451	12462	O	[None]	[None]	[None]
2266	11597317	11597317_76	12337	12463	.	.	12462	12463	O	[None]	[None]	[None]
2267	11597317	11597317_77	12464	12552	Such	JJ	12464	12468	O	[None]	[None]	[None]
2268	11597317	11597317_77	12464	12552	experiments	NNS	12469	12480	O	[None]	[None]	[None]
2269	11597317	11597317_77	12464	12552	could	MD	12481	12486	O	[None]	[None]	[None]
2270	11597317	11597317_77	12464	12552	also	RB	12487	12491	O	[None]	[None]	[None]
2271	11597317	11597317_77	12464	12552	reveal	VB	12492	12498	O	[None]	[None]	[None]
2272	11597317	11597317_77	12464	12552	additional	JJ	12499	12509	O	[None]	[None]	[None]
2273	11597317	11597317_77	12464	12552	roles	NNS	12510	12515	O	[None]	[None]	[None]
2274	11597317	11597317_77	12464	12552	for	IN	12516	12519	O	[None]	[None]	[None]
2275	11597317	11597317_77	12464	12552	BRCA2	NNP	12520	12525	B	['PR_reasoned_2017_04_17_Instance_30143']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2276	11597317	11597317_77	12464	12552	in	IN	12526	12528	O	[None]	[None]	[None]
2277	11597317	11597317_77	12464	12552	recombinational	JJ	12529	12544	O	[None]	[None]	[None]
2278	11597317	11597317_77	12464	12552	repair	NN	12545	12551	O	[None]	[None]	[None]
2279	11597317	11597317_77	12464	12552	.	.	12551	12552	O	[None]	[None]	[None]
2280	11597317	11597317_78	12553	12699	However	RB	12553	12560	O	[None]	[None]	[None]
2281	11597317	11597317_78	12553	12699	,	,	12560	12561	O	[None]	[None]	[None]
2282	11597317	11597317_78	12553	12699	several	JJ	12562	12569	O	[None]	[None]	[None]
2283	11597317	11597317_78	12553	12699	technical	JJ	12570	12579	O	[None]	[None]	[None]
2284	11597317	11597317_78	12553	12699	obstacles	NNS	12580	12589	O	[None]	[None]	[None]
2285	11597317	11597317_78	12553	12699	,	,	12589	12590	O	[None]	[None]	[None]
2286	11597317	11597317_78	12553	12699	including	VBG	12591	12600	O	[None]	[None]	[None]
2287	11597317	11597317_78	12553	12699	the	DT	12601	12604	O	[None]	[None]	[None]
2288	11597317	11597317_78	12553	12699	large	JJ	12605	12610	O	[None]	[None]	[None]
2289	11597317	11597317_78	12553	12699	size	NN	12611	12615	O	[None]	[None]	[None]
2290	11597317	11597317_78	12553	12699	of	IN	12616	12618	O	[None]	[None]	[None]
2291	11597317	11597317_78	12553	12699	BRCA2	NNP	12619	12624	B	['PR_reasoned_2017_04_17_Instance_30145']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2292	11597317	11597317_78	12553	12699	,	,	12624	12625	O	[None]	[None]	[None]
2293	11597317	11597317_78	12553	12699	promise	NN	12626	12633	O	[None]	[None]	[None]
2294	11597317	11597317_78	12553	12699	to	TO	12634	12636	O	[None]	[None]	[None]
2295	11597317	11597317_78	12553	12699	make	VB	12637	12641	O	[None]	[None]	[None]
2296	11597317	11597317_78	12553	12699	biochemical	JJ	12642	12653	O	[None]	[None]	[None]
2297	11597317	11597317_78	12553	12699	characterization	NN	12654	12670	O	[None]	[None]	[None]
2298	11597317	11597317_78	12553	12699	of	IN	12671	12673	O	[None]	[None]	[None]
2299	11597317	11597317_78	12553	12699	BRCA2	NNP	12674	12679	B	['PR_reasoned_2017_04_17_Instance_30147']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2300	11597317	11597317_78	12553	12699	function	NN	12680	12688	O	[None]	[None]	[None]
2301	11597317	11597317_78	12553	12699	difficult	JJ	12689	12698	O	[None]	[None]	[None]
2302	11597317	11597317_78	12553	12699	.	.	12698	12699	O	[None]	[None]	[None]
2303	11597317	11597317_79	12701	12850	Abbreviations	NNS	12701	12714	O	[None]	[None]	[None]
2304	11597317	11597317_79	12701	12850	DSB	NNP	12716	12719	O	[None]	[None]	[None]
2305	11597317	11597317_79	12701	12850	=	NNP	12720	12721	O	[None]	[None]	[None]
2306	11597317	11597317_79	12701	12850	double	JJ	12722	12728	O	[None]	[None]	[None]
2307	11597317	11597317_79	12701	12850	-	:	12728	12729	O	[None]	[None]	[None]
2308	11597317	11597317_79	12701	12850	strand	NN	12729	12735	O	[None]	[None]	[None]
2309	11597317	11597317_79	12701	12850	break	NN	12736	12741	O	[None]	[None]	[None]
2310	11597317	11597317_79	12701	12850	;	:	12741	12742	O	[None]	[None]	[None]
2311	11597317	11597317_79	12701	12850	dsDNA	CC	12743	12748	O	[None]	[None]	[None]
2312	11597317	11597317_79	12701	12850	=	NNP	12749	12750	O	[None]	[None]	[None]
2313	11597317	11597317_79	12701	12850	double	JJ	12751	12757	O	[None]	[None]	[None]
2314	11597317	11597317_79	12701	12850	-	:	12757	12758	O	[None]	[None]	[None]
2315	11597317	11597317_79	12701	12850	strand	NN	12758	12764	O	[None]	[None]	[None]
2316	11597317	11597317_79	12701	12850	DNA	NNP	12765	12768	O	[None]	[None]	[None]
2317	11597317	11597317_79	12701	12850	;	:	12768	12769	O	[None]	[None]	[None]
2318	11597317	11597317_79	12701	12850	ES	NNP	12770	12772	O	[None]	[None]	[None]
2319	11597317	11597317_79	12701	12850	=	NNP	12773	12774	O	[None]	[None]	[None]
2320	11597317	11597317_79	12701	12850	embryonic	JJ	12775	12784	O	[None]	[None]	[None]
2321	11597317	11597317_79	12701	12850	stem	NN	12785	12789	O	[None]	[None]	[None]
2322	11597317	11597317_79	12701	12850	;	:	12789	12790	O	[None]	[None]	[None]
2323	11597317	11597317_79	12701	12850	GFP	NNP	12791	12794	O	[None]	[None]	[None]
2324	11597317	11597317_79	12701	12850	=	NNP	12795	12796	O	[None]	[None]	[None]
2325	11597317	11597317_79	12701	12850	green	JJ	12797	12802	O	[None]	[None]	[None]
2326	11597317	11597317_79	12701	12850	fluorescent	NN	12803	12814	O	[None]	[None]	[None]
2327	11597317	11597317_79	12701	12850	protein	NN	12815	12822	O	[None]	[None]	[None]
2328	11597317	11597317_79	12701	12850	;	:	12822	12823	O	[None]	[None]	[None]
2329	11597317	11597317_79	12701	12850	ssDNA	CC	12824	12829	O	[None]	[None]	[None]
2330	11597317	11597317_79	12701	12850	=	VB	12830	12831	O	[None]	[None]	[None]
2331	11597317	11597317_79	12701	12850	single	JJ	12832	12838	O	[None]	[None]	[None]
2332	11597317	11597317_79	12701	12850	-	:	12838	12839	O	[None]	[None]	[None]
2333	11597317	11597317_79	12701	12850	strand	NN	12839	12845	O	[None]	[None]	[None]
2334	11597317	11597317_79	12701	12850	DNA	NN	12846	12849	O	[None]	[None]	[None]
2335	11597317	11597317_79	12701	12850	.	.	12849	12850	O	[None]	[None]	[None]
2336	11597317	11597317_80	12852	12950	Figures	NNS	12852	12859	O	[None]	[None]	[None]
2337	11597317	11597317_80	12852	12950	and	CC	12860	12863	O	[None]	[None]	[None]
2338	11597317	11597317_80	12852	12950	Tables	NNP	12864	12870	O	[None]	[None]	[None]
2339	11597317	11597317_80	12852	12950	Figure	NNP	12872	12878	O	[None]	[None]	[None]
2340	11597317	11597317_80	12852	12950	1	CD	12879	12880	O	[None]	[None]	[None]
2341	11597317	11597317_80	12852	12950	Recombination	NNP	12882	12895	O	[None]	[None]	[None]
2342	11597317	11597317_80	12852	12950	substrates	NNS	12896	12906	O	[None]	[None]	[None]
2343	11597317	11597317_80	12852	12950	used	VBD	12907	12911	O	[None]	[None]	[None]
2344	11597317	11597317_80	12852	12950	for	IN	12912	12915	O	[None]	[None]	[None]
2345	11597317	11597317_80	12852	12950	assaying	VBG	12916	12924	O	[None]	[None]	[None]
2346	11597317	11597317_80	12852	12950	homology	NN	12925	12933	O	[None]	[None]	[None]
2347	11597317	11597317_80	12852	12950	-	:	12933	12934	O	[None]	[None]	[None]
2348	11597317	11597317_80	12852	12950	directed	VBN	12934	12942	O	[None]	[None]	[None]
2349	11597317	11597317_80	12852	12950	repair	NN	12943	12949	O	[None]	[None]	[None]
2350	11597317	11597317_80	12852	12950	.	.	12949	12950	O	[None]	[None]	[None]
2351	11597317	11597317_81	12951	13149	Cutting	VBG	12951	12958	O	[None]	[None]	[None]
2352	11597317	11597317_81	12951	13149	at	IN	12959	12961	O	[None]	[None]	[None]
2353	11597317	11597317_81	12951	13149	the	DT	12962	12965	O	[None]	[None]	[None]
2354	11597317	11597317_81	12951	13149	I	PRP	12966	12967	B	['PR_reasoned_2017_04_17_Instance_57']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
2355	11597317	11597317_81	12951	13149	-	:	12967	12968	I	['PR_reasoned_2017_04_17_Instance_57']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
2356	11597317	11597317_81	12951	13149	SceI	NNP	12968	12972	I	['PR_reasoned_2017_04_17_Instance_57']	['PR:P03882']	['intron-encoded endonuclease I-SceI (yeast)']
2357	11597317	11597317_81	12951	13149	site	NN	12973	12977	O	[None]	[None]	[None]
2358	11597317	11597317_81	12951	13149	within	IN	12978	12984	O	[None]	[None]	[None]
2359	11597317	11597317_81	12951	13149	the	DT	12985	12988	O	[None]	[None]	[None]
2360	11597317	11597317_81	12951	13149	mutant	JJ	12989	12995	O	[None]	[None]	[None]
2361	11597317	11597317_81	12951	13149	GFP	NNP	12996	12999	O	[None]	[None]	[None]
2362	11597317	11597317_81	12951	13149	(	(	13000	13001	O	[None]	[None]	[None]
2363	11597317	11597317_81	12951	13149	SceGFP	NNP	13001	13007	O	[None]	[None]	[None]
2364	11597317	11597317_81	12951	13149	)	)	13007	13008	O	[None]	[None]	[None]
2365	11597317	11597317_81	12951	13149	results	NNS	13009	13016	O	[None]	[None]	[None]
2366	11597317	11597317_81	12951	13149	in	IN	13017	13019	O	[None]	[None]	[None]
2367	11597317	11597317_81	12951	13149	a	DT	13020	13021	O	[None]	[None]	[None]
2368	11597317	11597317_81	12951	13149	double	JJ	13022	13028	O	[None]	[None]	[None]
2369	11597317	11597317_81	12951	13149	-	:	13028	13029	O	[None]	[None]	[None]
2370	11597317	11597317_81	12951	13149	strand	NN	13029	13035	O	[None]	[None]	[None]
2371	11597317	11597317_81	12951	13149	break	NN	13036	13041	O	[None]	[None]	[None]
2372	11597317	11597317_81	12951	13149	that	WDT	13042	13046	O	[None]	[None]	[None]
2373	11597317	11597317_81	12951	13149	can	MD	13047	13050	O	[None]	[None]	[None]
2374	11597317	11597317_81	12951	13149	be	VB	13051	13053	O	[None]	[None]	[None]
2375	11597317	11597317_81	12951	13149	repaired	VBN	13054	13062	O	[None]	[None]	[None]
2376	11597317	11597317_81	12951	13149	through	IN	13063	13070	O	[None]	[None]	[None]
2377	11597317	11597317_81	12951	13149	homologous	JJ	13071	13081	O	[None]	[None]	[None]
2378	11597317	11597317_81	12951	13149	gene	NN	13082	13086	O	[None]	[None]	[None]
2379	11597317	11597317_81	12951	13149	conversion	NN	13087	13097	O	[None]	[None]	[None]
2380	11597317	11597317_81	12951	13149	using	VBG	13098	13103	O	[None]	[None]	[None]
2381	11597317	11597317_81	12951	13149	a	DT	13104	13105	O	[None]	[None]	[None]
2382	11597317	11597317_81	12951	13149	3	CD	13106	13107	O	[None]	[None]	[None]
2383	11597317	11597317_81	12951	13149	'-	JJ	13107	13109	O	[None]	[None]	[None]
2384	11597317	11597317_81	12951	13149	truncated	VBN	13109	13118	O	[None]	[None]	[None]
2385	11597317	11597317_81	12951	13149	copy	NN	13119	13123	O	[None]	[None]	[None]
2386	11597317	11597317_81	12951	13149	of	IN	13124	13126	O	[None]	[None]	[None]
2387	11597317	11597317_81	12951	13149	GFP	NNP	13127	13130	O	[None]	[None]	[None]
2388	11597317	11597317_81	12951	13149	as	IN	13131	13133	O	[None]	[None]	[None]
2389	11597317	11597317_81	12951	13149	sequence	NN	13134	13142	O	[None]	[None]	[None]
2390	11597317	11597317_81	12951	13149	donor	NN	13143	13148	O	[None]	[None]	[None]
2391	11597317	11597317_81	12951	13149	.	.	13148	13149	O	[None]	[None]	[None]
2392	11597317	11597317_82	13150	13226	The	DT	13150	13153	O	[None]	[None]	[None]
2393	11597317	11597317_82	13150	13226	mechanism	NN	13154	13163	O	[None]	[None]	[None]
2394	11597317	11597317_82	13150	13226	results	NNS	13164	13171	O	[None]	[None]	[None]
2395	11597317	11597317_82	13150	13226	in	IN	13172	13174	O	[None]	[None]	[None]
2396	11597317	11597317_82	13150	13226	the	DT	13175	13178	O	[None]	[None]	[None]
2397	11597317	11597317_82	13150	13226	formation	NN	13179	13188	O	[None]	[None]	[None]
2398	11597317	11597317_82	13150	13226	of	IN	13189	13191	O	[None]	[None]	[None]
2399	11597317	11597317_82	13150	13226	a	DT	13192	13193	O	[None]	[None]	[None]
2400	11597317	11597317_82	13150	13226	functional	JJ	13194	13204	O	[None]	[None]	[None]
2401	11597317	11597317_82	13150	13226	copy	NN	13205	13209	O	[None]	[None]	[None]
2402	11597317	11597317_82	13150	13226	of	IN	13210	13212	O	[None]	[None]	[None]
2403	11597317	11597317_82	13150	13226	the	DT	13213	13216	O	[None]	[None]	[None]
2404	11597317	11597317_82	13150	13226	GFP	NNP	13217	13220	O	[None]	[None]	[None]
2405	11597317	11597317_82	13150	13226	gene	NN	13221	13225	O	[None]	[None]	[None]
2406	11597317	11597317_82	13150	13226	.	.	13225	13226	O	[None]	[None]	[None]
2407	11597317	11597317_83	13227	13322	The	DT	13227	13230	O	[None]	[None]	[None]
2408	11597317	11597317_83	13227	13322	model	NN	13231	13236	O	[None]	[None]	[None]
2409	11597317	11597317_83	13227	13322	shown	VBN	13237	13242	O	[None]	[None]	[None]
2410	11597317	11597317_83	13227	13322	assumes	NNS	13243	13250	O	[None]	[None]	[None]
2411	11597317	11597317_83	13227	13322	gene	NN	13251	13255	O	[None]	[None]	[None]
2412	11597317	11597317_83	13227	13322	conversion	NN	13256	13266	O	[None]	[None]	[None]
2413	11597317	11597317_83	13227	13322	occurs	VBZ	13267	13273	O	[None]	[None]	[None]
2414	11597317	11597317_83	13227	13322	via	IN	13274	13277	O	[None]	[None]	[None]
2415	11597317	11597317_83	13227	13322	the	DT	13278	13281	O	[None]	[None]	[None]
2416	11597317	11597317_83	13227	13322	synthesis	NN	13282	13291	O	[None]	[None]	[None]
2417	11597317	11597317_83	13227	13322	-	:	13291	13292	O	[None]	[None]	[None]
2418	11597317	11597317_83	13227	13322	dependent	NN	13292	13301	O	[None]	[None]	[None]
2419	11597317	11597317_83	13227	13322	annealing	VBG	13302	13311	O	[None]	[None]	[None]
2420	11597317	11597317_83	13227	13322	mechanism	NN	13312	13321	O	[None]	[None]	[None]
2421	11597317	11597317_83	13227	13322	.	.	13321	13322	O	[None]	[None]	[None]
2422	11597317	11597317_84	13324	13413	Figure	NN	13324	13330	O	[None]	[None]	[None]
2423	11597317	11597317_84	13324	13413	2	CD	13331	13332	O	[None]	[None]	[None]
2424	11597317	11597317_84	13324	13413	Potential	JJ	13334	13343	O	[None]	[None]	[None]
2425	11597317	11597317_84	13324	13413	roles	NNS	13344	13349	O	[None]	[None]	[None]
2426	11597317	11597317_84	13324	13413	of	IN	13350	13352	O	[None]	[None]	[None]
2427	11597317	11597317_84	13324	13413	BRCA2	NNP	13353	13358	B	['PR_reasoned_2017_04_17_Instance_30149']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2428	11597317	11597317_84	13324	13413	in	IN	13359	13361	O	[None]	[None]	[None]
2429	11597317	11597317_84	13324	13413	promoting	VBG	13362	13371	O	[None]	[None]	[None]
2430	11597317	11597317_84	13324	13413	assembly	NN	13372	13380	O	[None]	[None]	[None]
2431	11597317	11597317_84	13324	13413	of	IN	13381	13383	O	[None]	[None]	[None]
2432	11597317	11597317_84	13324	13413	Rad51	NNP	13384	13389	B	['PR_reasoned_2017_04_17_Instance_30163']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2433	11597317	11597317_84	13324	13413	at	IN	13390	13392	O	[None]	[None]	[None]
2434	11597317	11597317_84	13324	13413	sites	NNS	13393	13398	O	[None]	[None]	[None]
2435	11597317	11597317_84	13324	13413	of	IN	13399	13401	O	[None]	[None]	[None]
2436	11597317	11597317_84	13324	13413	DNA	NNP	13402	13405	O	[None]	[None]	[None]
2437	11597317	11597317_84	13324	13413	damage	NN	13406	13412	O	[None]	[None]	[None]
2438	11597317	11597317_84	13324	13413	.	.	13412	13413	O	[None]	[None]	[None]
2439	11597317	11597317_85	13414	13513	Chromosomal	NNP	13414	13425	O	[None]	[None]	[None]
2440	11597317	11597317_85	13414	13513	DNA	NNP	13426	13429	O	[None]	[None]	[None]
2441	11597317	11597317_85	13414	13513	is	VBZ	13430	13432	O	[None]	[None]	[None]
2442	11597317	11597317_85	13414	13513	shown	VBN	13433	13438	O	[None]	[None]	[None]
2443	11597317	11597317_85	13414	13513	as	IN	13439	13441	O	[None]	[None]	[None]
2444	11597317	11597317_85	13414	13513	pairs	NNS	13442	13447	O	[None]	[None]	[None]
2445	11597317	11597317_85	13414	13513	of	IN	13448	13450	O	[None]	[None]	[None]
2446	11597317	11597317_85	13414	13513	straight	JJ	13451	13459	O	[None]	[None]	[None]
2447	11597317	11597317_85	13414	13513	lines	NNS	13460	13465	O	[None]	[None]	[None]
2448	11597317	11597317_85	13414	13513	,	,	13465	13466	O	[None]	[None]	[None]
2449	11597317	11597317_85	13414	13513	Rad51	NNP	13467	13472	B	['PR_reasoned_2017_04_17_Instance_30165']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2450	11597317	11597317_85	13414	13513	as	IN	13473	13475	O	[None]	[None]	[None]
2451	11597317	11597317_85	13414	13513	open	JJ	13476	13480	O	[None]	[None]	[None]
2452	11597317	11597317_85	13414	13513	circles	NNS	13481	13488	O	[None]	[None]	[None]
2453	11597317	11597317_85	13414	13513	,	,	13488	13489	O	[None]	[None]	[None]
2454	11597317	11597317_85	13414	13513	and	CC	13490	13493	O	[None]	[None]	[None]
2455	11597317	11597317_85	13414	13513	BRCA2	NNP	13494	13499	B	['PR_reasoned_2017_04_17_Instance_30151']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2456	11597317	11597317_85	13414	13513	as	IN	13500	13502	O	[None]	[None]	[None]
2457	11597317	11597317_85	13414	13513	grey	NN	13503	13507	O	[None]	[None]	[None]
2458	11597317	11597317_85	13414	13513	bars	NNS	13508	13512	O	[None]	[None]	[None]
2459	11597317	11597317_85	13414	13513	.	.	13512	13513	O	[None]	[None]	[None]
2460	11597317	11597317_86	13514	13563	(	(	13514	13515	O	[None]	[None]	[None]
2461	11597317	11597317_86	13514	13563	a	DT	13515	13516	O	[None]	[None]	[None]
2462	11597317	11597317_86	13514	13563	)	)	13516	13517	O	[None]	[None]	[None]
2463	11597317	11597317_86	13514	13563	Prevention	NN	13518	13528	O	[None]	[None]	[None]
2464	11597317	11597317_86	13514	13563	of	IN	13529	13531	O	[None]	[None]	[None]
2465	11597317	11597317_86	13514	13563	nonproductive	JJ	13532	13545	O	[None]	[None]	[None]
2466	11597317	11597317_86	13514	13563	DNA	NNP	13546	13549	O	[None]	[None]	[None]
2467	11597317	11597317_86	13514	13563	interactions	NNS	13550	13562	O	[None]	[None]	[None]
2468	11597317	11597317_86	13514	13563	.	.	13562	13563	O	[None]	[None]	[None]
2469	11597317	11597317_87	13564	13665	BRCA2	NNP	13564	13569	B	['PR_reasoned_2017_04_17_Instance_30153']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2470	11597317	11597317_87	13564	13665	–	NNP	13569	13570	O	[None]	[None]	[None]
2471	11597317	11597317_87	13564	13665	Rad51	NNP	13570	13575	B	['PR_reasoned_2017_04_17_Instance_30167']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2472	11597317	11597317_87	13564	13665	interaction	NN	13576	13587	O	[None]	[None]	[None]
2473	11597317	11597317_87	13564	13665	is	VBZ	13588	13590	O	[None]	[None]	[None]
2474	11597317	11597317_87	13564	13665	proposed	VBN	13591	13599	O	[None]	[None]	[None]
2475	11597317	11597317_87	13564	13665	to	TO	13600	13602	O	[None]	[None]	[None]
2476	11597317	11597317_87	13564	13665	suppress	VB	13603	13611	O	[None]	[None]	[None]
2477	11597317	11597317_87	13564	13665	RAD51	NNP	13612	13617	B	['PR_reasoned_2017_04_17_Instance_30169']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2478	11597317	11597317_87	13564	13665	–	NNP	13617	13618	O	[None]	[None]	[None]
2479	11597317	11597317_87	13564	13665	BRCA2	NNP	13618	13623	B	['PR_reasoned_2017_04_17_Instance_30155']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2480	11597317	11597317_87	13564	13665	interactions	NNS	13624	13636	O	[None]	[None]	[None]
2481	11597317	11597317_87	13564	13665	until	IN	13637	13642	O	[None]	[None]	[None]
2482	11597317	11597317_87	13564	13665	DNA	NNP	13643	13646	O	[None]	[None]	[None]
2483	11597317	11597317_87	13564	13665	damage	NN	13647	13653	O	[None]	[None]	[None]
2484	11597317	11597317_87	13564	13665	is	VBZ	13654	13656	O	[None]	[None]	[None]
2485	11597317	11597317_87	13564	13665	present	JJ	13657	13664	O	[None]	[None]	[None]
2486	11597317	11597317_87	13564	13665	.	.	13664	13665	O	[None]	[None]	[None]
2487	11597317	11597317_88	13666	13772	When	WRB	13666	13670	O	[None]	[None]	[None]
2488	11597317	11597317_88	13666	13772	damage	NN	13671	13677	O	[None]	[None]	[None]
2489	11597317	11597317_88	13666	13772	occurs	VBZ	13678	13684	O	[None]	[None]	[None]
2490	11597317	11597317_88	13666	13772	,	,	13684	13685	O	[None]	[None]	[None]
2491	11597317	11597317_88	13666	13772	Rad51	NNP	13686	13691	B	['PR_reasoned_2017_04_17_Instance_30171']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2492	11597317	11597317_88	13666	13772	is	VBZ	13692	13694	O	[None]	[None]	[None]
2493	11597317	11597317_88	13666	13772	recruited	VBN	13695	13704	O	[None]	[None]	[None]
2494	11597317	11597317_88	13666	13772	to	TO	13705	13707	O	[None]	[None]	[None]
2495	11597317	11597317_88	13666	13772	damaged	VB	13708	13715	O	[None]	[None]	[None]
2496	11597317	11597317_88	13666	13772	sites	NNS	13716	13721	O	[None]	[None]	[None]
2497	11597317	11597317_88	13666	13772	where	WRB	13722	13727	O	[None]	[None]	[None]
2498	11597317	11597317_88	13666	13772	is	VBZ	13728	13730	O	[None]	[None]	[None]
2499	11597317	11597317_88	13666	13772	polymerizes	VBN	13731	13742	O	[None]	[None]	[None]
2500	11597317	11597317_88	13666	13772	into	IN	13743	13747	O	[None]	[None]	[None]
2501	11597317	11597317_88	13666	13772	nucleoprotein	JJ	13748	13761	O	[None]	[None]	[None]
2502	11597317	11597317_88	13666	13772	filaments	NNS	13762	13771	O	[None]	[None]	[None]
2503	11597317	11597317_88	13666	13772	.	.	13771	13772	O	[None]	[None]	[None]
2504	11597317	11597317_89	13773	13960	In	IN	13773	13775	O	[None]	[None]	[None]
2505	11597317	11597317_89	13773	13960	this	DT	13776	13780	O	[None]	[None]	[None]
2506	11597317	11597317_89	13773	13960	model	NN	13781	13786	O	[None]	[None]	[None]
2507	11597317	11597317_89	13773	13960	,	,	13786	13787	O	[None]	[None]	[None]
2508	11597317	11597317_89	13773	13960	BRCA2	NNP	13788	13793	B	['PR_reasoned_2017_04_17_Instance_30157']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2509	11597317	11597317_89	13773	13960	is	VBZ	13794	13796	O	[None]	[None]	[None]
2510	11597317	11597317_89	13773	13960	not	RB	13797	13800	O	[None]	[None]	[None]
2511	11597317	11597317_89	13773	13960	required	VBN	13801	13809	O	[None]	[None]	[None]
2512	11597317	11597317_89	13773	13960	for	IN	13810	13813	O	[None]	[None]	[None]
2513	11597317	11597317_89	13773	13960	assembly	NN	13814	13822	O	[None]	[None]	[None]
2514	11597317	11597317_89	13773	13960	of	IN	13823	13825	O	[None]	[None]	[None]
2515	11597317	11597317_89	13773	13960	functional	JJ	13826	13836	O	[None]	[None]	[None]
2516	11597317	11597317_89	13773	13960	complexes	NNS	13837	13846	O	[None]	[None]	[None]
2517	11597317	11597317_89	13773	13960	at	IN	13847	13849	O	[None]	[None]	[None]
2518	11597317	11597317_89	13773	13960	damaged	VBN	13850	13857	O	[None]	[None]	[None]
2519	11597317	11597317_89	13773	13960	sites	NNS	13858	13863	O	[None]	[None]	[None]
2520	11597317	11597317_89	13773	13960	,	,	13863	13864	O	[None]	[None]	[None]
2521	11597317	11597317_89	13773	13960	only	RB	13865	13869	O	[None]	[None]	[None]
2522	11597317	11597317_89	13773	13960	to	TO	13870	13872	O	[None]	[None]	[None]
2523	11597317	11597317_89	13773	13960	prevent	VB	13873	13880	O	[None]	[None]	[None]
2524	11597317	11597317_89	13773	13960	a	DT	13881	13882	O	[None]	[None]	[None]
2525	11597317	11597317_89	13773	13960	substantial	JJ	13883	13894	O	[None]	[None]	[None]
2526	11597317	11597317_89	13773	13960	fraction	NN	13895	13903	O	[None]	[None]	[None]
2527	11597317	11597317_89	13773	13960	of	IN	13904	13906	O	[None]	[None]	[None]
2528	11597317	11597317_89	13773	13960	Rad51	NNP	13907	13912	B	['PR_reasoned_2017_04_17_Instance_30173']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2529	11597317	11597317_89	13773	13960	from	IN	13913	13917	O	[None]	[None]	[None]
2530	11597317	11597317_89	13773	13960	being	VBG	13918	13923	O	[None]	[None]	[None]
2531	11597317	11597317_89	13773	13960	sequestered	VBN	13924	13935	O	[None]	[None]	[None]
2532	11597317	11597317_89	13773	13960	in	IN	13936	13938	O	[None]	[None]	[None]
2533	11597317	11597317_89	13773	13960	a	DT	13939	13940	O	[None]	[None]	[None]
2534	11597317	11597317_89	13773	13960	nonfunctional	JJ	13941	13954	O	[None]	[None]	[None]
2535	11597317	11597317_89	13773	13960	form	NN	13955	13959	O	[None]	[None]	[None]
2536	11597317	11597317_89	13773	13960	.	.	13959	13960	O	[None]	[None]	[None]
2537	11597317	11597317_90	13961	14103	In	IN	13961	13963	O	[None]	[None]	[None]
2538	11597317	11597317_90	13961	14103	a	DT	13964	13965	O	[None]	[None]	[None]
2539	11597317	11597317_90	13961	14103	BRCA2	NNP	13966	13971	B	['PR_reasoned_2017_04_17_Instance_30159']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2540	11597317	11597317_90	13961	14103	-	:	13971	13972	O	[None]	[None]	[None]
2541	11597317	11597317_90	13961	14103	defective	NN	13972	13981	O	[None]	[None]	[None]
2542	11597317	11597317_90	13961	14103	cell	NN	13982	13986	O	[None]	[None]	[None]
2543	11597317	11597317_90	13961	14103	,	,	13986	13987	O	[None]	[None]	[None]
2544	11597317	11597317_90	13961	14103	mutant	JJ	13988	13994	O	[None]	[None]	[None]
2545	11597317	11597317_90	13961	14103	Rad51	NNP	13995	14000	B	['PR_reasoned_2017_04_17_Instance_30175']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2546	11597317	11597317_90	13961	14103	becomes	NNS	14001	14008	O	[None]	[None]	[None]
2547	11597317	11597317_90	13961	14103	associated	VBN	14009	14019	O	[None]	[None]	[None]
2548	11597317	11597317_90	13961	14103	with	IN	14020	14024	O	[None]	[None]	[None]
2549	11597317	11597317_90	13961	14103	DNA	NNP	14025	14028	O	[None]	[None]	[None]
2550	11597317	11597317_90	13961	14103	at	IN	14029	14031	O	[None]	[None]	[None]
2551	11597317	11597317_90	13961	14103	random	NN	14032	14038	O	[None]	[None]	[None]
2552	11597317	11597317_90	13961	14103	sites	NNS	14039	14044	O	[None]	[None]	[None]
2553	11597317	11597317_90	13961	14103	and	CC	14045	14048	O	[None]	[None]	[None]
2554	11597317	11597317_90	13961	14103	is	VBZ	14049	14051	O	[None]	[None]	[None]
2555	11597317	11597317_90	13961	14103	therefore	RB	14052	14061	O	[None]	[None]	[None]
2556	11597317	11597317_90	13961	14103	not	RB	14062	14065	O	[None]	[None]	[None]
2557	11597317	11597317_90	13961	14103	readily	RB	14066	14073	O	[None]	[None]	[None]
2558	11597317	11597317_90	13961	14103	recruited	VBN	14074	14083	O	[None]	[None]	[None]
2559	11597317	11597317_90	13961	14103	to	TO	14084	14086	O	[None]	[None]	[None]
2560	11597317	11597317_90	13961	14103	sites	NNS	14087	14092	O	[None]	[None]	[None]
2561	11597317	11597317_90	13961	14103	of	IN	14093	14095	O	[None]	[None]	[None]
2562	11597317	11597317_90	13961	14103	damage	NN	14096	14102	O	[None]	[None]	[None]
2563	11597317	11597317_90	13961	14103	.	.	14102	14103	O	[None]	[None]	[None]
2564	11597317	11597317_91	14104	14128	(	(	14104	14105	O	[None]	[None]	[None]
2565	11597317	11597317_91	14104	14128	b	NN	14105	14106	O	[None]	[None]	[None]
2566	11597317	11597317_91	14104	14128	)	)	14106	14107	O	[None]	[None]	[None]
2567	11597317	11597317_91	14104	14128	Positive	NNP	14108	14116	O	[None]	[None]	[None]
2568	11597317	11597317_91	14104	14128	regulation	NN	14117	14127	O	[None]	[None]	[None]
2569	11597317	11597317_91	14104	14128	.	.	14127	14128	O	[None]	[None]	[None]
2570	11597317	11597317_92	14129	14252	BRCA2	NNP	14129	14134	B	['PR_reasoned_2017_04_17_Instance_30161']	['PR:000004804']	['breast cancer type 2 susceptibility protein']
2571	11597317	11597317_92	14129	14252	is	VBZ	14135	14137	O	[None]	[None]	[None]
2572	11597317	11597317_92	14129	14252	proposed	VBN	14138	14146	O	[None]	[None]	[None]
2573	11597317	11597317_92	14129	14252	to	TO	14147	14149	O	[None]	[None]	[None]
2574	11597317	11597317_92	14129	14252	be	VB	14150	14152	O	[None]	[None]	[None]
2575	11597317	11597317_92	14129	14252	required	VBN	14153	14161	O	[None]	[None]	[None]
2576	11597317	11597317_92	14129	14252	for	IN	14162	14165	O	[None]	[None]	[None]
2577	11597317	11597317_92	14129	14252	Rad51	NNP	14166	14171	B	['PR_reasoned_2017_04_17_Instance_30177']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2578	11597317	11597317_92	14129	14252	to	TO	14172	14174	O	[None]	[None]	[None]
2579	11597317	11597317_92	14129	14252	assemble	VB	14175	14183	O	[None]	[None]	[None]
2580	11597317	11597317_92	14129	14252	into	IN	14184	14188	O	[None]	[None]	[None]
2581	11597317	11597317_92	14129	14252	functional	JJ	14189	14199	O	[None]	[None]	[None]
2582	11597317	11597317_92	14129	14252	recombinational	JJ	14200	14215	O	[None]	[None]	[None]
2583	11597317	11597317_92	14129	14252	repair	NN	14216	14222	O	[None]	[None]	[None]
2584	11597317	11597317_92	14129	14252	complexes	NNS	14223	14232	O	[None]	[None]	[None]
2585	11597317	11597317_92	14129	14252	at	IN	14233	14235	O	[None]	[None]	[None]
2586	11597317	11597317_92	14129	14252	sites	NNS	14236	14241	O	[None]	[None]	[None]
2587	11597317	11597317_92	14129	14252	of	IN	14242	14244	O	[None]	[None]	[None]
2588	11597317	11597317_92	14129	14252	damage	NN	14245	14251	O	[None]	[None]	[None]
2589	11597317	11597317_92	14129	14252	.	.	14251	14252	O	[None]	[None]	[None]
2590	11597317	11597317_93	14253	14358	In	IN	14253	14255	O	[None]	[None]	[None]
2591	11597317	11597317_93	14253	14358	BRCA	NNP	14256	14260	O	[None]	[None]	[None]
2592	11597317	11597317_93	14253	14358	-	:	14260	14261	O	[None]	[None]	[None]
2593	11597317	11597317_93	14253	14358	defective	JJ	14261	14270	O	[None]	[None]	[None]
2594	11597317	11597317_93	14253	14358	cells	NNS	14271	14276	O	[None]	[None]	[None]
2595	11597317	11597317_93	14253	14358	,	,	14276	14277	O	[None]	[None]	[None]
2596	11597317	11597317_93	14253	14358	Rad51	NNP	14278	14283	B	['PR_reasoned_2017_04_17_Instance_30179']	['PR:000013672']	['DNA repair protein RAD51 homolog 1']
2597	11597317	11597317_93	14253	14358	fails	VBZ	14284	14289	O	[None]	[None]	[None]
2598	11597317	11597317_93	14253	14358	to	TO	14290	14292	O	[None]	[None]	[None]
2599	11597317	11597317_93	14253	14358	associate	VB	14293	14302	O	[None]	[None]	[None]
2600	11597317	11597317_93	14253	14358	with	IN	14303	14307	O	[None]	[None]	[None]
2601	11597317	11597317_93	14253	14358	sites	NNS	14308	14313	O	[None]	[None]	[None]
2602	11597317	11597317_93	14253	14358	of	IN	14314	14316	O	[None]	[None]	[None]
2603	11597317	11597317_93	14253	14358	damage	NN	14317	14323	O	[None]	[None]	[None]
2604	11597317	11597317_93	14253	14358	due	JJ	14324	14327	O	[None]	[None]	[None]
2605	11597317	11597317_93	14253	14358	to	TO	14328	14330	O	[None]	[None]	[None]
2606	11597317	11597317_93	14253	14358	lack	VB	14331	14335	O	[None]	[None]	[None]
2607	11597317	11597317_93	14253	14358	of	IN	14336	14338	O	[None]	[None]	[None]
2608	11597317	11597317_93	14253	14358	an	DT	14339	14341	O	[None]	[None]	[None]
2609	11597317	11597317_93	14253	14358	assembly	NN	14342	14350	O	[None]	[None]	[None]
2610	11597317	11597317_93	14253	14358	factor	NN	14351	14357	O	[None]	[None]	[None]
2611	11597317	11597317_93	14253	14358	.	.	14357	14358	O	[None]	[None]	[None]
